WO2024005082A1 - Anti-viral decorative sheet, and anti-viral adhesive processed sheet and anti-viral decorative board each using same - Google Patents

Anti-viral decorative sheet, and anti-viral adhesive processed sheet and anti-viral decorative board each using same Download PDF

Info

Publication number
WO2024005082A1
WO2024005082A1 PCT/JP2023/024007 JP2023024007W WO2024005082A1 WO 2024005082 A1 WO2024005082 A1 WO 2024005082A1 JP 2023024007 W JP2023024007 W JP 2023024007W WO 2024005082 A1 WO2024005082 A1 WO 2024005082A1
Authority
WO
WIPO (PCT)
Prior art keywords
antiviral
layer
curable resin
resin layer
decorative sheet
Prior art date
Application number
PCT/JP2023/024007
Other languages
French (fr)
Japanese (ja)
Inventor
智美 中島
陽亮 住田
梨紗 良波
雅貴 和田
利成 茅原
Original Assignee
大日本印刷株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大日本印刷株式会社 filed Critical 大日本印刷株式会社
Publication of WO2024005082A1 publication Critical patent/WO2024005082A1/en

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00Layered products comprising a layer of synthetic resin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00Layered products comprising a layer of synthetic resin
    • B32B27/18Layered products comprising a layer of synthetic resin characterised by the use of special additives
    • EFIXED CONSTRUCTIONS
    • E04BUILDING
    • E04FFINISHING WORK ON BUILDINGS, e.g. STAIRS, FLOORS
    • E04F13/00Coverings or linings, e.g. for walls or ceilings
    • E04F13/07Coverings or linings, e.g. for walls or ceilings composed of covering or lining elements; Sub-structures therefor; Fastening means therefor

Definitions

  • the present invention relates to an antiviral decorative sheet, an antiviral adhesive processed sheet using the same, and an antiviral decorative board, and in particular an antiviral decorative sheet having antiviral properties against non-enveloped viruses, and an antiviral decorative sheet using the same.
  • the present invention relates to an antiviral adhesive sheet and an antiviral decorative board.
  • decorative sheets have been used for surface decoration of fittings, floors, walls, etc. used as interior materials of buildings.
  • decorative sheets are widely used that are composed of a laminate that has a base sheet, a transparent resin layer, and a surface protective layer in order in the thickness direction, and decorations can be applied on the base sheet as necessary.
  • a primer layer may be provided between the transparent resin layer and the surface protection layer to improve adhesion, and an ionizing radiation curing type may be added to the resin component of the surface protection layer to increase the scratch resistance of the surface protection layer. It is known that it contains resin.
  • Patent Document 1 states that ⁇ a surface protective layer formed of a single layer or a multilayer is provided on a base sheet, and an antiviral agent is provided on the outermost layer located on the outermost surface of the surface protective layer. "A decorative sheet to which is added.” is disclosed.
  • Patent Document 1 discloses that the antiviral agent contains at least one of a carboxylic acid material, a sulfonic acid material, or a quaternary ammonium salt as an organic material, so that it is effective against both enveloped viruses and non-enveloped viruses. It is stated that an antiviral effect is exhibited (Claim 7 and paragraphs [0044] to [0047]). However, in the Examples of Patent Document 1, it is stated that antiviral properties against enveloped viruses were confirmed as an antiviral performance test, but antiviral properties against non-enveloped viruses were not specifically confirmed.
  • enveloped viruses can be inactivated relatively easily by destroying the envelope (lipid layer), so it is easy to obtain an antiviral effect with a wide variety of known antiviral agents, and the effect can be expressed even with a small amount added. Since it is easy to use, it is possible to impart antiviral performance while maintaining the surface performance that the surface protective layer should originally have.
  • non-enveloped viruses are relatively difficult to inactivate, and it is difficult to obtain the same effect with the same antiviral agent and the same additive amount as for enveloped viruses. In order to obtain the same effect with the same antiviral agent, it is necessary to increase the amount added, which poses a problem that the surface performance that the surface protective layer should originally have may be inhibited.
  • the present inventors have discovered that the above object can be achieved by containing a specific antiviral agent in the surface protective layer, and have completed the present invention.
  • a decorative sheet comprising a crosslinked curable resin layer on the outermost layer, (1)
  • the crosslinked curable resin layer contains a cured product of a crosslinked curable resin and an antiviral agent
  • the antiviral agent is an antiviral agent having antiviral properties against non-enveloped viruses, and contains a carboxylic acid derivative and a styrene polymer derivative, and at least triethylamine, N , N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1,3-propanediamine
  • An antiviral cosmetic sheet characterized by: 2.
  • the antiviral agent contains triethylamine, N,N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1, as constituent components of the styrene polymer derivative.
  • the antiviral decorative sheet according to item 1 above which contains all of 3-propanediamine. 3.
  • the antiviral decorative sheet according to item 1 or 2 wherein the crosslinked curable resin layer has fine irregularities having an arithmetic mean roughness Ra of 0.1 ⁇ m or more on the outermost surface. 4.
  • the central point of the antiviral agent that accounts for 50% or more of the entire antiviral agent is the middle layer.
  • the antiviral decorative sheet according to any one of items 1 to 7 above, which is present in the upper layer is present in the upper layer.
  • any one of items 1 to 13 above which is composed of a laminate comprising at least a base sheet, a picture pattern layer, a transparent thermoplastic resin layer, and the crosslinked curable resin layer in order in the thickness direction.
  • An antiviral adhesive processed sheet comprising a laminate comprising at least an adhesive sheet and an antiviral decorative sheet according to any one of items 1 to 15 above, in order in the thickness direction. 17.
  • An antiviral decorative board comprising a laminate comprising at least a decorative board base material and an antiviral decorative sheet according to any one of items 1 to 15 above, in order in the thickness direction. 18.
  • An antiviral decorative board comprising a laminate including at least a decorative board base material and an antiviral pressure-sensitive adhesive sheet according to item 16 above, in order in the thickness direction.
  • the antiviral decorative sheet of the present invention contains a specific antiviral agent in the crosslinked curable resin layer (surface protective layer), which is the outermost layer, so that the surface performance of the surface protective layer (scratch resistance, impact resistance, It is possible to exhibit an antiviral effect particularly against non-enveloped viruses while maintaining arbitrary surface properties that a surface protective layer should originally have, such as chemical resistance.
  • the decorative sheet can be made into an antiviral adhesive processed sheet by being combined with an adhesive sheet, and the decorative sheet and the adhesive processed sheet can be made into an antiviral decorative board by being combined with a decorative laminate base material, respectively.
  • FIG. 1 is a schematic cross-sectional view showing an example of an antiviral decorative sheet of the present invention.
  • FIG. 1 is a schematic cross-sectional view showing an example of an antiviral pressure-sensitive adhesive sheet of the present invention.
  • FIG. 1 is a cross-sectional view schematically showing an example of the constituent members of the antiviral decorative board of the present invention.
  • FIG. 2 is a schematic cross-sectional view for explaining the relationship between the thickness A of the smooth portion of the crosslinked curable resin layer (surface protective layer) of the antiviral decorative sheet of the present invention and the position of the center point of the antiviral agent. It is a figure which shows the diamond indenter (a) used for the measurement of Martens hardness in this specification, the schematic diagram (b) of indentation operation, and an example of indentation load and displacement (c).
  • the antiviral decorative sheet of the present invention (hereinafter also referred to as “the decorative sheet of the present invention") is a decorative sheet comprising a crosslinked curable resin layer on the outermost layer, (1)
  • the crosslinked curable resin layer contains a cured product of a crosslinked curable resin and an antiviral agent
  • the antiviral agent is an antiviral agent having antiviral properties against non-enveloped viruses, and contains a carboxylic acid derivative and a styrene polymer derivative, and at least triethylamine, N , N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1,3-propanediamine, It is characterized by
  • the decorative sheet of the present invention improves the surface performance (scratch resistance, impact resistance, chemical resistance) of the surface protection layer by containing a specific antiviral agent in the crosslinked curing resin layer (surface protection layer), which is the outermost layer. It is possible to exhibit an antiviral effect particularly against non-enveloped viruses while maintaining the arbitrary surface properties that a surface protective layer should originally have.
  • the decorative sheet can be made into an antiviral adhesive processed sheet by being combined with an adhesive sheet, and the decorative sheet and the adhesive processed sheet can be made into an antiviral decorative board by being combined with a decorative laminate base material, respectively.
  • the decorative sheet of the present invention includes a cross-linked curable resin layer on the outermost layer, and the cross-linked curable resin layer and the antiviral agent contained therein satisfy the predetermined requirements shown in (1) and (2) above. If so, the specific structure (layer structure) is not limited.
  • the decorative sheet of the present invention is composed of a laminate including at least a base sheet, a transparent thermoplastic resin layer, and a crosslinked curable resin layer in this order in the thickness direction. It's okay.
  • the decorative sheet of the present invention is composed of a laminate including, in order in the thickness direction, for example, a base sheet, a pattern layer, a transparent thermoplastic resin layer, and a crosslinked curable resin layer. It's okay.
  • the outermost crosslinked curable resin layer has a role as a so-called surface protective layer.
  • FIG. 1 is a schematic cross-sectional view showing an example of the decorative sheet of the present invention.
  • a pattern layer 3, a transparent adhesive layer 4, a transparent thermoplastic resin layer 5, a primer layer 6, and a cross-linked curable resin layer 7 are laminated in this order on a base sheet 2.
  • a back primer layer 8 is further provided on the back side of the sheet 2.
  • an embossed uneven pattern is formed.
  • the presence mode of the antiviral agent 9 is schematically shown.
  • the thickness of the cross-linked curable resin layer 7 is the thickness shown by A in the figure.
  • a bulge (convex portion) exceeding the thickness A of the smooth portion may be formed by being present on the surface side.
  • fine irregularities may be formed on the outermost surface of the crosslinked curable resin layer 7 in addition to the convex portions caused by the antiviral agent 9. Note that the convex portion shown in FIG. 1 is a bulge caused by the antiviral agent 9, but the antiviral agent 9 itself is not exposed, but is a bulge as a crosslinked curable resin layer.
  • the present invention provides an antiviral adhesive sheet (hereinafter also referred to as "adhesive sheet of the present invention") which is composed of a laminate that includes at least an adhesive sheet and a decorative sheet of the present invention in this order in the thickness direction.
  • the present invention also includes the inventions (for example, the embodiment shown in FIG. 2). Note that although FIG. 2 illustrates the configuration of the adhesive processed sheet 11 that includes the adhesive sheet 10 on the back surface of the decorative sheet 1 shown in FIG. 1, the configuration of the decorative sheet 1 is not limited to this.
  • the present invention provides an antiviral decorative board (hereinafter referred to as " Also included is the invention (for example, the embodiment shown in FIG. 3) (also referred to as “the decorative laminate of the present invention”).
  • the structure of the decorative board 13 which equipped the back surface of the decorative sheet 1 shown in FIG. 1 with the decorative board base material 12 is illustrated.
  • the decorative board 13 may have a configuration in which the decorative board base material 12 is provided on the back surface of the adhesive processed sheet 11 shown in FIG.
  • the surface that is visually recognized after construction of the decorative sheet of the present invention that is, the direction in which the crosslinked curable resin layer (surface protection layer) is laminated when viewed from the base sheet, is referred to as “top” or “front”.
  • the direction in which the back primer layer is laminated when viewed from the base sheet is called the “bottom” or “back surface.”
  • Such a relationship is the same in the case of the adhesive processed sheet of the present invention and the decorative board of the present invention.
  • the side of the cross-linked curable resin layer (surface protective layer)" in the laminate it is also abbreviated as “the cross-linked curable resin layer (surface protective layer) side.”
  • each layer of the decorative sheet of the present invention will be explained using FIG. 1 as an example.
  • the layer structure of the decorative sheet of the present invention is not limited to the embodiment shown in FIG. 1, and as described above, various layer structures can be adopted as a laminate.
  • the lower and upper limits of the numerical range represented by " ⁇ " mean "more than or equal to” (for example, if ⁇ to ⁇ , it is more than or equal to ⁇ and less than or equal to ⁇ ).
  • Base material sheet The base material sheet has picture pattern layers etc. laminated in sequence on its surface (front surface). Note that the outermost layer is a crosslinked curable resin layer (surface protection layer).
  • the base sheet examples include a variety of resin films, paper, resin-impregnated paper, etc.
  • resin films those containing thermoplastic resin as a resin component are preferred.
  • examples include polymers, ionomers, acrylic esters, methacrylic esters, and the like.
  • at least one of polyvinyl chloride and polyolefin can be suitably used.
  • the base sheet may be colored.
  • a coloring agent pigment or dye
  • a coloring agent for example, inorganic pigments such as titanium dioxide, carbon black, and iron oxide, and organic pigments such as phthalocyanine blue, as well as various dyes can be used. One type or two or more types can be selected from these. Further, the amount of the coloring agent added may be appropriately set depending on the desired color tone and the like.
  • the base sheet contains various additives such as fillers, matting agents, foaming agents, flame retardants, lubricants, antistatic agents, antioxidants, ultraviolet absorbers, and light stabilizers as necessary. It may be
  • the thickness of the base sheet can be appropriately set depending on the purpose of the final product, how it is used, etc., but is generally preferably 50 to 250 ⁇ m.
  • the surface (front surface) of the base sheet may be subjected to corona discharge treatment in order to improve the adhesion of the ink forming the picture pattern layer.
  • the method and conditions for the corona discharge treatment may be carried out according to known methods.
  • the back side of the base sheet may be subjected to corona discharge treatment, a picture pattern layer (so-called back print), a back primer layer (described later), a backer layer (described later), etc. Good too.
  • the picture pattern layer is an arbitrary layer that imparts a desired picture (design) to the decorative sheet of the present invention, and the type of picture is not limited. Examples include wood grain patterns, leather patterns, stone grain patterns, sand grain patterns, tiling patterns, brickwork patterns, cloth grain patterns, geometric figures, letters, symbols, abstract patterns, flower patterns, landscapes, characters, and the like.
  • the method of forming the picture pattern layer is not particularly limited, and for example, an ink obtained by dissolving (or dispersing) a known coloring agent (dye or pigment) together with a binder resin in a solvent (or dispersion medium) may be used. It may be formed on the surface of the base sheet by a known printing method.
  • an aqueous composition can also be used from the viewpoint of reducing VOC of the decorative sheet.
  • colorants include inorganic pigments such as carbon black, titanium white, zinc white, Bengara, navy blue, and cadmium red; azo pigments, lake pigments, anthraquinone pigments, quinacridone pigments, phthalocyanine pigments, isoindolinone pigments, and dioxazine pigments.
  • organic pigments such as; metal powder pigments such as aluminum powder and bronze powder; pearlescent pigments such as titanium oxide-coated mica and bismuth chloride oxide; fluorescent pigments; and luminous pigments.
  • These colorants can be used alone or in combination of two or more. These colorants may be used together with fillers such as silica, extender pigments such as organic beads, neutralizing agents, surfactants, and the like.
  • binder resins include polyester, polyacrylate, polyvinyl acetate, polybutadiene, polyvinyl chloride, chlorinated polypropylene, polyethylene, polystyrene, polystyrene-acrylate copolymer, and rosin derivatives. , alcohol adducts of styrene-maleic anhydride copolymers, cellulose resins, etc. can also be used in combination.
  • polyacrylamide resin poly(meth)acrylic acid resin, polyethylene oxide resin, polyN-vinylpyrrolidone resin, water-soluble polyester resin, water-soluble polyamide resin, water-soluble amino type resins, water-soluble phenolic resins, other water-soluble synthetic resins; water-soluble natural polymers such as polynucleotides, polypeptides, and polysaccharides; etc.
  • natural rubber, synthetic rubber, polyvinyl acetate resin, (meth)acrylic resin, polyvinyl chloride resin, polyurethane-polyacrylic resin, or modified products thereof, and other resins may also be used.
  • the above binder resins can be used alone or in combination of two or more.
  • solvent examples include petroleum organic solvents such as hexane, heptane, octane, toluene, xylene, ethylbenzene, cyclohexane, and methylcyclohexane; ethyl acetate, butyl acetate, 2-methoxyethyl acetate, and 2-acetic acid.
  • petroleum organic solvents such as hexane, heptane, octane, toluene, xylene, ethylbenzene, cyclohexane, and methylcyclohexane
  • ethyl acetate butyl acetate
  • 2-methoxyethyl acetate examples include 2-acetic acid.
  • organic solvents such as ethoxyethyl; alcohol organic solvents such as methyl alcohol, ethyl alcohol, n-propyl alcohol, isopropyl alcohol, isobutyl alcohol, ethylene glycol, propylene glycol; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, and cyclohexanone Ether organic solvents such as diethyl ether, dioxane, and tetrahydrofuran; chlorinated organic solvents such as dichloromethane, carbon tetrachloride, trichlorethylene, and tetrachloroethylene; and inorganic solvents such as water.
  • solvents or dispersion media
  • solvents can be used alone or in combination of two or more.
  • Examples of the printing method used to form the picture pattern layer include gravure printing, offset printing, screen printing, flexographic printing, electrostatic printing, and inkjet printing.
  • examples of methods include roll coating, knife coating, air knife coating, die coating, lip coating, comma coating, kiss coating, flow coating, dip coating, etc.
  • Various coating methods such as a coating method can be mentioned.
  • hand-drawing methods, suminagashi methods, photographic methods, transfer methods, laser beam drawing methods, electron beam drawing methods, partial vapor deposition of metals, etching methods, etc. may be used, or they may be used in combination with other forming methods. good.
  • the thickness of the picture pattern layer is not particularly limited and can be set as appropriate depending on the product characteristics, but the layer thickness is approximately 0.1 to 15 ⁇ m.
  • the transparent resin layer is a layer that can be provided arbitrarily, and is not particularly limited as long as it is transparent, and may be colorless and transparent, colored transparent, translucent, or the like.
  • the material of the transparent resin layer is not limited, it is preferably made of thermoplastic resin.
  • thermoplastic resin Specifically, polyvinyl chloride, polyethylene terephthalate, polybutylene terephthalate, polyamide, polyethylene, polypropylene, polycarbonate, polyethylene naphthalate, ethylene-vinyl acetate copolymer, ethylene-acrylic acid copolymer, ethylene-acrylic acid ester copolymer Examples include polymers, ionomers, acrylic esters, methacrylic esters, and the like.
  • the transparent resin layer contains a thermoplastic resin
  • the transparent resin layer is particularly referred to as a "transparent thermoplastic resin layer.”
  • the transparent resin layer may be colored as long as it has transparency.
  • the transparent resin layer may contain various additives such as flame retardants, lubricants, antistatic agents, antioxidants, ultraviolet absorbers, and light stabilizers as necessary. It's okay.
  • the thickness of the transparent resin layer is not limited, but is preferably 40 ⁇ m or more and 300 ⁇ m or less, more preferably 60 ⁇ m or more and 200 ⁇ m or less, and most preferably 60 ⁇ m or more and 100 ⁇ m or less.
  • a transparent adhesive layer may be formed in order to improve the adhesion between the pattern layer and the transparent resin layer or the cross-linked curable resin layer (surface protection layer) described below.
  • the transparent adhesive layer is not particularly limited as long as it is transparent, and may be colorless and transparent, colored and transparent, translucent, or the like.
  • the adhesive is not particularly limited, and adhesives known in the field of decorative sheets can be used.
  • adhesives known in the field of decorative sheets include thermoplastic resins such as polyamide resins, acrylic resins, and vinyl acetate resins, and thermosetting resins such as urethane resins. These adhesives can be used alone or in combination of two or more. Furthermore, a two-component curing type polyurethane resin or polyester resin using isocyanate as a curing agent can also be applied.
  • the thickness of the transparent adhesive layer is not particularly limited, but is approximately 0.1 to 30 ⁇ m, preferably approximately 1 to 20 ⁇ m.
  • Primer layer A primer layer for a crosslinked curable resin layer may be provided on the transparent resin layer.
  • This primer layer has the effect of increasing the adhesion between the transparent resin layer and the cross-linked curable resin layer described below, and in combination with the cross-linked curable resin layer, it can improve the bending processability and scratch resistance of the decorative sheet.
  • the primer layer is not particularly limited as long as it is transparent, and may be colorless and transparent, colored and transparent, translucent, or the like.
  • the primer layer can be formed by applying a known primer agent to the surface of the transparent resin layer.
  • primer agents include acrylic modified urethane resins (acrylic urethane copolymer resins), urethane resin primers made of polycarbonate-based acrylic urethane copolymer resins, and urethane-cellulose resins (for example, urethane and nitrified cotton).
  • a resin-based primer agent made of a block copolymer of acrylic and urethane, etc. may be mentioned.
  • a urethane resin-based primer agent containing a polycarbonate-based acrylic urethane copolymer resin can be preferably used from the viewpoint of scratch resistance and weather resistance.
  • Additives may be added to the primer agent if necessary.
  • additives include weathering agents such as ultraviolet absorbers and light stabilizers; fillers such as silica, calcium carbonate, and clay; flame retardants such as magnesium hydroxide; antioxidants; lubricants; and blowing agents.
  • weathering agents such as ultraviolet absorbers and light stabilizers
  • fillers such as silica, calcium carbonate, and clay
  • flame retardants such as magnesium hydroxide
  • antioxidants such as lubricants
  • blowing agents such as magnesium hydroxide
  • the blending amount of the additive can be appropriately set depending on the product characteristics.
  • examples of the ultraviolet absorber include benzophenone ultraviolet absorbers, benzotriazole ultraviolet absorbers, triazine ultraviolet absorbers, and the like.
  • the light stabilizer for example, hindered amine light stabilizer (HALS) is suitable.
  • HALS hindered amine light stabilizer
  • the content of these weathering agents is not limited, but may be approximately 1,000 to 100,000 ppm by mass for each of the ultraviolet absorber and light stabilizer.
  • the thickness of the primer layer is not limited, but is preferably 0.5 ⁇ m or more and 12 ⁇ m or less, more preferably 1 ⁇ m or more and 8 ⁇ m or less. By setting it within this range, the folding processability and scratch resistance of the decorative sheet can be easily improved by combining with the crosslinked curable resin layer. In addition, it becomes easier to contain additives such as weathering agents, and it becomes easier to impart weather resistance to the decorative sheet.
  • the decorative sheet of the present invention includes a cross-linked curable resin layer (surface protective layer) on the outermost layer, and the cross-linked curable resin layer and the antiviral agent contained therein meet the predetermined conditions shown in (1) and (2) below.
  • the crosslinked curable resin layer contains a cured product of a crosslinked curable resin and an antiviral agent
  • the antiviral agent is an antiviral agent having antiviral properties against non-enveloped viruses, and contains a carboxylic acid derivative and a styrene polymer derivative, and at least triethylamine, N , N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1,3-propanediamine.
  • the crosslinked curable resin is not particularly limited as long as it is transparent, and may be colorless and transparent, colored and transparent, translucent, etc.
  • the resin component of the crosslinked curable resin is not limited, but preferably contains an ionizing radiation curable resin or a two-part curable urethane resin.
  • the material is substantially made of these resins.
  • the outermost layer is formed of an ionizing radiation curable resin or a two-component urethane resin, the abrasion resistance, impact resistance, stain resistance, scratch resistance, weather resistance, etc. of the decorative sheet can be easily improved.
  • ionizing radiation curable resins are preferred.
  • the above C. S. R. As an index of anti-slip property for various uses in terms of value, if it is 0.25 or more (especially 0.25 or more and less than 0.30), it can be judged that it is suitable for fittings, and if it is 0.30 or more (especially 0.30 If the value is 0.38 or more (especially 0.38 or more and less than 0.50), it is considered suitable for use as a normal floor, and if it is 0.38 or more (particularly 0.38 or more and less than 0.50), it is suitable for use as an anti-slip floor that exhibits a high level of anti-slip properties. It can be determined that
  • Ionizing radiation-curable resins are not particularly limited, and include prepolymers (including oligomers) and/or monomers containing radically polymerizable double bonds in their molecules that can be polymerized and crosslinked by irradiation with ionizing radiation such as ultraviolet rays and electron beams.
  • a transparent resin whose main component is These prepolymers or monomers can be used alone or in combination.
  • the curing reaction is usually a crosslinking curing reaction.
  • the prepolymer or monomer is a compound having a radically polymerizable unsaturated group such as a (meth)acryloyl group or a (meth)acryloyloxy group, or a cationically polymerizable functional group such as an epoxy group in the molecule.
  • a polyene/thiol-based prepolymer made of a combination of polyene and polythiol.
  • the (meth)acryloyl group means an acryloyl group or a methacryloyl group.
  • prepolymers having radically polymerizable unsaturated groups include polyester (meth)acrylate, urethane (meth)acrylate, epoxy (meth)acrylate, melamine (meth)acrylate, triazine (meth)acrylate, and silicone (meth)acrylate. etc.
  • the weight average molecular weight of these is usually preferably about 250 to 100,000.
  • the weight average molecular weight in this specification is an average molecular weight measured by GPC analysis (gel permeation chromatography) and converted to standard polystyrene.
  • Examples of the monomer having a radically polymerizable unsaturated group include methyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, phenoxyethyl (meth)acrylate, and the like as monofunctional monomers.
  • polyfunctional monomers examples include diethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, trimethylolpropane ethylene oxide tri(meth)acrylate, dipentaerythritol tetra( Examples thereof include meth)acrylate, dipentaerythritol penta(meth)acrylate, and dipentaerythritol hexa(meth)acrylate.
  • Examples of the prepolymer having a cationically polymerizable functional group include prepolymers of epoxy resins such as bisphenol-type epoxy resins and novolak-type epoxy compounds, and vinyl ether-based resins such as fatty acid vinyl ethers and aromatic vinyl ethers.
  • Examples of the thiol include polythiols such as trimethylolpropane trithioglycolate and pentaerythritol tetrathioglycolate.
  • Examples of the polyene include polyurethane made of diol and diisocyanate with allyl alcohol added to both ends.
  • a mixed resin containing an aliphatic urethane (meth)acrylate oligomer (B) having 15 radically polymerizable unsaturated groups can be used.
  • the crosslinked curable resin layer can be formed. It has the advantage that it is easy to adjust the surface performance according to the application, such as by making it into a form with excellent impact resistance or a form with excellent processing suitability such as V-cut.
  • the content ratio of the oligomer (A) and the oligomer (B) in the ionizing radiation curable resin is not limited, but when the total amount of the oligomer (A) and the oligomer (B) is 100% by mass, the oligomer It is preferable that (A) be in the range of 50 to 90% by mass and the oligomer (B) be in the range of 10 to 50% by mass. Within this range, it is easy to set the Martens hardness of the cross-linked curable resin layer (after curing) to 30 N/mm 2 or more and 180 N/mm 2 or less, and the anti-slip property of the cross-linked curable resin layer can be used for various purposes (slip resistance value (C.S.R. value) of 0.25 or more).
  • a mixed resin containing two types of aliphatic urethane (meth)acrylates, Resin A and Resin B below, can also be used as the ionizing radiation curable resin.
  • (meth)acrylate means acrylate or methacrylate.
  • Resin A is an aliphatic urethane (meth)acrylate having an isocyanurate skeleton, and is not limited as long as it satisfies this requirement.
  • Acrylates are preferred. Specific examples include a trimer of hexamethylene diisocyanate (particularly 1,6-hexamethylene diisocyanate), a trimer of tolylene diisocyanate, a trimer of metaxylene diisocyanate, and the like.
  • tolylene diisocyanate and metaxylene diisocyanate may have inferior weather resistance than hexamethylene diisocyanate in that they have a benzene ring, these diisocyanates are preferably hydrogenated.
  • These resins A have the effect of improving the stain resistance, alkali resistance, etc. of the crosslinked curable resin layer.
  • Resin B is an aliphatic urethane (meth)acrylate that does not have an isocyanurate skeleton but has an alicyclic skeleton, and is not limited as long as it satisfies this requirement, but for example, at least one of isophorone and cyclohexane as the alicyclic skeleton. It is preferable to have.
  • examples include urethane oligomers, which are polymers containing isophorone diisocyanate and butanediol as monomers, with acrylate added to the ends, and PG-modified diacrylates of hydrogenated dicyclohexylmethane diisocyanate (hydrogenated MDI). It will be done.
  • These resins B have the effect of imparting flexibility to the cross-linked curable resin layer, and when combined with resin A, the cross-linked curable resin layer has excellent stain resistance, alkali resistance, etc. over a long period of time, as well as impact resistance. It has the effect of suppressing the occurrence of cracks and cracks when applied or processed.
  • Ionizing radiation-curable resins are mainly composed of prepolymers (including oligomers) and/or monomers that contain radically polymerizable double bonds in their molecules that can be polymerized and crosslinked by irradiation with ionizing radiation such as ultraviolet rays and electron beams.
  • the curing reaction is usually a crosslinking curing reaction.
  • the ionizing radiation used to cure the ionizing radiation curable resin electromagnetic waves or charged particles having energy capable of curing molecules in the ionizing radiation curable resin (composition) are used.
  • ultraviolet rays or electron beams may be used, but visible light, X-rays, ion beams, etc. may also be used.
  • the properties of the raw material resin can be directly reflected in the properties of the resin components of the crosslinked curable resin layer since it does not contain a photopolymerization initiator, and when a weathering agent is used in combination. It is preferable to use an electron beam curable resin from the viewpoint of widening the range of selection.
  • Two-component curable urethane resins are not particularly limited, but include polyol components (acrylic polyols, polyester polyols, polyether polyols, epoxy polyols, etc.) having an OH group as a main component, and isocyanate components (tolylene diethylene chloride) as a curing agent component. isocyanate, hexamethylene diisocyanate, metaxylene diisocyanate, etc.) can be used.
  • crosslinked curable resins exemplified above can be used alone or in combination of two or more.
  • the crosslinked curable resin layer contains an antiviral agent in addition to the cured product of the crosslinked curable resin.
  • Viruses are generally classified into enveloped viruses (having an envelope) and non-enveloped viruses (having no envelope), depending on the presence or absence of an envelope (lipid membrane).
  • Enveloped viruses include, for example, influenza virus, herpes virus, AIDS virus, hepatitis B virus, and the like.
  • non-enveloped viruses include, for example, norovirus, feline calicivirus, rhinovirus, adenovirus, and the like.
  • the antiviral agent used in the present invention (hereinafter also referred to as “the antiviral agent of the present invention”) is an antiviral agent that has antiviral properties against non-enveloped viruses and contains carboxylic acid derivatives and styrene polymer derivatives.
  • the carboxylic acid derivative contains at least triethylamine, N,N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1,3- It is characterized by containing all propanediamine.
  • the antiviral agent of the present invention further contains triethylamine, N,N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2- as constituent components of the styrene polymer derivative.
  • triethylamine, N,N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2- as constituent components of the styrene polymer derivative.
  • all of the tetramethyl-1,3-propanediamine is contained.
  • the carboxylic acid derivative is not limited as long as the above-mentioned predetermined component is detected when the organic structure is analyzed, but examples of preparation methods include, for example, cyclohexanecarboxylic acid (manufactured by Shin Nippon Chemical Co., Ltd.), triethylamine, etc.
  • a carboxylic acid derivative can be prepared by mixing and reacting raw materials containing 1,3-propanediamine (manufactured by Tokyo Chemical Industry Co., Ltd.).
  • the styrene polymer derivative is preferably one in which the above-described predetermined constituent components are detected when the organic structure is analyzed, and examples of preparation methods include, for example, sodium p-styrene sulfonate (manufactured by Tosoh Corporation). ; trade name "Spinomer NaSS”), styrene monomer (manufactured by Wako Pure Chemical Industries, Ltd.), and denatured ethanol (manufactured by Wako Pure Chemical Industries, Ltd.; trade name "86% Ethanol-ME”) are mixed and reacted to form a styrene polymer. Derivatives can be prepared.
  • the antiviral agent of the present invention can be produced by mixing (kneading) the above carboxylic acid derivative and the above styrene polymer derivative at a desired mixing ratio, and pulverizing the mixture to a desired size using a known pulverizing means such as a jet mill. It can be prepared.
  • the content ratio of the carboxylic acid derivative and the styrene polymer derivative is not limited, it is preferable that the mass ratio is 1:1 to 10:1, and 2:1 to 5:1. It is more preferable that there be. By setting such a content ratio (mixing ratio), it becomes easier to obtain an antiviral effect against non-enveloped viruses.
  • the shape of the antiviral agent (primary particles) of the present invention is not limited, but examples thereof include spheres, ellipsoids, polyhedrons, scales, and the like.
  • the average particle diameter of the antiviral agent of the present invention is not limited, but it is preferably 2 ⁇ m or more and 15 ⁇ m or less, and more preferably 3 ⁇ m or more and 12 ⁇ m or less. Note that the average particle diameter in this specification is a value specified as the mass average value D50 in particle size distribution measurement by laser light diffraction method.
  • the antiviral agent of the present invention has antiviral properties against viruses (particularly non-enveloped viruses) is presumed as follows, but is not limited to the mechanism presumed below.
  • Various viruses bind to sugar chain receptors on the surface of host cells (the sugar chain end is neuraminic acid) and invade into host cells, but the antiviral agent of the present invention has an ionic group similar to neuraminic acid, so it By binding to and capturing the virus instead of cells, it is thought to prevent the virus from binding to host cell receptors and exert an antiviral effect.
  • the plurality of amino groups described above that are constituents of the carboxylic acid derivative bind (capture) to the spike protein of an enveloped virus and the capsid (protein shell) of a non-enveloped virus.
  • enveloped viruses are thought to be inactivated by the sulfonic acid groups of styrene polymer derivatives destroying their envelopes, and non-enveloped viruses are thought to be inactivated by the carboxyl groups of carboxylic acid derivative compounds oxidizing capsids. It will be done.
  • the sulfonic acid group is thought to mainly contribute to the destruction of the envelope, but since it has oxidizing power, it is also involved in the oxidation of the capsid of non-enveloped viruses, just like the carboxy group. Therefore, in order to efficiently inactivate non-enveloped viruses and also inactivate enveloped viruses, it is effective to use a carboxylic acid derivative and a styrene polymer derivative at the same time.
  • the antiviral agent of the present invention has an advantage over conventional products in that it can inactivate non-enveloped viruses at a content that does not impede the surface performance of the surface protective layer, but there is also a presumed mechanism for inactivating enveloped viruses. As described above, the antiviral agent of the present invention has an antiviral effect not only against non-enveloped viruses but also against enveloped viruses.
  • the content of the antiviral agent of the present invention with respect to 100 parts by mass of the crosslinked curable resin is preferably 1 part by mass or more and 10 parts by mass or less, more preferably 2 parts by mass or more and 6 parts by mass or less. Within this content range, a predetermined antiviral effect can generally be exhibited without affecting the surface performance of the surface protective layer.
  • the thickness of the cross-linked curable resin layer is preferably such that the average thickness of the smooth portion is 2 ⁇ m or more when the cross-linked curable resin layer does not have convex portions caused by the antiviral agent of the present invention.
  • the average thickness of the smooth portion excluding the convex portions is 2 ⁇ m or more.
  • the average thickness of the smooth portion is preferably 4 ⁇ m or more among 2 ⁇ m or more, and the upper limit of the average thickness is about 35 ⁇ m.
  • the average thickness of the cross-linked curable resin layer is determined by the thickness of the flat area (thickness A in FIG. In this specification, it means the average value of the thickness of arbitrary 10 points in the width of 1 cm of the cross-sectional observation image of the cross-linked curable resin layer. "Width" is a direction perpendicular to the thickness direction.
  • the crosslinked curable resin layer is formed by applying a composition for forming a crosslinked curable resin layer containing a crosslinked curable resin and the antiviral agent of the present invention onto the primer layer by a known coating method such as gravure coating or roll coating. It can be formed by curing the resin after coating. Specifically, after coating the composition for forming a cross-linked curable resin layer, the antiviral agent of the present invention lifts up in the coating film before it is completely cured, so that it reaches the outermost surface of the cross-linked curable resin layer. Even if protrusions are formed due to the antiviral agent, or the antiviral agent partially aggregates in the coating film, and the particle size of the antiviral agent becomes larger in appearance, there is no problem with the expression of antiviral performance. None.
  • the thickness of the smooth part of the cross-linked curable resin layer is divided into three equal parts and divided into a lower layer, a middle layer, and an upper layer, 50% or more of the entire antiviral agent of the present invention (the entire number) It is preferable that the central point of the antiviral agent exists in the middle layer or the upper layer (that is, the middle layer or above).
  • FIG. 4 exemplarily shows the relationship between the thickness A of the smooth portion of the crosslinked curable resin layer and the position of the center point of the antiviral agent.
  • the position of the center point of the antiviral agent is the middle layer or upper layer of the thickness of the smooth part of the crosslinked curing resin layer (the middle layer includes the lower layer).
  • the antiviral agent 9-3 is an example in which the central point of the antiviral agent exists in the lower layer. .
  • the center point of the antiviral agent is determined by drawing a circle with the smallest diameter in the cross-sectional observation image of the cross-linked cured resin layer so that the antiviral agent of the present invention, which has various shapes that are not necessarily circular, can be completely accommodated.
  • the center of is set as the center point.
  • the proportion of the central point of the antiviral agent of the present invention in the middle layer or upper layer is preferably 50% or more, more preferably 67% or more, as described above. Within this range, the antiviral effect of the antiviral agent of the present invention can be easily obtained.
  • the content of the antiviral agent of the present invention is 10 parts by mass or less with respect to 100 parts by mass of the crosslinked curable resin, it generally does not affect the surface performance of the surface protective layer. It is possible to exert the desired antiviral effect without any need for treatment.
  • the cut surface was observed using a digital microscope (manufactured by Keyence Corporation, model number: This is done by observing with a VHX-7000 (magnification: 200x).
  • the crosslinked curable resin layer has fine irregularities with an arithmetic mean roughness Ra of 0.1 ⁇ m or more on the outermost surface.
  • Such fine irregularities may be formed due to the antiviral agent by lifting the antiviral agent, or may be formed by physical processing such as sandblasting or fine embossing.
  • the arithmetic mean roughness Ra of the outermost surface is more preferably 1.0 ⁇ m or more, and the preferable upper limit of Ra is about 40 ⁇ m or less. Since the surface area of the outermost surface increases due to the formation of such fine irregularities, it becomes easier to obtain an antiviral effect compared to a case without fine irregularities.
  • the arithmetic mean roughness Ra in this specification is a value measured by a surface roughness measuring device (“SURFCOM-FLEX-50A”, manufactured by Tokyo Seimitsu Co., Ltd.) in accordance with JIS B0601 (2001).
  • the Martens hardness of the crosslinked curable resin layer is preferably 30 N/mm 2 or more and 180 N/mm 2 or less, more preferably 60 N/mm 2 or more and 180 N/mm 2 or less.
  • the Martens hardness in this specification is a value measured using a Martens hardness measuring device PICODENTOR HM-500 (manufactured by Fisher Instruments) in accordance with ISO14577. Specifically, the measurement is performed by using a diamond indenter (Vickers indenter) shown in FIG. 5(a) and pushing the diamond indenter into the measurement sample as shown in FIG. 5(b). The indentation conditions were as shown in Figure 5(c) at room temperature (laboratory environment temperature), first a load of 0 to 5 mN was applied for 10 seconds, then a load of 5 mN was held for 5 seconds, and finally a load of 5 mN was applied for 10 seconds. Unload to ⁇ 0 mN in 10 seconds.
  • the Martens hardness of the cross-section of the cross-linked curable resin layer was measured in order to avoid the influence of the hardness of layers other than the cross-linked curable resin layer.
  • the decorative sheet is embedded in a resin (resin such as a cold-curing type epoxy two-component curing resin or UV-curing resin), and is left at room temperature (23 ⁇ 5°C) for at least 24 hours to harden. , cut the cured embedding sample, mechanically polish it to expose the cross-section of the cross-linked cured resin layer, and place it on the cross-section (if fine particles such as fillers are included in the layer, avoid the fine particles). ) The Martens hardness of the cross section was measured by indenting it with a diamond indenter.
  • the slip resistance value (C.S.R. value) is used as an index of anti-slip property. It becomes easier to adjust the value to 0.25 or more.
  • C. S. R. the slip resistance value
  • the slip resistance value (C.S.R. value) in this specification is the slip resistance value (C.S.R.
  • the Martens hardness of the cross-linked curable resin layer is 30 N/mm 2 or more and 180 N/mm 2 or less
  • the corresponding Martens hardness of the base sheet and/or transparent thermoplastic resin layer is, for example, 30 N/mm 2 or more and 180 N/mm 2 or less. /mm 2 or more and 80 N/mm 2 or less.
  • a phenyl ether derivative compound can be contained in the crosslinked curable resin layer in order to complement the antiviral performance of the crosslinked curable resin layer.
  • phenyl ether derivative compounds include polyoxyethylene alkyl ether, which is known to exhibit antiviral performance as an ether type nonionic surfactant.
  • the cross-linked curable resin layer contains coloring agents such as dyes and pigments, fillers such as inorganic fillers, weathering agents, and antifoaming agents within the range that does not affect the surface performance of the surface protective layer and the specified antiviral properties.
  • Various additives may be added, such as a leveling agent, a thixotropic agent, a flame retardant, an antibacterial agent different from the antiviral agent, and an antiallergen agent different from the antiviral agent.
  • a leveling agent such as a thixotropic agent, a flame retardant, an antibacterial agent different from the antiviral agent, and an antiallergen agent different from the antiviral agent.
  • an embodiment may be adopted in which, in addition to the antiviral agent, at least one selected from the group consisting of an antibacterial agent and an antiallergen agent is further included.
  • inorganic fillers are often used mainly as matting agents, but by including an inorganic filler in the crosslinked curable resin layer, it can also be
  • the above antibacterial agents include inorganic antibacterial agents and organic antibacterial agents.
  • inorganic antibacterial agents are desirable because they are generally safer than organic antibacterial agents and have excellent durability and heat resistance.
  • the inorganic antibacterial agent refers to one in which antibacterial metals such as silver, copper, and zinc are supported on various inorganic carriers.
  • silver-containing inorganic antibacterial agents silver-containing inorganic particles
  • specifically silver-supported zeolite particles are preferred.
  • the above anti-allergen agent contains either an inorganic compound or an organic compound, and each may be used alone, or two or more different types may be mixed.
  • the inorganic compound is preferably a material supporting a metal.
  • an agent similar or the same as an antibacterial agent may also be effective.
  • the content of the antibacterial agent and antiallergen agent may be optimized so as to obtain the desired antibacterial property and the desired antiallergenic property.
  • the inorganic material of the inorganic compound is preferably at least one selected from the group consisting of titanium oxide, calcium phosphate, calcium silicate, zirconium phosphate, zeolite, silica alumina, magnesium silicate, and magnesium phosphate, among which titanium oxide and phosphorus are preferred. Acid zirconium etc. are preferred.
  • the metal supported on the inorganic material is preferably at least one selected from the group consisting of silver, gold, platinum, zinc, and copper, and among these, zinc is preferred.
  • "Atomy Ball TZ-R: Zinc supported on titanium oxide” manufactured by JGC Shokubai can be suitably used, and these anti-allergen agents are effective against various allergens such as dust mites and pollen. It acts on
  • organic compound at least one monomer component selected from the group consisting of water-insoluble polymers containing phenolic hydroxyl groups or polyphenol compounds supported on inorganic solid acids, styrene sulfonic acid and salts thereof; It is preferable that it is a polymer containing.
  • water-insoluble polymers containing phenolic hydroxyl groups As water-insoluble polymers containing phenolic hydroxyl groups, commercially available products such as “Aller Buster (trade name)” manufactured by Sekisui Chemical Co., Ltd. and “Maruka Linker M (trade name)” manufactured by Maruzen Sekiyu Co., Ltd. are used. can do. Further, as a combination of a polyphenol compound and a zirconium compound, there is “Aleli Move (trade name)” manufactured by Toagosei Co., Ltd., and the like. These anti-allergen agents act effectively against various allergens such as dust mites and pollen.
  • At least one monomer component selected from the group consisting of styrene sulfonic acid and its salts materials such as those shown in Japanese Patent No. 6136433 can be used.
  • an organic compound and an inorganic compound for example, an anionic phenol-based material and a zinc-based material having anti-allergenic properties may be used.
  • Anionic phenolic materials include tannin, tannic acid tartarite, phenolsulfonic acid formaldehyde resin, sulfone compounds of novolac type resin, methanesulfonic acid of novolac type resin, methanesulfonic acid of resol type resin, and benzylated phenol sulfone. It is appropriately selected and used from acids, thiophenol compounds, dihydroxy, diphenylsulfone compounds, ligand compounds, metal chelate compounds thereof, and the like.
  • the zinc-based material is appropriately selected from water-soluble zinc compounds, water-insoluble zinc compounds, zinc/metal oxide composite materials, etc., and water-insoluble zinc compounds and/or water-insoluble zinc/metal oxide composite particles are used. It is preferable that the metal oxide is water-dispersed, has a particle size of 50 ⁇ m or less, and contains at least one of titania, silica, and alumina.
  • Embossing is performed to impart a desired texture such as a wood grain pattern to the decorative sheet, and may be performed on the transparent resin layer and/or on the crosslinked curable resin layer.
  • a cross-linked curable resin layer is heated and softened, then pressed and shaped with an embossing plate having a desired pattern of unevenness, and then cooled and fixed to give a texture.
  • Embossing can be performed with a known single-fed or rotary embossing machine.
  • embossed uneven pattern examples include wood grain conduit grooves, raised patterns (embossed annual ring uneven patterns), hairlines, sand grains, satin finishes, and the like.
  • the embossed recesses may be filled with ink by wiping, if necessary.
  • ink is filled into the embossed recesses while scraping the surface with a doctor blade.
  • the ink to be filled it is usually possible to use an ink having a two-component curing type urethane resin as a binder.
  • the product value can be increased by expressing a design that is closer to the actual wood grain.
  • a back primer layer may be provided on the back side of the back primer layer base sheet, if necessary. For example, it is effective when producing a decorative laminate by bonding a base sheet and a decorative laminate base material.
  • the back primer layer can be formed by applying a known primer agent to the base sheet.
  • primer agents include acrylic modified urethane resins (acrylic urethane copolymer resins), urethane resin primers made of polycarbonate-based acrylic urethane copolymer resins, and urethane-cellulose resins (for example, urethane and nitrified cotton).
  • a resin-based primer agent made of a block copolymer of acrylic and urethane, etc. may be mentioned.
  • Additives may be added to the primer agent if necessary.
  • additives include fillers such as calcium carbonate and clay, flame retardants such as magnesium hydroxide, antioxidants, lubricants, foaming agents, ultraviolet absorbers, and light stabilizers.
  • the blending amount of the additive can be appropriately set depending on the product characteristics.
  • the thickness of the back primer layer is not particularly limited, but is usually about 0.01 to 10 ⁇ m, preferably about 0.1 to 1 ⁇ m.
  • Synthetic resin backer layer A synthetic resin backer layer may be provided on the back side of the base sheet, if necessary. By having the synthetic resin backer layer, the impact resistance of the decorative sheet is further improved. In addition, when the above-mentioned back primer layer is also provided, the synthetic resin backer layer and the back primer layer are provided on the back surface of the base sheet in this order from the base sheet side.
  • Examples of the resin constituting the synthetic resin backer layer include polypropylene, ethylene-vinyl alcohol copolymer, polymethylene, polymethylpentene, polyethylene terephthalate, and highly heat-resistant polyalkylene terephthalate [for example, a portion of ethylene glycol , polyethylene terephthalate substituted with 4-cyclohexanedimethanol or diethylene glycol, so-called PET-G (manufactured by Eastman Chemical Company)], polybutylene terephthalate, polyethylene naphthalate, polyethylene naphthalate-isophthalate copolymer,
  • Examples include diene rubbers such as polycarbonate, polyarylate, polyimide, polystyrene, polyamide, ABS, styrene-butadiene rubber, isoprene rubber, and chloroprene rubber, non-diene rubbers such as butyl rubber and ethylene propylene rubber, natural rubber, thermoplastic elastomers, etc. .
  • the thickness of the synthetic resin backer layer is preferably 0.1 to 0.6 mm, more preferably 0.15 to 0.45 mm, and even more preferably 0.20 to 0.40 mm.
  • the thickness of the synthetic resin backer layer is preferably 0.1 to 0.6 mm, more preferably 0.15 to 0.45 mm, and even more preferably 0.20 to 0.40 mm.
  • the additive is vesiculated.
  • the method for forming various additives into vesicles is not particularly limited, and may be formed by any known method, and among them, supercritical reverse phase evaporation is preferred.
  • examples of the vesicle formation treatment method include the Bangham method, the extrusion method, the hydration method, the reverse phase evaporation method, and the freeze-thaw method.
  • a vesiculation treatment method in the Bangham method, chloroform or a mixed solvent of chloroform/methanol is placed in a container such as a flask, and then phospholipids are added and dissolved. Thereafter, the solvent is removed using an evaporator to form a thin film made of lipids, and after a dispersion of additives is added, vesicles are obtained by hydration and dispersion using a vortex mixer.
  • the extrusion method is a method for obtaining vesicles by preparing a thin film of phospholipid solution and passing it through a filter instead of the mixer used as an external perturbation in the Bangham method.
  • the hydration method is a preparation method that is almost the same as the Bangham method, but it is a method in which vesicles are obtained by gentle stirring and dispersion without using a mixer.
  • phospholipids are dissolved in diethyl ether or chloroform, a solution containing additives is added to create a W/O emulsion, the organic solvent is removed from the emulsion under reduced pressure, and water is added. This method is used to obtain vesicles.
  • the freeze-thaw method is a method that uses cooling and heating as external perturbations, and is a method that obtains vesicles by repeating this cooling and heating.
  • the supercritical reverse phase evaporation method is a method in which water-soluble or hydrophilic substances are uniformly dissolved in carbon dioxide in a supercritical state or at a temperature or pressure above the supercritical point.
  • an aqueous phase containing various additives as an encapsulating substance is added to form a capsule-shaped vesicle containing various additives as an encapsulating substance in a single layer of membrane.
  • carbon dioxide in a supercritical state means carbon dioxide in a supercritical state at a critical temperature (30.98°C) and a critical pressure (7.3773 ⁇ 0.0030 MPa) or higher;
  • Carbon dioxide under pressure conditions means carbon dioxide under conditions where only the critical temperature or only the critical pressure exceeds the critical condition.
  • the above-mentioned phospholipids include phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidic acid, phosphatidylglycerol, phosphatidylinositol, cardiolipin, egg yolk lecithin, hydrogenated egg yolk lecithin, soybean lecithin, glycerophospholipids such as hydrogenated soybean lecithin, sphingomyelin, and ceramide.
  • Examples include sphingophospholipids such as phosphorylethanolamine and ceramide phosphorylglycerol.
  • a dispersant such as a nonionic surfactant or a mixture of this and cholesterol or triacylglycerol can be used.
  • nonionic surfactants examples include polyglycerin ether, dialkylglycerin, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether, polyoxyethylene sorbitan fatty acid ester, sorbitan fatty acid ester, polyoxyethylene polyoxypropylene copolymer, and polybutadiene.
  • polyoxyethylene copolymer polybutadiene-poly2-vinylpyridine, polystyrene-polyacrylic acid copolymer, polyethylene oxide-polyethylethylene copolymer, polyoxyethylene-polycaprolactam copolymer, etc. The above can be used.
  • the above-mentioned cholesterols include one or more of cholesterol, ⁇ -cholestanol, ⁇ -cholestanol, cholestane, desmosterol (5,24-cholestadien-3 ⁇ -ol), sodium cholate, cholecalciferol, etc. Can be used.
  • the outer membrane of the liposome may be formed from a mixture of a phospholipid and a dispersant.
  • the outer membrane in the decorative sheet of the present invention, by forming the outer membrane as a liposome formed from phospholipid, it is possible to improve the compatibility between the resin composition, which is the main component of each layer, and various additives.
  • the antiviral adhesive processed sheet of the present invention (adhesive processed sheet of the present invention) is composed of a laminate comprising at least an adhesive sheet and a decorative sheet of the present invention in this order in the thickness direction.
  • the pressure-sensitive adhesive sheet is not particularly limited, and any pressure-sensitive adhesive sheet used in the field of decorative sheets and other functional sheets can be used as appropriate.
  • the adhesive processed sheet of the present invention can be applied to the surfaces of various articles for floors and adherends, and can optionally be imparted with antiviral properties.
  • FIG. 2 shows an example of an antiviral pressure-sensitive adhesive sheet 11 in which the decorative sheet 1 of the present invention (the surface opposite to the cross-linked curable resin layer and the pressure-sensitive adhesive sheet 10 are laminated in this order) on the pressure-sensitive adhesive sheet 10. shows.
  • the antiviral decorative board of the present invention (the decorative board of the present invention) comprises at least, in order in the thickness direction, a decorative board base material, and a decorative sheet of the present invention or an adhesive processed sheet of the present invention. Composed of laminates.
  • FIG. 3 shows an antiviral decorative board in which the decorative sheet 1 of the present invention (the surface opposite to the cross-linked curing resin layer side and the decorative board base material 12 are laminated) on the decorative board base material 12 in this order.
  • An example of No. 13 is shown below.
  • Decorative board base materials include, but are not limited to, medium-density wood fiberboard, high-density wood fiberboard, particle board, softwood plywood, hardwood plywood, early-wood plywood, cork sheet, cork-containing composite base material, thermoplastic At least one type of resin board (resin board whose main component is polyvinyl chloride resin, polypropylene resin, polyethylene resin, acrylic resin, ABS resin, etc., or a foamed version thereof) can be used. These decorative laminate base materials may be used alone or in combination and laminated together.
  • examples of coniferous trees include Japanese pine, Japanese pine, Ezo pine, cedar, cypress, pine, sequoia, spruce, and the like.
  • examples of broad-leaved trees include lauan, china, birch, sen, beech, oak, and meranti.
  • examples of fast-growing trees include poplar, falcata, acacia, chameleon, eucalyptus, terminaria, and the like.
  • the number of laminated wood veneers is not limited, but is usually preferably 3 to 7, more preferably 5 to 7.
  • the adhesive used when producing the wood plywood is not limited, and a wide variety of known woodworking adhesives can be used.
  • the adhesive include polyvinyl acetate, polyvinyl chloride, vinyl chloride-vinyl acetate copolymer, ethylene-acrylic acid copolymer, ionomer, butadiene-acrylonitrile rubber, neoprene rubber, natural rubber, etc. as active ingredients.
  • examples include adhesives that can be used.
  • thermosetting adhesives include melamine-based, phenol-based, urea-based (vinyl acetate-urea, etc.) adhesives, and the like.
  • cork sheet not only so-called natural cork, which is a highly elastic material made by exfoliating and processing the cork tissue of cork oak bark, but also so-called synthetic cork, which is made to resemble cork, can be used.
  • the cork sheet may be a single layer, or may be a laminate of a plurality of cork sheets having different elastic moduli and densities.
  • cork-containing composite base material examples include a composite material formed by laminating and bonding a cork sheet and other materials (for example, medium-density wood fiberboard, high-density wood fiberboard).
  • the thickness of the decorative board base material is not limited, but is preferably about 2 to 15 mm, more preferably about 2 to 12 mm.
  • the lamination method for laminating the decorative sheet or adhesive processed sheet and the decorative laminate base material is not limited, and for example, a method of pasting each with an adhesive can be adopted.
  • the adhesive sheet has sufficient adhesion to the decorative laminate base material, it is possible to adopt a method of attaching the adhesive sheet and the decorative laminate base material without using an adhesive. can.
  • the adhesive may be appropriately selected from known adhesives depending on the type of adherend.
  • acrylic, urethane-acrylic, polyvinyl acetate, polyvinyl chloride, vinyl chloride-vinyl acetate copolymer, ethylene-acrylic acid copolymer, ionomer, butadiene-acrylonitrile rubber, neoprene rubber natural Examples include rubber.
  • These adhesives may be used alone or in combination of two or more.
  • Example 1 A 60 ⁇ m thick colored polypropylene film was prepared as a base sheet.
  • a back primer layer (thickness: 2 ⁇ m) was formed on the back side of the base sheet. Further, a pattern layer was formed on the front surface of the base sheet by gravure printing using a two-component urethane ink (trade name "V180", manufactured by Toyo Ink Co., Ltd.) to a thickness of 2 ⁇ m.
  • V180 two-component urethane ink
  • a transparent adhesive layer was formed on the pattern layer using urethane resin to a thickness of 2 ⁇ m.
  • a sheet of transparent random polypropylene resin was laminated on the transparent adhesive layer by an extrusion lamination method to a thickness of 80 ⁇ m to form a transparent resin layer.
  • a primer layer was formed by applying a primer agent containing a two-component curable urethane resin to a thickness of 2 ⁇ m.
  • a crosslinked curable resin layer was formed by irradiating the electron beam under the conditions of an acceleration voltage of 165 KeV and 5 Mrad to cure the electron beam curable resin, thereby producing a decorative sheet.
  • the following antiviral agent was set to be contained in an amount of 3 parts by mass based on 100 parts by mass of the crosslinked curable resin.
  • the proportion of the central point of the antiviral agent present in the middle layer or upper layer was 60% of the total.
  • (Crosslinked curable resin layer forming composition) As a crosslinked curable resin, a total of 100 parts by mass of urethane acrylate resin consisting of 30 parts by mass of a polyfunctional urethane oligomer and 70 parts by mass of a bifunctional oligomer (the Martens hardness of the crosslinked curable resin layer after curing is 110 N/mm 2 (prescription) ⁇ Antiviral agent (3 parts by mass per 100 parts by mass of resin)
  • the carboxylic acid derivatives include cyclohexanecarboxylic acid (manufactured by New Japan Chemical Co., Ltd.), triethylamine (manufactured by Tokyo Chemical Industry Co., Ltd.), N,N-dimethylallylamine (manufactured by Tokyo Chemical Industry Co., Ltd.), and 2,4-dimethylpyrrole (manufactured by Tokyo Chemical Industry Co., Ltd.).
  • styrene polymer derivatives include sodium p-styrene sulfonate (manufactured by Tosoh Corporation; trade name “Spinomer NaSS”), styrene monomer (manufactured by Wako Pure Chemical Industries, Ltd.), and denatured ethanol (manufactured by Wako Pure Chemical Industries, Ltd.; trade name "86”). % ethanol-ME”) were mixed and reacted.
  • the antiviral agent was prepared by sequentially mixing the above carboxylic acid derivative and the above styrene polymer derivative at a mass ratio of 3:1, and then pulverizing the mixture with a jet mill (Nissin Engineering, trade name "SJ-100").
  • a jet mill Nisin Engineering, trade name "SJ-100”
  • the antiviral agent was measured using a laser diffraction particle size distribution analyzer (manufactured by HORIBA) in accordance with JIS Z8825-1, the average particle diameter was 10 ⁇ m.
  • - Antibacterial agent content is 0.5 parts by mass per 100 parts by mass of resin
  • Silver-supported zeolite particles (trade name “Zeomic”, manufactured by Sinanen Zeomic Co., Ltd., average particle size 10 ⁇ m)
  • ⁇ Weather resistant agent triazine-based ultraviolet absorber (UVA "LA-F70", manufactured by ADEKA) (content: 1 part by mass per 100 parts by mass of resin)
  • Light stabilizer (radical scavenger) HALS "Tinuvin 152", manufactured by BASF) (content is 0.3 parts by mass per 100 parts by mass of resin)
  • Example 2 9 parts by mass of a photoreaction initiator (trade name "Irgacure 184", manufactured by BASF) was added to 100 parts by mass of the crosslinked curable resin, and the coating amount of the composition for forming a crosslinked curable resin layer was 5 ⁇ m.
  • a photoreaction initiator trade name "Irgacure 184", manufactured by BASF
  • the average particle size of the virus agent is 4 ⁇ m
  • the average particle size of the antibacterial agent is 2.5 ⁇ m
  • ultraviolet rays with a wavelength of 300 nm are irradiated using an ultraviolet irradiation device (the Martens hardness of the crosslinked resin layer after curing is 70 N/ mm2 )
  • the ultraviolet absorber was changed to a benzotriazole type (UVA "Tinuvin 329", manufactured by BASF) (content per 100 parts by mass of resin was 5 parts by mass), and the content of light stabilizer was
  • a decorative sheet was produced in the same manner as in Example 1, except that 2 parts by mass was changed from 100 parts by mass of the resin to form a crosslinked curable resin layer.
  • the proportion of the central point of the antiviral agent present in the middle layer or upper layer was 65% of the total.
  • Comparative example 1 A decorative sheet was produced in the same manner as in Example 1, except that the antiviral agent was prepared by pulverizing only the styrene polymer derivative described in Example 1 using a jet mill. In addition, in the cross-sectional observation of the crosslinked curable resin layer, the proportion of the central point of the antiviral agent present in the middle layer or upper layer (that is, the middle layer or above) was 60% of the total.
  • Example 3 A colored polyethylene sheet with a thickness of 80 ⁇ m was prepared as a base sheet.
  • a back primer layer (thickness: 2 ⁇ m) was formed on the back side of the base sheet. Further, a pattern layer was formed on the front surface of the base sheet by gravure printing using a two-component urethane ink (trade name "V180", manufactured by Toyo Ink Co., Ltd.) to a thickness of 2 ⁇ m.
  • V180 two-component urethane ink
  • the following transparent resin layer was laminated by a dry laminating method using a dry laminating adhesive (trade name "Takelac A540", manufactured by Mitsui Chemicals, Co., Ltd.; coating amount: 2 g/m 2 ). Furthermore, an embossed pattern was applied to the front surface of the bonded transparent resin layer.
  • a dry laminating adhesive trade name "Takelac A540", manufactured by Mitsui Chemicals, Co., Ltd.; coating amount: 2 g/m 2 .
  • the transparent resin layer contains 0.5 parts by mass of a hindered phenolic antioxidant (trade name "Irganox 1010", manufactured by BASF) and triazine-based ultraviolet absorber based on 100 parts by mass of highly crystalline homopolypropylene resin.
  • a resin composition containing 0.5 parts by mass of an agent (trade name "CYASORBUV-1164", manufactured by SUNCEM) and 0.5 parts by mass of a NOR type light stabilizer (trade name "Tinuvin XT850FF”, manufactured by BASF). It was obtained by melt-extruding using an extruder to form a transparent highly crystalline homopolypropylene sheet with a thickness of 100 ⁇ m.
  • both surfaces of the transparent resin layer were subjected to corona treatment, and the wetting tension of the sheet surface was set to 40 dyn/cm or more.
  • a decorative sheet was obtained by applying the following composition for forming a crosslinked curable resin layer to a transparent resin layer provided with an embossed pattern and curing the coating film.
  • the proportion of the central point of the antiviral agent present in the middle layer or upper layer was 80% of the total.
  • the composition for forming a crosslinked curable resin layer is prepared by blending the following curing agent, gloss modifier, ultraviolet absorber, light stabilizer, and diluting solvent into the following polymer solution A.
  • Example 4 A decorative sheet was obtained in the same manner as in Example 3, except that the composition for forming a crosslinked curable resin layer used in Example 3 was changed to the following composition. In addition, in the cross-sectional observation of the cross-linked curable resin layer, the proportion of the central point of the antiviral agent existing in the middle layer or upper layer (ie, the middle layer or above) was 58% of the total.
  • Thermosetting/photocuring hybrid curable composition The thermosetting/photocuring hybrid curable composition is prepared by blending the following curing agent, photoinitiator, gloss modifier, ultraviolet absorber, light stabilizer, and diluting solvent with the following polymer solution A and monomer. did.
  • ⁇ Polymer solution A 80 g of methyl methacrylate and 20 g of 2-hydroxyethyl methacrylate were introduced into a four-necked flask equipped with a stirrer, a nitrogen inlet tube, and a reflux condenser, and 100 g of ethyl acetate was added and dissolved, and the mixture was placed on an oil bath under a nitrogen atmosphere. It was stirred with Next, polymerization was started by blending 0.2 g of ⁇ , ⁇ '-azobisisobutyronitrile, and heating and stirring was continued for 5 hours on an oil bath at 60°C to form a colorless and viscous polymer solution A. Obtained.
  • Blending 40 parts by mass, monomer Product name: Dipentaerythritol hexaacrylate Blending: 40 parts by mass, curing agent Product name: Duranate 24A-100 (manufactured by Asahi Kasei Corporation) Formula: 10 parts by mass/photoinitiator Product name: Irgacure 184 (manufactured by BASF) Blend: 10 parts by mass/Gloss modifier (inorganic particles) Product name: Sunsphere H122 (manufactured by AGC SI Tech Co., Ltd.) Properties: Spherical, average particle size 12 ⁇ m, pore volume 2ml/g Formula: 10 parts by mass/UV absorber Product name: Tinuvin400 (manufactured by BASF) Formula: 5.0 parts by mass/light stabilizer Product name: Tinuvin123 (manufactured by BASF) Blend: 2.0 parts by mass/diluent Solvent Name: Ethyl acetate Blend: 50 parts by mass,
  • Test example 1 Regarding the decorative sheets produced in Examples and Comparative Examples, the proportion of the central point of the antiviral agent in the middle layer or upper layer (i.e., the middle layer or above) of the crosslinked curable resin layer, and the arithmetic mean roughness of the surface of the crosslinked curable resin layer. Ra and antiviral performance were evaluated.
  • Each measurement method and evaluation method are as follows.
  • Arithmetic mean roughness Ra defined in JIS B0601 (2001) was measured using a surface roughness measuring device (product number "SURFCOM-FLEX-50A", manufactured by Tokyo Seimitsu Co., Ltd.) under the following conditions. In addition, depending on the measured Ra, we decided to change the evaluation length and cutoff value to a suitable value and perform the measurement again.
  • ⁇ Cross-sectional observation> 1 In order to observe the cross section of the produced decorative sheet, an arbitrarily selected area was cut in the thickness direction of the decorative sheet using a single-edged trimming razor. 2) A width of 200 ⁇ m was observed from the cross-sectional side of the cut decorative sheet using a digital microscope (manufactured by Keyence Corporation, model number: VHX-7000, magnification: 200x). 3) Confirm the position of the center point of the antiviral agent present in the entire area of the cross-sectional photograph observed, and calculate the proportion of the antiviral agent whose center point exists in the middle layer or upper layer (i.e., above the middle layer) of the crosslinked curing resin layer as shown below. Calculated using the formula.
  • Virus species Non-enveloped virus (feline calicivirus) +: Antiviral activity value after 24 hours is 2.0 or more, -: Antiviral activity value after 24 hours is less than 2.0
  • Table 1 The results are shown in Table 1 below.
  • the decorative sheets of Examples 1 to 4 containing the antiviral agent of the present invention have antiviral performance against non-enveloped viruses at a content that does not impair the surface performance of the surface protective layer. I can see that it is being done.
  • Antiviral decorative sheet 1.
  • Base sheet 3. Picture pattern layer 4.
  • Transparent adhesive layer 5.
  • Transparent resin layer 6.
  • Cross-linked curing resin layer (surface protection layer) 8.
  • Back primer layer 9.
  • Antiviral agent 10.
  • Adhesive sheet 11.
  • Antiviral adhesive processed sheet 12.
  • Decorative board base material 13.
  • Upper layer b. middle layer c.

Landscapes

  • Engineering & Computer Science (AREA)
  • Architecture (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • Laminated Bodies (AREA)

Abstract

The present invention provides an anti-viral decorative sheet that exhibits an anti-viral effect particularly against a non-enveloped virus while keeping the surface performance of a surface-protecting layer. More specifically, the present invention provides an anti-viral decorative sheet having a crosslinking-cured resin layer as an outermost surface layer, the anti-viral decorative sheet being characterized in that (1) the crosslinking-cured resin layer comprises a cured product of a crosslinking-cured resin and an anti-viral agent and (2) the anti-viral agent has an anti-viral effect against a non-enveloped virus, contains a carboxylic acid derivative and a styrene polymer derivative, and contains, as at least constituent components for the carboxylic acid derivative, all of triethylamine, N,N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine and N,N,2,2-tetramethyl-1,3-propanediamine.

Description

抗ウイルス性化粧シート、それを用いた抗ウイルス性粘着加工シート及び抗ウイルス性化粧板Antiviral decorative sheet, antiviral adhesive processed sheet using the same, and antiviral decorative board
 本発明は、抗ウイルス性化粧シート、それを用いた抗ウイルス性粘着加工シート及び抗ウイルス性化粧板に関し、特にノンエンベロープウイルスに対して抗ウイルス性を有する抗ウイルス性化粧シート、それを用いた抗ウイルス性粘着加工シート及び抗ウイルス性化粧板に関する。 The present invention relates to an antiviral decorative sheet, an antiviral adhesive processed sheet using the same, and an antiviral decorative board, and in particular an antiviral decorative sheet having antiviral properties against non-enveloped viruses, and an antiviral decorative sheet using the same. The present invention relates to an antiviral adhesive sheet and an antiviral decorative board.
 従来、建築物の内装材に用いられる建具、床、壁等の表面化粧等のために各種の化粧シートが用いられている。例えば、厚さ方向において順に、基材シートと、透明性樹脂層と、表面保護層とを有する積層体から構成される化粧シートが幅広く用いられており、必要に応じて基材シート上に装飾層を設けたり、接着性を高めるために透明性樹脂層と表面保護層との間にプライマー層を設けたり、表面保護層の耐傷性を高めるために表面保護層の樹脂成分に電離放射線硬化型樹脂を含有すること等が知られている。 Conventionally, various decorative sheets have been used for surface decoration of fittings, floors, walls, etc. used as interior materials of buildings. For example, decorative sheets are widely used that are composed of a laminate that has a base sheet, a transparent resin layer, and a surface protective layer in order in the thickness direction, and decorations can be applied on the base sheet as necessary. A primer layer may be provided between the transparent resin layer and the surface protection layer to improve adhesion, and an ionizing radiation curing type may be added to the resin component of the surface protection layer to increase the scratch resistance of the surface protection layer. It is known that it contains resin.
 化粧シートに機能性を付与する一例として、抗ウイルス性を有する化粧シートが知られている。具体例としては、例えば、特許文献1には「基材シート上に単層又は複層で形成された表面保護層が設けられ、前記表面保護層の最表面に位置する最表層に抗ウイルス剤が添加されている化粧シート。」が開示されている。 As an example of adding functionality to a decorative sheet, a decorative sheet with antiviral properties is known. As a specific example, for example, Patent Document 1 states that ``a surface protective layer formed of a single layer or a multilayer is provided on a base sheet, and an antiviral agent is provided on the outermost layer located on the outermost surface of the surface protective layer. "A decorative sheet to which is added." is disclosed.
 特許文献1には、抗ウイルス剤が有機材料としてカルボン酸系材料、スルホン酸系材料又は4級アンモニウム塩のうち少なくともいずれか1種を含むことにより、エンベロープウイルス及びノンエンベロープウイルスの両方に対して抗ウイルス効果が発揮されることとなると記載されている(請求項7及び[0044]~[0047]段落)。しかしながら、特許文献1の実施例においては、抗ウイルス性能試験としてエンベロープウイルスに対する抗ウイルス性を確認したことは記載されているが、ノンエンベロープウイルスに対する抗ウイルス性は具体的に確認されていない。 Patent Document 1 discloses that the antiviral agent contains at least one of a carboxylic acid material, a sulfonic acid material, or a quaternary ammonium salt as an organic material, so that it is effective against both enveloped viruses and non-enveloped viruses. It is stated that an antiviral effect is exhibited (Claim 7 and paragraphs [0044] to [0047]). However, in the Examples of Patent Document 1, it is stated that antiviral properties against enveloped viruses were confirmed as an antiviral performance test, but antiviral properties against non-enveloped viruses were not specifically confirmed.
 一般に、エンベロープウイルスはエンベロープ(脂質層)を破壊することにより比較的容易に不活化できるため、公知の多種多様な抗ウイルス剤により抗ウイルス効果が得られ易く、また少ない添加量でも効果が発現し易いため、表面保護層が本来備えるべき表面性能を維持しつつ抗ウイルス性能を付与することが可能である。これに対して、ノンエンベロープウイルスは不活化が比較的困難であり、エンベロープウイルスと同じ抗ウイルス剤及び同じ添加量では効果は得られ難く、特許文献1の化粧シートにおいても、ノンエンベロープウイルスに対して同じ抗ウイルス剤で効果を得るには添加量を増量する必要があり、それにより表面保護層が本来備えるべき表面性能を阻害する可能性があるという問題がある。 In general, enveloped viruses can be inactivated relatively easily by destroying the envelope (lipid layer), so it is easy to obtain an antiviral effect with a wide variety of known antiviral agents, and the effect can be expressed even with a small amount added. Since it is easy to use, it is possible to impart antiviral performance while maintaining the surface performance that the surface protective layer should originally have. On the other hand, non-enveloped viruses are relatively difficult to inactivate, and it is difficult to obtain the same effect with the same antiviral agent and the same additive amount as for enveloped viruses. In order to obtain the same effect with the same antiviral agent, it is necessary to increase the amount added, which poses a problem that the surface performance that the surface protective layer should originally have may be inhibited.
 よって、表面保護層の表面性能を維持しつつ、特にノンエンベロープウイルスに対しても抗ウイルス効果を発揮する抗ウイルス性化粧シートの開発が求められている。 Therefore, there is a need to develop an antiviral decorative sheet that maintains the surface performance of the surface protective layer and exhibits antiviral effects, especially against non-enveloped viruses.
特開2022-41101号公報Japanese Patent Application Publication No. 2022-41101
 本発明は、表面保護層の表面性能を維持しつつ、特にノンエンベロープウイルスに対しても抗ウイルス効果を発揮する抗ウイルス性化粧シートを提供することを目的とする。また、前記化粧シートを用いた抗ウイルス性粘着加工シート及び抗ウイルス性化粧板を提供することも目的とする。 An object of the present invention is to provide an antiviral decorative sheet that exhibits an antiviral effect particularly against non-enveloped viruses while maintaining the surface performance of the surface protective layer. Another object of the present invention is to provide an antiviral pressure-sensitive adhesive sheet and an antiviral decorative board using the decorative sheet.
 本発明者は、鋭意研究を重ねた結果、表面保護層に特定の抗ウイルス剤を含有することにより上記目的を達成できることを見出し、本発明を完成するに至った。 As a result of extensive research, the present inventors have discovered that the above object can be achieved by containing a specific antiviral agent in the surface protective layer, and have completed the present invention.
 即ち、本発明は、下記の抗ウイルス性化粧シート、それを用いた抗ウイルス性粘着加工シート及び抗ウイルス性化粧板に関する。
1.最表層に架橋硬化型樹脂層を備える化粧シートであって、
(1)前記架橋硬化型樹脂層は、架橋硬化型樹脂の硬化物及び抗ウイルス剤を含有し、
(2)前記抗ウイルス剤は、ノンエンベロープウイルスに対して抗ウイルス性を有する抗ウイルス剤であって、カルボン酸誘導体及びスチレンポリマー誘導体を含有し、少なくとも前記カルボン酸誘導体の構成成分としてトリエチルアミン、N,N-ジメチルアリルアミン、ジメチルピロール、テトラメチル-1、3-プロパンジアミン、及びN,N,2,2-テトラメチル-1,3-プロパンジアミンを全て含有する、
ことを特徴とする抗ウイルス性化粧シート。
2.前記抗ウイルス剤は、前記スチレンポリマー誘導体の構成成分としてトリエチルアミン、N,N-ジメチルアリルアミン、ジメチルピロール、テトラメチル-1、3-プロパンジアミン、及びN,N,2,2-テトラメチル-1,3-プロパンジアミンを全て含有する、上記項1に記載の抗ウイルス性化粧シート。
3.前記架橋硬化型樹脂層は、最表面に算術平均粗さRaが0.1μm以上である微細凹凸を有する、上記項1又は2に記載の抗ウイルス性化粧シート。
4.前記微細凹凸の前記算術平均粗さRaが40μm以下である、上記項3に記載の抗ウイルス性化粧シート。
5.前記架橋硬化型樹脂層は、更に銀含有無機粒子からなる抗菌剤を含有する、上記項1~4のいずれか一項に記載の抗ウイルス性化粧シート。
6.前記架橋硬化型樹脂層は、更にトリアジン系紫外線吸収剤及び/又は光安定剤を含有する、上記項1~5のいずれか一項に記載の抗ウイルス性化粧シート。
7.前記抗ウイルス剤は、前記カルボン酸誘導体及び前記スチレンポリマー誘導体を、順に質量比で1:1~10:1の割合で含有する、上記項1~6のいずれか一項に記載の抗ウイルス性化粧シート。
8.前記架橋硬化型樹脂層の平滑部の厚さを三等分して下層、中層及び上層と区分した際に前記抗ウイルス剤の全体のうち50%以上の前記抗ウイルス剤の中心点が前記中層又は前記上層に存在する、上記項1~7のいずれか一項に記載の抗ウイルス性化粧シート。
9.前記架橋硬化型樹脂100質量部に対して前記抗ウイルス剤を1質量部以上10質量部以下含有する、上記項1~8のいずれか一項に記載の抗ウイルス性化粧シート。
10.前記架橋硬化型樹脂層の平滑部の平均厚さが2μm以上35μm以下である、上記項1~9のいずれか一項に記載の抗ウイルス性化粧シート。
11.前記抗ウイルス剤の平均粒子径が2μm以上15μm以下である、上記項1~10のいずれか一項に記載の抗ウイルス性化粧シート。
12.前記架橋硬化型樹脂は、電離放射線硬化型樹脂を含有する、上記項1~11のいずれか一項に記載の抗ウイルス性化粧シート。
13.前記架橋硬化型樹脂層のマルテンス硬さが30N/mm以上180N/mm以下である、上記項1~12のいずれか一項に記載の抗ウイルス性化粧シート。
14.厚さ方向において順に、基材シートと、絵柄模様層と、透明性熱可塑性樹脂層と、前記架橋硬化型樹脂層とを少なくとも備える積層体から構成される、上記項1~13のいずれか一項に記載の抗ウイルス性化粧シート。
15.前記基材シート及び/又は前記透明性熱可塑性樹脂層のマルテンス硬さが30N/mm以上80N/mm以下である、上記項14に記載の抗ウイルス性化粧シート。
16.厚さ方向において順に、粘着シートと、上記項1~15のいずれか一項に記載の抗ウイルス性化粧シートとを少なくとも備える積層体から構成される抗ウイルス性粘着加工シート。
17.厚さ方向において順に、化粧板基材と、上記項1~15のいずれか一項に記載の抗ウイルス性化粧シートとを少なくとも備える積層体から構成される抗ウイルス性化粧板。
18.厚さ方向において順に、化粧板基材と、上記項16に記載の抗ウイルス性粘着加工シートとを少なくとも備える積層体から構成される抗ウイルス性化粧板。
That is, the present invention relates to the following antiviral decorative sheet, antiviral adhesive processed sheet and antiviral decorative board using the same.
1. A decorative sheet comprising a crosslinked curable resin layer on the outermost layer,
(1) The crosslinked curable resin layer contains a cured product of a crosslinked curable resin and an antiviral agent,
(2) The antiviral agent is an antiviral agent having antiviral properties against non-enveloped viruses, and contains a carboxylic acid derivative and a styrene polymer derivative, and at least triethylamine, N , N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1,3-propanediamine,
An antiviral cosmetic sheet characterized by:
2. The antiviral agent contains triethylamine, N,N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1, as constituent components of the styrene polymer derivative. The antiviral decorative sheet according to item 1 above, which contains all of 3-propanediamine.
3. 3. The antiviral decorative sheet according to item 1 or 2, wherein the crosslinked curable resin layer has fine irregularities having an arithmetic mean roughness Ra of 0.1 μm or more on the outermost surface.
4. 4. The antiviral decorative sheet according to item 3, wherein the arithmetic mean roughness Ra of the fine irregularities is 40 μm or less.
5. 5. The antiviral decorative sheet according to any one of items 1 to 4 above, wherein the crosslinked curable resin layer further contains an antibacterial agent made of silver-containing inorganic particles.
6. 6. The antiviral decorative sheet according to any one of items 1 to 5 above, wherein the crosslinked curable resin layer further contains a triazine-based ultraviolet absorber and/or a light stabilizer.
7. The antiviral agent according to any one of items 1 to 6 above, wherein the antiviral agent contains the carboxylic acid derivative and the styrene polymer derivative in a mass ratio of 1:1 to 10:1. Cosmetic sheet.
8. When the thickness of the smooth part of the cross-linked curable resin layer is divided into thirds and divided into a lower layer, a middle layer, and an upper layer, the central point of the antiviral agent that accounts for 50% or more of the entire antiviral agent is the middle layer. or the antiviral decorative sheet according to any one of items 1 to 7 above, which is present in the upper layer.
9. The antiviral decorative sheet according to any one of items 1 to 8 above, which contains the antiviral agent in an amount of 1 part by mass or more and 10 parts by mass or less based on 100 parts by mass of the crosslinked curable resin.
10. 10. The antiviral decorative sheet according to any one of items 1 to 9 above, wherein the average thickness of the smooth portion of the crosslinked curable resin layer is 2 μm or more and 35 μm or less.
11. The antiviral decorative sheet according to any one of items 1 to 10 above, wherein the antiviral agent has an average particle diameter of 2 μm or more and 15 μm or less.
12. 12. The antiviral decorative sheet according to any one of items 1 to 11 above, wherein the crosslinked curable resin contains an ionizing radiation curable resin.
13. 13. The antiviral decorative sheet according to any one of items 1 to 12 above, wherein the crosslinked curable resin layer has a Martens hardness of 30 N/mm 2 or more and 180 N/mm 2 or less.
14. Any one of items 1 to 13 above, which is composed of a laminate comprising at least a base sheet, a picture pattern layer, a transparent thermoplastic resin layer, and the crosslinked curable resin layer in order in the thickness direction. The antiviral cosmetic sheet described in section.
15. 15. The antiviral decorative sheet according to item 14, wherein the base sheet and/or the transparent thermoplastic resin layer has a Martens hardness of 30 N/mm 2 or more and 80 N/mm 2 or less.
16. An antiviral adhesive processed sheet comprising a laminate comprising at least an adhesive sheet and an antiviral decorative sheet according to any one of items 1 to 15 above, in order in the thickness direction.
17. An antiviral decorative board comprising a laminate comprising at least a decorative board base material and an antiviral decorative sheet according to any one of items 1 to 15 above, in order in the thickness direction.
18. An antiviral decorative board comprising a laminate including at least a decorative board base material and an antiviral pressure-sensitive adhesive sheet according to item 16 above, in order in the thickness direction.
 本発明の抗ウイルス性化粧シートは、最表層である架橋硬化型樹脂層(表面保護層)に特定の抗ウイルス剤を含有することにより、表面保護層の表面性能(耐傷性、耐衝撃性、耐薬品性等の表面保護層が本来備えるべき任意の表面性能)を維持しつつ、特にノンエンベロープウイルスに対しても抗ウイルス効果を発揮することができる。また、当該化粧シートは、粘着シートと組み合わせることにより抗ウイルス性粘着加工シートとでき、当該化粧シート及び当該粘着加工シートは、それぞれ化粧板基材と組み合わせることにより、抗ウイルス性化粧板とできる。 The antiviral decorative sheet of the present invention contains a specific antiviral agent in the crosslinked curable resin layer (surface protective layer), which is the outermost layer, so that the surface performance of the surface protective layer (scratch resistance, impact resistance, It is possible to exhibit an antiviral effect particularly against non-enveloped viruses while maintaining arbitrary surface properties that a surface protective layer should originally have, such as chemical resistance. Moreover, the decorative sheet can be made into an antiviral adhesive processed sheet by being combined with an adhesive sheet, and the decorative sheet and the adhesive processed sheet can be made into an antiviral decorative board by being combined with a decorative laminate base material, respectively.
本発明の抗ウイルス性化粧シートの一例を示す断面模式図である。FIG. 1 is a schematic cross-sectional view showing an example of an antiviral decorative sheet of the present invention. 本発明の抗ウイルス性粘着加工シートの一例を示す断面模式図である。FIG. 1 is a schematic cross-sectional view showing an example of an antiviral pressure-sensitive adhesive sheet of the present invention. 本発明の抗ウイルス性化粧板の構成部材の一例を模式的に示した断面図である。FIG. 1 is a cross-sectional view schematically showing an example of the constituent members of the antiviral decorative board of the present invention. 本発明の抗ウイルス性化粧シートの架橋硬化型樹脂層(表面保護層)の平滑部の厚さAと抗ウイルス剤の中心点の位置との関係を説明するための断面模式図である。FIG. 2 is a schematic cross-sectional view for explaining the relationship between the thickness A of the smooth portion of the crosslinked curable resin layer (surface protective layer) of the antiviral decorative sheet of the present invention and the position of the center point of the antiviral agent. 本明細書におけるマルテンス硬さの測定に用いるダイヤモンド圧子(a)、押し込み操作の模式図(b)及び押し込み荷重と変位の一例(c)を示す図である。It is a figure which shows the diamond indenter (a) used for the measurement of Martens hardness in this specification, the schematic diagram (b) of indentation operation, and an example of indentation load and displacement (c).
 1.抗ウイルス性化粧シート
 本発明の抗ウイルス性化粧シート(以下、「本発明の化粧シート」ともいう)は、最表層に架橋硬化型樹脂層を備える化粧シートであって、
(1)前記架橋硬化型樹脂層は、架橋硬化型樹脂の硬化物及び抗ウイルス剤を含有し、
(2)前記抗ウイルス剤は、ノンエンベロープウイルスに対して抗ウイルス性を有する抗ウイルス剤であって、カルボン酸誘導体及びスチレンポリマー誘導体を含有し、少なくとも前記カルボン酸誘導体の構成成分としてトリエチルアミン、N,N-ジメチルアリルアミン、ジメチルピロール、テトラメチル-1、3-プロパンジアミン、及びN,N,2,2-テトラメチル-1,3-プロパンジアミンを全て含有する、
ことを特徴とする。
1. Antiviral Decorative Sheet The antiviral decorative sheet of the present invention (hereinafter also referred to as "the decorative sheet of the present invention") is a decorative sheet comprising a crosslinked curable resin layer on the outermost layer,
(1) The crosslinked curable resin layer contains a cured product of a crosslinked curable resin and an antiviral agent,
(2) The antiviral agent is an antiviral agent having antiviral properties against non-enveloped viruses, and contains a carboxylic acid derivative and a styrene polymer derivative, and at least triethylamine, N , N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1,3-propanediamine,
It is characterized by
 本発明の化粧シートは、最表層である架橋硬化型樹脂層(表面保護層)に特定の抗ウイルス剤を含有することにより、表面保護層の表面性能(耐傷性、耐衝撃性、耐薬品性等の表面保護層が本来備えるべき任意の表面性能)を維持しつつ、特にノンエンベロープウイルスに対しても抗ウイルス効果を発揮することができる。また、当該化粧シートは、粘着シートと組み合わせることにより抗ウイルス性粘着加工シートとでき、当該化粧シート及び当該粘着加工シートは、それぞれ化粧板基材と組み合わせることにより、抗ウイルス性化粧板とできる。 The decorative sheet of the present invention improves the surface performance (scratch resistance, impact resistance, chemical resistance) of the surface protection layer by containing a specific antiviral agent in the crosslinked curing resin layer (surface protection layer), which is the outermost layer. It is possible to exhibit an antiviral effect particularly against non-enveloped viruses while maintaining the arbitrary surface properties that a surface protective layer should originally have. Moreover, the decorative sheet can be made into an antiviral adhesive processed sheet by being combined with an adhesive sheet, and the decorative sheet and the adhesive processed sheet can be made into an antiviral decorative board by being combined with a decorative laminate base material, respectively.
 本発明の化粧シートは、最表層に架橋硬化型樹脂層を備えるとともに、当該架橋硬化型樹脂層及びそれに含まれる抗ウイルス剤が、上記(1)及び(2)に示す所定の要件を満たしていれば、その具体的構成(層構成)については限定されない。 The decorative sheet of the present invention includes a cross-linked curable resin layer on the outermost layer, and the cross-linked curable resin layer and the antiviral agent contained therein satisfy the predetermined requirements shown in (1) and (2) above. If so, the specific structure (layer structure) is not limited.
 具体的な実施態様では、本発明の化粧シートは、厚さ方向において順に、例えば、基材シートと、透明性熱可塑性樹脂層と、架橋硬化型樹脂層とを少なくとも備える積層体から構成されていてもよい。また、本発明の化粧シートは、厚さ方向において順に、例えば、基材シートと、絵柄模様層と、透明性熱可塑性樹脂層と、架橋硬化型樹脂層とを少なくとも備える積層体から構成されていてもよい。なお、本発明の化粧シートにおいて、最表層の架橋硬化型樹脂層はいわゆる表面保護層としての役割を有する。 In a specific embodiment, the decorative sheet of the present invention is composed of a laminate including at least a base sheet, a transparent thermoplastic resin layer, and a crosslinked curable resin layer in this order in the thickness direction. It's okay. Further, the decorative sheet of the present invention is composed of a laminate including, in order in the thickness direction, for example, a base sheet, a pattern layer, a transparent thermoplastic resin layer, and a crosslinked curable resin layer. It's okay. In the decorative sheet of the present invention, the outermost crosslinked curable resin layer has a role as a so-called surface protective layer.
 図1は本発明の化粧シートの一例を示す断面模式図である。図1では、基材シート2上に、絵柄模様層3、透明性接着剤層4、透明性熱可塑性樹脂層5、プライマー層6及び架橋硬化型樹脂層7が順に積層されており、基材シート2の裏面に裏面プライマー層8が更に備えられている。また、エンボス凹凸模様が形成されている。更に、架橋硬化型樹脂層7には、抗ウイルス剤9の存在態様が模式的に示されている。架橋硬化型樹脂層7の厚さ(最表面の盛り上がりを除いた平滑部の厚さ)は図中Aで示される厚さであるが、抗ウイルス剤9が架橋硬化型樹脂層7のおもて面側に存在することにより平滑部の厚さAを超える盛り上がり(凸部)が形成されていてもよい。また、架橋硬化型樹脂層7の最表面には、抗ウイルス剤9に起因する凸部以外に微細凹凸が形成されていてもよい。なお、図1に示す凸部は抗ウイルス剤9に起因する盛り上がりであるが、抗ウイルス剤9自体が露出しているのではなく、架橋硬化型樹脂層としての盛り上がりである。 FIG. 1 is a schematic cross-sectional view showing an example of the decorative sheet of the present invention. In FIG. 1, a pattern layer 3, a transparent adhesive layer 4, a transparent thermoplastic resin layer 5, a primer layer 6, and a cross-linked curable resin layer 7 are laminated in this order on a base sheet 2. A back primer layer 8 is further provided on the back side of the sheet 2. Furthermore, an embossed uneven pattern is formed. Further, in the crosslinked curable resin layer 7, the presence mode of the antiviral agent 9 is schematically shown. The thickness of the cross-linked curable resin layer 7 (thickness of the smooth part excluding the bulges on the outermost surface) is the thickness shown by A in the figure. A bulge (convex portion) exceeding the thickness A of the smooth portion may be formed by being present on the surface side. Moreover, fine irregularities may be formed on the outermost surface of the crosslinked curable resin layer 7 in addition to the convex portions caused by the antiviral agent 9. Note that the convex portion shown in FIG. 1 is a bulge caused by the antiviral agent 9, but the antiviral agent 9 itself is not exposed, but is a bulge as a crosslinked curable resin layer.
 更に、本発明には、厚さ方向において順に、粘着シートと、本発明の化粧シートとを少なくとも備える積層体から構成される抗ウイルス性粘着加工シート(以下、「本発明の粘着加工シート」ともいう)の発明(例えば、図2に示す態様)も包含されている。なお、図2では、図1に示した化粧シート1の裏面に粘着シート10を備えた粘着加工シート11の構成を例示しているが、化粧シート1の構成はこれに限定されない。 Furthermore, the present invention provides an antiviral adhesive sheet (hereinafter also referred to as "adhesive sheet of the present invention") which is composed of a laminate that includes at least an adhesive sheet and a decorative sheet of the present invention in this order in the thickness direction. The present invention also includes the inventions (for example, the embodiment shown in FIG. 2). Note that although FIG. 2 illustrates the configuration of the adhesive processed sheet 11 that includes the adhesive sheet 10 on the back surface of the decorative sheet 1 shown in FIG. 1, the configuration of the decorative sheet 1 is not limited to this.
 更に、本発明には、厚さ方向において順に、化粧板基材と、本発明の化粧シート又は本発明の粘着加工シートとを少なくとも備える積層体から構成される抗ウイルス性化粧板(以下、「本発明の化粧板」ともいう)の発明(例えば、図3に示す態様)も包含されている。なお、図3では、図1に示した化粧シート1の裏面に化粧板基材12を備えた化粧板13の構成を例示している。また、図2に示した粘着加工シート11の裏面に化粧板基材12を備えた化粧板13の構成としてもよい。 Furthermore, the present invention provides an antiviral decorative board (hereinafter referred to as " Also included is the invention (for example, the embodiment shown in FIG. 3) (also referred to as "the decorative laminate of the present invention"). In addition, in FIG. 3, the structure of the decorative board 13 which equipped the back surface of the decorative sheet 1 shown in FIG. 1 with the decorative board base material 12 is illustrated. Further, the decorative board 13 may have a configuration in which the decorative board base material 12 is provided on the back surface of the adhesive processed sheet 11 shown in FIG.
 本明細書では、本発明の化粧シートの施工後に視認される面、すなわち基材シートから見て架橋硬化型樹脂層(表面保護層)が積層されている方向を「上」又は「おもて面」と称し、基材シートから見て裏面プライマー層が積層されている方向を「下」又は「裏面」と称する。このような関係は、本発明の粘着加工シート及び本発明の化粧板の場合でも同じである。なお、積層体において「架橋硬化型樹脂層(表面保護層)の側」という場合に、略記して「架橋硬化型樹脂層(表面保護層)側」ともいう。 In this specification, the surface that is visually recognized after construction of the decorative sheet of the present invention, that is, the direction in which the crosslinked curable resin layer (surface protection layer) is laminated when viewed from the base sheet, is referred to as "top" or "front". The direction in which the back primer layer is laminated when viewed from the base sheet is called the "bottom" or "back surface." Such a relationship is the same in the case of the adhesive processed sheet of the present invention and the decorative board of the present invention. In addition, when referring to "the side of the cross-linked curable resin layer (surface protective layer)" in the laminate, it is also abbreviated as "the cross-linked curable resin layer (surface protective layer) side."
 以下、図1を例示的に用いて本発明の化粧シートの各層について説明する。但し、本発明の化粧シートの層構成は図1の態様に限定されず、前述の通り積層体として種々の層構成を採ることができる。なお、以下の記載において、「~」で表される数値範囲の下限上限は「以上以下」を意味する(例えば、α~βならば、α以上β以下である)。  Hereinafter, each layer of the decorative sheet of the present invention will be explained using FIG. 1 as an example. However, the layer structure of the decorative sheet of the present invention is not limited to the embodiment shown in FIG. 1, and as described above, various layer structures can be adopted as a laminate. In the following description, the lower and upper limits of the numerical range represented by "~" mean "more than or equal to" (for example, if α to β, it is more than or equal to α and less than or equal to β). 
 基材シート
 基材シートは、その表面(おもて面)には絵柄模様層等が順次積層される。なお、最表層は架橋硬化型樹脂層(表面保護層)である。
Base material sheet The base material sheet has picture pattern layers etc. laminated in sequence on its surface (front surface). Note that the outermost layer is a crosslinked curable resin layer (surface protection layer).
 基材シートとしては、樹脂製フィルム、紙、樹脂含浸紙等の種々のものを例示することができるが、樹脂製フィルムの中でも樹脂成分として熱可塑性樹脂を含有するものが好適である。具体的には、ポリ塩化ビニル、ポリエチレンテレフタレート、ポリブチレンテレフタレート、ポリアミド、ポリエチレン、ポリプロピレン、ポリカーボネート、ポリエチレンナフタレート、エチレン-酢酸ビニル共重合体、エチレン-アクリル酸共重合体、エチレン-アクリル酸エステル共重合体、アイオノマー、アクリル酸エステル、メタアクリル酸エステル等が挙げられる。本発明では、ポリ塩化ビニル及びポリオレフィン(ポリエチレン、ポリプロピレン等)の少なくとも一種を好適に用いることができる。 Examples of the base sheet include a variety of resin films, paper, resin-impregnated paper, etc. Among resin films, those containing thermoplastic resin as a resin component are preferred. Specifically, polyvinyl chloride, polyethylene terephthalate, polybutylene terephthalate, polyamide, polyethylene, polypropylene, polycarbonate, polyethylene naphthalate, ethylene-vinyl acetate copolymer, ethylene-acrylic acid copolymer, ethylene-acrylic acid ester copolymer Examples include polymers, ionomers, acrylic esters, methacrylic esters, and the like. In the present invention, at least one of polyvinyl chloride and polyolefin (polyethylene, polypropylene, etc.) can be suitably used.
 基材シートは、着色されていてもよい。例えば、熱可塑性樹脂に対して着色剤(顔料又は染料)を添加して着色することができる。着色剤としては、例えば、二酸化チタン、カーボンブラック、酸化鉄等の無機顔料、フタロシアニンブルー等の有機顔料のほか、各種の染料も使用することができる。これらは、1種又は2種以上を選ぶことができる。また、着色剤の添加量も、所望の色合い等に応じて適宜設定すればよい。 The base sheet may be colored. For example, a coloring agent (pigment or dye) can be added to a thermoplastic resin to color it. As the coloring agent, for example, inorganic pigments such as titanium dioxide, carbon black, and iron oxide, and organic pigments such as phthalocyanine blue, as well as various dyes can be used. One type or two or more types can be selected from these. Further, the amount of the coloring agent added may be appropriately set depending on the desired color tone and the like.
 基材シートには、必要に応じて、充填剤、艶消し剤、発泡剤、難燃剤、滑剤、帯電防止剤、酸化防止剤、紫外線吸収剤、光安定化剤等の各種の添加剤が含まれていてもよい。 The base sheet contains various additives such as fillers, matting agents, foaming agents, flame retardants, lubricants, antistatic agents, antioxidants, ultraviolet absorbers, and light stabilizers as necessary. It may be
 基材シートの厚みは、最終製品の用途、使用方法等により適宜設定できるが、一般には50~250μmが好ましい。 The thickness of the base sheet can be appropriately set depending on the purpose of the final product, how it is used, etc., but is generally preferably 50 to 250 μm.
 基材シートは、必要に応じて、絵柄模様層を形成するインキの密着性を高めるために表面(おもて面)にコロナ放電処理を施してもよい。コロナ放電処理の方法・条件は、公知の方法に従って実施すればよい。また、必要に応じて、基材シートの裏面にコロナ放電処理を施したり、絵柄模様層(いわゆるバックプリント)を形成したり、後述する裏面プライマー層、後述するバッカー層等を形成したりしてもよい。 If necessary, the surface (front surface) of the base sheet may be subjected to corona discharge treatment in order to improve the adhesion of the ink forming the picture pattern layer. The method and conditions for the corona discharge treatment may be carried out according to known methods. In addition, if necessary, the back side of the base sheet may be subjected to corona discharge treatment, a picture pattern layer (so-called back print), a back primer layer (described later), a backer layer (described later), etc. Good too.
 絵柄模様層
 絵柄模様層は、本発明の化粧シートに所望の絵柄(意匠)を付与する任意層であり、絵柄の種類等は限定的ではない。例えば、木目模様、レザー模様、石目模様、砂目模様、タイル貼模様、煉瓦積模様、布目模様、幾何学図形、文字、記号、抽象模様、草花模様、風景、キャラクター等が挙げられる。
Picture Pattern Layer The picture pattern layer is an arbitrary layer that imparts a desired picture (design) to the decorative sheet of the present invention, and the type of picture is not limited. Examples include wood grain patterns, leather patterns, stone grain patterns, sand grain patterns, tiling patterns, brickwork patterns, cloth grain patterns, geometric figures, letters, symbols, abstract patterns, flower patterns, landscapes, characters, and the like.
 絵柄模様層の形成方法は特に限定されず、例えば、公知の着色剤(染料又は顔料)を結着材樹脂とともに溶剤(又は分散媒)中に溶解(又は分散)して得られるインキを用いた既知の印刷法により、基材シート表面に形成すればよい。インキとしては、化粧シートのVOCを低減する観点からは水性組成物を用いることもできる。 The method of forming the picture pattern layer is not particularly limited, and for example, an ink obtained by dissolving (or dispersing) a known coloring agent (dye or pigment) together with a binder resin in a solvent (or dispersion medium) may be used. It may be formed on the surface of the base sheet by a known printing method. As the ink, an aqueous composition can also be used from the viewpoint of reducing VOC of the decorative sheet.
 着色剤としては、例えば、カーボンブラック、チタン白、亜鉛華、弁柄、紺青、カドミウムレッド等の無機顔料;アゾ顔料、レーキ顔料、アントラキノン顔料、キナクリドン顔料、フタロシアニン顔料、イソインドリノン顔料、ジオキサジン顔料等の有機顔料;アルミニウム粉、ブロンズ粉等の金属粉顔料;酸化チタン被覆雲母、酸化塩化ビスマス等の真珠光沢顔料;蛍光顔料;夜光顔料等が挙げられる。これらの着色剤は、単独又は2種以上を混合して使用できる。これらの着色剤は、シリカ等のフィラー、有機ビーズ等の体質顔料、中和剤、界面活性剤等とともに用いてもよい。 Examples of colorants include inorganic pigments such as carbon black, titanium white, zinc white, Bengara, navy blue, and cadmium red; azo pigments, lake pigments, anthraquinone pigments, quinacridone pigments, phthalocyanine pigments, isoindolinone pigments, and dioxazine pigments. organic pigments such as; metal powder pigments such as aluminum powder and bronze powder; pearlescent pigments such as titanium oxide-coated mica and bismuth chloride oxide; fluorescent pigments; and luminous pigments. These colorants can be used alone or in combination of two or more. These colorants may be used together with fillers such as silica, extender pigments such as organic beads, neutralizing agents, surfactants, and the like.
 結着材樹脂としては、親水性処理されたポリエステル系ウレタン樹脂のほか、ポリエステル、ポリアクリレート、ポリビニルアセテート、ポリブタジエン、ポリ塩化ビニル、塩素化ポリプロピレン、ポリエチレン、ポリスチレン、ポリスチレン-アクリレート共重合体、ロジン誘導体、スチレン-無水マレイン酸共重合体のアルコール付加物、セルロース系樹脂なども併用できる。より具体的には、例えば、ポリアクリルアミド系樹脂、ポリ(メタ)アクリル酸系樹脂、ポリエチレンオキシド系樹脂、ポリN-ビニルピロリドン系樹脂、水溶性ポリエステル系樹脂、水溶性ポリアミド系樹脂、水溶性アミノ系樹脂、水溶性フェノール系樹脂、その他の水溶性合成樹脂;ポリヌクレオチド、ポリペプチド、多糖類等の水溶性天然高分子;等も使用することができる。また、例えば、天然ゴム、合成ゴム、ポリ酢酸ビニル系樹脂、(メタ)アクリル系樹脂、ポリ塩化ビニル系樹脂、ポリウレタン-ポリアクリル系樹脂等又はそれらの変性物、その他の樹脂を使用することもできる。上記結着材樹脂は、単独又は2種以上を組み合わせて用いることができる。 In addition to hydrophilically treated polyester urethane resins, binder resins include polyester, polyacrylate, polyvinyl acetate, polybutadiene, polyvinyl chloride, chlorinated polypropylene, polyethylene, polystyrene, polystyrene-acrylate copolymer, and rosin derivatives. , alcohol adducts of styrene-maleic anhydride copolymers, cellulose resins, etc. can also be used in combination. More specifically, for example, polyacrylamide resin, poly(meth)acrylic acid resin, polyethylene oxide resin, polyN-vinylpyrrolidone resin, water-soluble polyester resin, water-soluble polyamide resin, water-soluble amino type resins, water-soluble phenolic resins, other water-soluble synthetic resins; water-soluble natural polymers such as polynucleotides, polypeptides, and polysaccharides; etc. can also be used. Furthermore, for example, natural rubber, synthetic rubber, polyvinyl acetate resin, (meth)acrylic resin, polyvinyl chloride resin, polyurethane-polyacrylic resin, or modified products thereof, and other resins may also be used. can. The above binder resins can be used alone or in combination of two or more.
 溶剤(又は分散媒)としては、例えば、ヘキサン、ヘプタン、オクタン、トルエン、キシレン、エチルベンゼン、シクロヘキサン、メチルシクロヘキサン等の石油系有機溶剤;酢酸エチル、酢酸ブチル、酢酸-2-メトキシエチル、酢酸-2-エトキシエチル等のエステル系有機溶剤;メチルアルコール、エチルアルコール、ノルマルプロピルアルコール、イソプロピルアルコール、イソブチルアルコール、エチレングリコール、プロピレングリコール等のアルコール系有機溶剤;アセトン、メチルエチルケトン、メチルイソブチルケトン、シクロヘキサノン等のケトン系有機溶剤;ジエチルエーテル、ジオキサン、テトラヒドロフラン等のエーテル系有機溶剤;ジクロロメタン、四塩化炭素、トリクロロエチレン、テトラクロロエチレン等の塩素系有機溶剤;水等の無機溶剤等が挙げられる。これらの溶剤(又は分散媒)は、単独又は2種以上を混合して使用できる。 Examples of the solvent (or dispersion medium) include petroleum organic solvents such as hexane, heptane, octane, toluene, xylene, ethylbenzene, cyclohexane, and methylcyclohexane; ethyl acetate, butyl acetate, 2-methoxyethyl acetate, and 2-acetic acid. - Ester organic solvents such as ethoxyethyl; alcohol organic solvents such as methyl alcohol, ethyl alcohol, n-propyl alcohol, isopropyl alcohol, isobutyl alcohol, ethylene glycol, propylene glycol; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, and cyclohexanone Ether organic solvents such as diethyl ether, dioxane, and tetrahydrofuran; chlorinated organic solvents such as dichloromethane, carbon tetrachloride, trichlorethylene, and tetrachloroethylene; and inorganic solvents such as water. These solvents (or dispersion media) can be used alone or in combination of two or more.
 絵柄模様層の形成に用いる印刷法としては、例えば、グラビア印刷法、オフセット印刷法、スクリーン印刷法、フレキソ印刷法、静電印刷法、インクジェット印刷法等が挙げられる。また、全面ベタ状の絵柄模様層を形成する場合には、例えば、ロールコート法、ナイフコート法、エアーナイフコート法、ダイコート法、リップコート法、コンマコート法、キスコート法、フローコート法、ディップコート法等の各種コーティング法が挙げられる。その他、手描き法、墨流し法、写真法、転写法、レーザービーム描画法、電子ビーム描画法、金属等の部分蒸着法、エッチング法等を用いたり、他の形成方法と組み合わせて用いたりしてもよい。 Examples of the printing method used to form the picture pattern layer include gravure printing, offset printing, screen printing, flexographic printing, electrostatic printing, and inkjet printing. In addition, when forming a pattern layer that is solid on the entire surface, examples of methods include roll coating, knife coating, air knife coating, die coating, lip coating, comma coating, kiss coating, flow coating, dip coating, etc. Various coating methods such as a coating method can be mentioned. In addition, hand-drawing methods, suminagashi methods, photographic methods, transfer methods, laser beam drawing methods, electron beam drawing methods, partial vapor deposition of metals, etching methods, etc. may be used, or they may be used in combination with other forming methods. good.
 絵柄模様層の厚さは特に限定されず、製品特性に応じて適宜設定できるが、層厚は0.1~15μm程度である。 The thickness of the picture pattern layer is not particularly limited and can be set as appropriate depending on the product characteristics, but the layer thickness is approximately 0.1 to 15 μm.
 透明性樹脂層
 透明性樹脂層は任意に設けることができる層であり、透明性であれば特に限定されず、無色透明、着色透明、半透明等のいずれであってもよい。上記透明性樹脂層の材質は限定されないが、熱可塑性樹脂により形成されたものが好適である。具体的には、ポリ塩化ビニル、ポリエチレンテレフタレート、ポリブチレンテレフタレート、ポリアミド、ポリエチレン、ポリプロピレン、ポリカーボネート、ポリエチレンナフタレート、エチレン-酢酸ビニル共重合体、エチレン-アクリル酸共重合体、エチレン-アクリル酸エステル共重合体、アイオノマー、アクリル酸エステル、メタアクリル酸エステル等が挙げられる。本発明では、ポリ塩化ビニル及びポリオレフィン(ポリエチレン、ポリプロピレン等)の少なくとも一種を好適に用いることができる。本明細書では、透明性樹脂層が熱可塑性樹脂を含有する場合には、透明性樹脂層を特に「透明性熱可塑性樹脂層」と称する。
Transparent resin layer The transparent resin layer is a layer that can be provided arbitrarily, and is not particularly limited as long as it is transparent, and may be colorless and transparent, colored transparent, translucent, or the like. Although the material of the transparent resin layer is not limited, it is preferably made of thermoplastic resin. Specifically, polyvinyl chloride, polyethylene terephthalate, polybutylene terephthalate, polyamide, polyethylene, polypropylene, polycarbonate, polyethylene naphthalate, ethylene-vinyl acetate copolymer, ethylene-acrylic acid copolymer, ethylene-acrylic acid ester copolymer Examples include polymers, ionomers, acrylic esters, methacrylic esters, and the like. In the present invention, at least one of polyvinyl chloride and polyolefin (polyethylene, polypropylene, etc.) can be suitably used. In this specification, when the transparent resin layer contains a thermoplastic resin, the transparent resin layer is particularly referred to as a "transparent thermoplastic resin layer."
 なお、透明性樹脂層は、透明性を有する限り、着色されていてもよい。 Note that the transparent resin layer may be colored as long as it has transparency.
 また、透明性樹脂層は、透明性を有する限り、必要に応じて、難燃剤、滑剤、帯電防止剤、酸化防止剤、紫外線吸収剤、光安定化剤等の各種の添加剤が含まれていてもよい。 In addition, as long as the transparent resin layer has transparency, it may contain various additives such as flame retardants, lubricants, antistatic agents, antioxidants, ultraviolet absorbers, and light stabilizers as necessary. It's okay.
 透明性樹脂層の厚さは限定的ではないが、40μm以上300μm以下が好ましく、その中でも60μm以上200μm以下がより好ましく、60μm以上100μm以下が最も好ましい。透明性樹脂層の厚さを上記範囲に設定することにより、深いエンボスを形成することができると共に、傷の発生や絵柄模様層の摩耗による削れ(絵柄取られ)を抑制する効果が得られ易い。 The thickness of the transparent resin layer is not limited, but is preferably 40 μm or more and 300 μm or less, more preferably 60 μm or more and 200 μm or less, and most preferably 60 μm or more and 100 μm or less. By setting the thickness of the transparent resin layer within the above range, deep embossing can be formed, and the effect of suppressing the occurrence of scratches and scraping (pattern removal) due to wear of the pattern layer can be easily obtained. .
 透明性接着剤層
 絵柄模様層と、透明性樹脂層又は後述する架橋硬化型樹脂層(表面保護層)との密着性を高めるために透明性接着剤層を形成してもよい。透明性接着剤層は、透明性のものであれば特に限定されず、無色透明、着色透明、半透明等のいずれであってもよい。
Transparent Adhesive Layer A transparent adhesive layer may be formed in order to improve the adhesion between the pattern layer and the transparent resin layer or the cross-linked curable resin layer (surface protection layer) described below. The transparent adhesive layer is not particularly limited as long as it is transparent, and may be colorless and transparent, colored and transparent, translucent, or the like.
 接着剤としては特に限定されず、化粧シートの分野で公知の接着剤が使用できる。化粧シートの分野で公知の接着剤としては、例えば、ポリアミド樹脂、アクリル樹脂、酢酸ビニル樹脂等の熱可塑性樹脂、ウレタン系樹脂等の熱硬化性樹脂等が挙げられる。これら接着剤は1種単独で又は2種以上を組み合わせて用いることができる。また、イソシアネートを硬化剤とする二液硬化型ポリウレタン樹脂又はポリエステル樹脂も適用し得る。 The adhesive is not particularly limited, and adhesives known in the field of decorative sheets can be used. Examples of adhesives known in the field of decorative sheets include thermoplastic resins such as polyamide resins, acrylic resins, and vinyl acetate resins, and thermosetting resins such as urethane resins. These adhesives can be used alone or in combination of two or more. Furthermore, a two-component curing type polyurethane resin or polyester resin using isocyanate as a curing agent can also be applied.
 透明性接着剤層の厚さは特に限定されないが、厚さが0.1~30μm程度、好ましくは1~20μm程度である。 The thickness of the transparent adhesive layer is not particularly limited, but is approximately 0.1 to 30 μm, preferably approximately 1 to 20 μm.
 プライマー層
 透明性樹脂層の上には、架橋硬化型樹脂層(表面保護層)用のプライマー層を設けてもよい。このプライマー層は透明性樹脂層と後述の架橋硬化型樹脂層との密着性を高める作用に加えて、架橋硬化型樹脂層との組み合わせにより化粧シートの折り曲げ加工性や耐傷性を高めることができる。プライマー層は透明性のものであれば特に限定されず、無色透明、着色透明、半透明等のいずれであってもよい。
Primer layer A primer layer for a crosslinked curable resin layer (surface protection layer) may be provided on the transparent resin layer. This primer layer has the effect of increasing the adhesion between the transparent resin layer and the cross-linked curable resin layer described below, and in combination with the cross-linked curable resin layer, it can improve the bending processability and scratch resistance of the decorative sheet. . The primer layer is not particularly limited as long as it is transparent, and may be colorless and transparent, colored and transparent, translucent, or the like.
 プライマー層は、公知のプライマー剤を透明性樹脂層の表面に塗布することにより形成できる。プライマー剤としては、例えば、アクリル変性ウレタン樹脂(アクリルウレタン系共重合体樹脂)、ポリカーボネート系アクリルウレタン共重合体樹脂等からなるウレタン樹脂系プライマー剤、ウレタン-セルロース系樹脂(例えば、ウレタンと硝化綿の混合物にヘキサメチレンジイソシアネートを添加してなる樹脂)からなるプライマー剤、アクリルとウレタンのブロック共重合体からなる樹脂系プライマー剤等が挙げられる。これらの中でも、耐傷性及び耐候性の観点からポリカーボネート系アクリルウレタン共重合体樹脂を含むウレタン樹脂系プライマー剤が好適に使用できる。 The primer layer can be formed by applying a known primer agent to the surface of the transparent resin layer. Examples of primer agents include acrylic modified urethane resins (acrylic urethane copolymer resins), urethane resin primers made of polycarbonate-based acrylic urethane copolymer resins, and urethane-cellulose resins (for example, urethane and nitrified cotton). A resin-based primer agent made of a block copolymer of acrylic and urethane, etc. may be mentioned. Among these, a urethane resin-based primer agent containing a polycarbonate-based acrylic urethane copolymer resin can be preferably used from the viewpoint of scratch resistance and weather resistance.
 プライマー剤には、必要に応じて、添加剤を配合してもよい。添加剤としては、例えば、紫外線吸収剤、光安定剤等の耐候剤;シリカ、炭酸カルシウム、クレー等のフィラー;水酸化マグネシウム等の難燃剤;酸化防止剤;滑剤;発泡剤などが挙げられる。添加剤の配合量は、製品特性に応じて適宜設定できる。 Additives may be added to the primer agent if necessary. Examples of additives include weathering agents such as ultraviolet absorbers and light stabilizers; fillers such as silica, calcium carbonate, and clay; flame retardants such as magnesium hydroxide; antioxidants; lubricants; and blowing agents. The blending amount of the additive can be appropriately set depending on the product characteristics.
 上記の添加剤のうち、紫外線吸収剤としては、例えば、ベンゾフェノン系紫外線吸収剤、ベンゾトリアゾール系紫外線吸収剤、トリアジン系紫外線吸収剤等が挙げられる。光安定剤としては、例えば、ヒンダードアミン系光安定剤(HALS)が好適である。これらの耐候剤の含有量は限定されないが、紫外線吸収剤、光安定剤のそれぞれについて1000~100000質量ppm程度とすればよい。特に本発明では、トリアジン系紫外線吸収剤及び/又はヒンダードアミン系光安定剤を用いることが好ましい。 Among the above additives, examples of the ultraviolet absorber include benzophenone ultraviolet absorbers, benzotriazole ultraviolet absorbers, triazine ultraviolet absorbers, and the like. As the light stabilizer, for example, hindered amine light stabilizer (HALS) is suitable. The content of these weathering agents is not limited, but may be approximately 1,000 to 100,000 ppm by mass for each of the ultraviolet absorber and light stabilizer. In particular, in the present invention, it is preferable to use a triazine-based ultraviolet absorber and/or a hindered amine-based light stabilizer.
 プライマー層の厚さは限定的ではないが、0.5μm以上12μm以下が好ましく、1μm以上8μm以下がより好ましい。かかる範囲内に設定することにより、架橋硬化型樹脂層との組み合わせにより化粧シートの折り曲げ加工性や耐傷性を高め易くなる。また、耐候剤などの添加剤を含有し易くなり、化粧シートに耐候性も付与し易くなる。 The thickness of the primer layer is not limited, but is preferably 0.5 μm or more and 12 μm or less, more preferably 1 μm or more and 8 μm or less. By setting it within this range, the folding processability and scratch resistance of the decorative sheet can be easily improved by combining with the crosslinked curable resin layer. In addition, it becomes easier to contain additives such as weathering agents, and it becomes easier to impart weather resistance to the decorative sheet.
 架橋硬化型樹脂層(表面保護層)
 本発明の化粧シートは、最表層に架橋硬化型樹脂層(表面保護層)を備え、当該架橋硬化型樹脂層及びそれに含まれる抗ウイルス剤が、下記(1)及び(2)に示す所定の要件を満たすことにより、表面保護層の表面性能を維持しつつ、特にノンエンベロープウイルスに対しても抗ウイルス効果を発揮することができる。
(1)前記架橋硬化型樹脂層は、架橋硬化型樹脂の硬化物及び抗ウイルス剤を含有し、
(2)前記抗ウイルス剤は、ノンエンベロープウイルスに対して抗ウイルス性を有する抗ウイルス剤であって、カルボン酸誘導体及びスチレンポリマー誘導体を含有し、少なくとも前記カルボン酸誘導体の構成成分としてトリエチルアミン、N,N-ジメチルアリルアミン、ジメチルピロール、テトラメチル-1、3-プロパンジアミン、及びN,N,2,2-テトラメチル-1,3-プロパンジアミンを全て含有する。
Cross-linked curing resin layer (surface protection layer)
The decorative sheet of the present invention includes a cross-linked curable resin layer (surface protective layer) on the outermost layer, and the cross-linked curable resin layer and the antiviral agent contained therein meet the predetermined conditions shown in (1) and (2) below. By satisfying the requirements, it is possible to maintain the surface performance of the surface protective layer while exhibiting an antiviral effect, especially against non-enveloped viruses.
(1) The crosslinked curable resin layer contains a cured product of a crosslinked curable resin and an antiviral agent,
(2) The antiviral agent is an antiviral agent having antiviral properties against non-enveloped viruses, and contains a carboxylic acid derivative and a styrene polymer derivative, and at least triethylamine, N , N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1,3-propanediamine.
 架橋硬化型樹脂は透明性のものであれば特に限定されず、無色透明、着色透明、半透明等のいずれであってもよい。 The crosslinked curable resin is not particularly limited as long as it is transparent, and may be colorless and transparent, colored and transparent, translucent, etc.
 架橋硬化型樹脂の樹脂成分は限定的ではないが、電離放射線硬化型樹脂又は2液硬化型ウレタン系樹脂を含有することが好ましい。実質的には、これらの樹脂から形成されているものが好ましい。電離放射線硬化型樹脂又は2液硬化型ウレタン系樹脂により最表層を形成する場合には、化粧シートの耐摩耗性、耐衝撃性、耐汚染性、耐擦傷性、耐候性等を高め易い。これらの中でも、電離放射線硬化型樹脂が好ましい。これらの樹脂を用いることにより、架橋硬化型樹脂層のマルテンス硬さを30N/mm以上180N/mm以下に調整し易くなり、それにより防滑性の指標として、滑り抵抗値(C.S.R.値)を0.25以上に調整し易くなる。 The resin component of the crosslinked curable resin is not limited, but preferably contains an ionizing radiation curable resin or a two-part curable urethane resin. Preferably, the material is substantially made of these resins. When the outermost layer is formed of an ionizing radiation curable resin or a two-component urethane resin, the abrasion resistance, impact resistance, stain resistance, scratch resistance, weather resistance, etc. of the decorative sheet can be easily improved. Among these, ionizing radiation curable resins are preferred. By using these resins, it becomes easier to adjust the Martens hardness of the cross-linked curable resin layer to 30 N/mm 2 or more and 180 N/mm 2 or less, thereby increasing the slip resistance value (C.S.) as an index of anti-slip property. R. value) can be easily adjusted to 0.25 or more.
 なお、上記C.S.R.値における各種用途での防滑性の指標としては、0.25以上(特に0.25以上0.30未満)であれば建具用途として適していると判断でき、0.30以上(特に0.30以上0.38未満)であれば通常フロア用途として適していると判断でき、0.38以上(特に0.38以上0.50未満)であれば高度な防滑性を発揮する防滑フロア用途として適していると判断できる。 In addition, the above C. S. R. As an index of anti-slip property for various uses in terms of value, if it is 0.25 or more (especially 0.25 or more and less than 0.30), it can be judged that it is suitable for fittings, and if it is 0.30 or more (especially 0.30 If the value is 0.38 or more (especially 0.38 or more and less than 0.50), it is considered suitable for use as a normal floor, and if it is 0.38 or more (particularly 0.38 or more and less than 0.50), it is suitable for use as an anti-slip floor that exhibits a high level of anti-slip properties. It can be determined that
 電離放射線硬化型樹脂としては特に限定されず、紫外線、電子線等の電離放射線の照射により重合架橋反応可能なラジカル重合性二重結合を分子中に含むプレポリマー(オリゴマーを含む)及び/又はモノマーを主成分とする透明性樹脂が使用できる。これらのプレポリマー又はモノマーは、単体又は複数を混合して使用できる。硬化反応は、通常、架橋硬化反応である。 Ionizing radiation-curable resins are not particularly limited, and include prepolymers (including oligomers) and/or monomers containing radically polymerizable double bonds in their molecules that can be polymerized and crosslinked by irradiation with ionizing radiation such as ultraviolet rays and electron beams. A transparent resin whose main component is These prepolymers or monomers can be used alone or in combination. The curing reaction is usually a crosslinking curing reaction.
 具体的には、前記プレポリマー又はモノマーとしては、分子中に(メタ)アクリロイル基、(メタ)アクリロイルオキシ基等のラジカル重合性不飽和基、エポキシ基等のカチオン重合性官能基等を有する化合物が挙げられる。また、ポリエンとポリチオールとの組み合わせによるポリエン/チオール系のプレポリマーも好ましい。ここで、(メタ)アクリロイル基とは、アクリロイル基又はメタクリロイル基の意味である。 Specifically, the prepolymer or monomer is a compound having a radically polymerizable unsaturated group such as a (meth)acryloyl group or a (meth)acryloyloxy group, or a cationically polymerizable functional group such as an epoxy group in the molecule. can be mentioned. Also preferred is a polyene/thiol-based prepolymer made of a combination of polyene and polythiol. Here, the (meth)acryloyl group means an acryloyl group or a methacryloyl group.
 ラジカル重合性不飽和基を有するプレポリマーとしては、例えば、ポリエステル(メタ)アクリレート、ウレタン(メタ)アクリレート、エポキシ(メタ)アクリレート、メラミン(メタ)アクリレート、トリアジン(メタ)アクリレート、シリコーン(メタ)アクリレート等が挙げられる。これらの重量平均分子量としては、通常250~100000程度が好ましい。ここで、本明細書における重量平均分子量は、GPC分析(ゲルパーミエーションクロマトグラフィー)によって測定され、且つ標準ポリスチレンで換算された平均分子量である。 Examples of prepolymers having radically polymerizable unsaturated groups include polyester (meth)acrylate, urethane (meth)acrylate, epoxy (meth)acrylate, melamine (meth)acrylate, triazine (meth)acrylate, and silicone (meth)acrylate. etc. The weight average molecular weight of these is usually preferably about 250 to 100,000. Here, the weight average molecular weight in this specification is an average molecular weight measured by GPC analysis (gel permeation chromatography) and converted to standard polystyrene.
 ラジカル重合性不飽和基を有するモノマーとしては、例えば、単官能モノマーとして、メチル(メタ)アクリレート、2-エチルヘキシル(メタ)アクリレート、フェノキシエチル(メタ)アクリレート等が挙げられる。また、多官能モノマーとしては、例えば、ジエチレングリコールジ(メタ)アクリレート、プロピレングリコールジ(メタ)アクリレート、トリメチロールプロパントリ(メタ)アクリレート、トリメチロールプロパンエチレンオキサイドトリ(メタ)アクリレート、ジペンタエリスリトールテトラ(メタ)アクリレート、ジペンタエリスリトールペンタ(メタ)アクリレート、ジペンタエリスリトールヘキサ(メタ)アクリレート等が挙げられる。 Examples of the monomer having a radically polymerizable unsaturated group include methyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, phenoxyethyl (meth)acrylate, and the like as monofunctional monomers. Examples of polyfunctional monomers include diethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, trimethylolpropane ethylene oxide tri(meth)acrylate, dipentaerythritol tetra( Examples thereof include meth)acrylate, dipentaerythritol penta(meth)acrylate, and dipentaerythritol hexa(meth)acrylate.
 カチオン重合性官能基を有するプレポリマーとしては、例えば、ビスフェノール型エポキシ樹脂、ノボラック型エポキシ化合物等のエポキシ系樹脂、脂肪酸系ビニルエーテル、芳香族系ビニルエーテル等のビニルエーテル系樹脂のプレポリマーが挙げられる。また、チオールとしては、例えば、トリメチロールプロパントリチオグリコレート、ペンタエリスリトールテトラチオグリコレート等のポリチオールが挙げられる。ポリエンとしては、例えば、ジオール及びジイソシアネートによるポリウレタンの両端にアリルアルコールを付加したものが挙げられる。 Examples of the prepolymer having a cationically polymerizable functional group include prepolymers of epoxy resins such as bisphenol-type epoxy resins and novolak-type epoxy compounds, and vinyl ether-based resins such as fatty acid vinyl ethers and aromatic vinyl ethers. Examples of the thiol include polythiols such as trimethylolpropane trithioglycolate and pentaerythritol tetrathioglycolate. Examples of the polyene include polyurethane made of diol and diisocyanate with allyl alcohol added to both ends.
 本発明では、電離放射線硬化型樹脂として、1分子中に2個のラジカル重合性不飽和基を有する重量平均分子量1000~3000のウレタン(メタ)アクリレートオリゴマー(A)と1分子中に3個~15個のラジカル重合性不飽和基を有する脂肪族ウレタン(メタ)アクリレートオリゴマー(B)を含有する混合樹脂を用いることができる。かかる混合樹脂を用いる場合には、架橋密度が高いため耐傷性、耐汚染性等の効果が得られ易い上、重量平均分子量及び/又は配合量を適宜調整することにより、架橋硬化型樹脂層を耐衝撃性に優れた態様としたり、Vカットなどの加工適性に優れた態様としたりする等、用途に応じた表面性能に調整し易いという利点がある。 In the present invention, as an ionizing radiation curable resin, a urethane (meth)acrylate oligomer (A) having a weight average molecular weight of 1,000 to 3,000 and having two radically polymerizable unsaturated groups in one molecule and a urethane (meth)acrylate oligomer (A) having two radically polymerizable unsaturated groups in one molecule, A mixed resin containing an aliphatic urethane (meth)acrylate oligomer (B) having 15 radically polymerizable unsaturated groups can be used. When using such a mixed resin, it is easy to obtain effects such as scratch resistance and stain resistance due to the high crosslinking density, and by appropriately adjusting the weight average molecular weight and/or blending amount, the crosslinked curable resin layer can be formed. It has the advantage that it is easy to adjust the surface performance according to the application, such as by making it into a form with excellent impact resistance or a form with excellent processing suitability such as V-cut.
 電離放射線硬化型樹脂中の上記オリゴマー(A)、上記オリゴマー(B)の含有割合は限定的ではないが、オリゴマー(A)及びオリゴマー(B)の合計量を100質量%とした場合に、オリゴマー(A)が50~90質量%、オリゴマー(B)が10~50質量%の範囲であれば好ましい。この範囲であれば、架橋硬化型樹脂層(硬化後)のマルテンス硬さを30N/mm以上180N/mm以下に設定し易く、架橋硬化型樹脂層の防滑性を各種用途(滑り抵抗値(C.S.R.値)が0.25以上)に調整し易い。 The content ratio of the oligomer (A) and the oligomer (B) in the ionizing radiation curable resin is not limited, but when the total amount of the oligomer (A) and the oligomer (B) is 100% by mass, the oligomer It is preferable that (A) be in the range of 50 to 90% by mass and the oligomer (B) be in the range of 10 to 50% by mass. Within this range, it is easy to set the Martens hardness of the cross-linked curable resin layer (after curing) to 30 N/mm 2 or more and 180 N/mm 2 or less, and the anti-slip property of the cross-linked curable resin layer can be used for various purposes (slip resistance value (C.S.R. value) of 0.25 or more).
 本発明では、電離放射線硬化型樹脂として、下記の樹脂A及び樹脂Bの二種類の脂肪族ウレタン(メタ)アクリレートを含有する混合樹脂を用いることもできる。ここで、(メタ)アクリレートとは、アクリレート又はメタクリレートの意味である。 In the present invention, a mixed resin containing two types of aliphatic urethane (meth)acrylates, Resin A and Resin B below, can also be used as the ionizing radiation curable resin. Here, (meth)acrylate means acrylate or methacrylate.
 樹脂Aはイソシアヌレート骨格を有する脂肪族ウレタン(メタ)アクリレートであり、この要件を満たす限り限定的ではないが、例えば、ジイソシアネートの三量体により形成されるイソシアヌレート骨格を有する脂肪族ウレタン(メタ)アクリレートが好ましい。具体的には、ヘキサメチレンジイソシアネート(特に1,6-ヘキサメチレンジイソシアネート)の三量体、トリレンジイソシアネートの三量体、メタキシレンジイソシアネートの三量体等が挙げられる。なお、トリレンジイソシアネート及びメタキシレンジイソシアネートはベンゼン環を有する点でヘキサメチレンジイソシアネートよりも耐候性が劣る可能性があるため、これらのジイソシアネートは水素添加されていることが好ましい。これらの樹脂Aは、架橋硬化型樹脂層の耐汚染性、耐アルカリ性等を向上させる効果がある。 Resin A is an aliphatic urethane (meth)acrylate having an isocyanurate skeleton, and is not limited as long as it satisfies this requirement. ) Acrylates are preferred. Specific examples include a trimer of hexamethylene diisocyanate (particularly 1,6-hexamethylene diisocyanate), a trimer of tolylene diisocyanate, a trimer of metaxylene diisocyanate, and the like. In addition, since tolylene diisocyanate and metaxylene diisocyanate may have inferior weather resistance than hexamethylene diisocyanate in that they have a benzene ring, these diisocyanates are preferably hydrogenated. These resins A have the effect of improving the stain resistance, alkali resistance, etc. of the crosslinked curable resin layer.
 樹脂Bはイソシアヌレート骨格を有さず、脂環骨格を有する脂肪族ウレタン(メタ)アクリレートであり、この要件を満たす限り限定的ではないが、例えば、当該脂環骨格としてイソホロン及びシクロヘキサンの少なくとも一種を有することが好ましい。具体的には、イソホロンジイソシアネートとブタンジオールとをモノマーとする重合体であるウレタンオリゴマーの末端にアクリレートを付加したもの、水素添加ジシクロヘキシルメタンジイソシアナート(水添MDI)のPG変性ジアクリレート等が挙げられる。これらの樹脂Bは、架橋硬化型樹脂層に柔軟性を付与する効果があり、樹脂Aとの組み合わせにより架橋硬化型樹脂層に長期間に亘る優れた耐汚染性、耐アルカリ性等とともに、衝撃が加わった際や加工時の割れやクラックの発生を抑制する効果を与える。 Resin B is an aliphatic urethane (meth)acrylate that does not have an isocyanurate skeleton but has an alicyclic skeleton, and is not limited as long as it satisfies this requirement, but for example, at least one of isophorone and cyclohexane as the alicyclic skeleton. It is preferable to have. Specifically, examples include urethane oligomers, which are polymers containing isophorone diisocyanate and butanediol as monomers, with acrylate added to the ends, and PG-modified diacrylates of hydrogenated dicyclohexylmethane diisocyanate (hydrogenated MDI). It will be done. These resins B have the effect of imparting flexibility to the cross-linked curable resin layer, and when combined with resin A, the cross-linked curable resin layer has excellent stain resistance, alkali resistance, etc. over a long period of time, as well as impact resistance. It has the effect of suppressing the occurrence of cracks and cracks when applied or processed.
 なお、電離放射線硬化型樹脂は、紫外線、電子線等の電離放射線の照射により重合架橋反応可能なラジカル重合性二重結合を分子中に含むプレポリマー(オリゴマーを含む)及び/又はモノマーを主成分とする透明性樹脂であって、硬化反応は、通常、架橋硬化反応である。電離放射線硬化型樹脂を硬化させるために用いる電離放射線としては、電離放射線硬化型樹脂(組成物)中の分子を硬化反応させ得るエネルギーを有する電磁波又は荷電粒子が用いられる。通常は紫外線又は電子線を用いればよいが、可視光線、X線、イオン線等を用いてもよい。なお、本発明では電離放射線硬化型樹脂の中でも、光重合開始剤を含まない点で原料樹脂の性質がそのまま架橋硬化型樹脂層の樹脂成分の性質に反映できる点、且つ耐候剤を併用する場合の選択の幅が広がるという点から電子線硬化型樹脂を用いることが好ましい。 Ionizing radiation-curable resins are mainly composed of prepolymers (including oligomers) and/or monomers that contain radically polymerizable double bonds in their molecules that can be polymerized and crosslinked by irradiation with ionizing radiation such as ultraviolet rays and electron beams. The curing reaction is usually a crosslinking curing reaction. As the ionizing radiation used to cure the ionizing radiation curable resin, electromagnetic waves or charged particles having energy capable of curing molecules in the ionizing radiation curable resin (composition) are used. Usually, ultraviolet rays or electron beams may be used, but visible light, X-rays, ion beams, etc. may also be used. In addition, in the present invention, among ionizing radiation curable resins, the properties of the raw material resin can be directly reflected in the properties of the resin components of the crosslinked curable resin layer since it does not contain a photopolymerization initiator, and when a weathering agent is used in combination. It is preferable to use an electron beam curable resin from the viewpoint of widening the range of selection.
 2液硬化型ウレタン系樹脂としては特に限定されないが、中でも主剤としてOH基を有するポリオール成分(アクリルポリオール、ポリエステルポリオール、ポリエーテルポリオール、エポキシポリオール等)と、硬化剤成分であるイソシアネート成分(トリレンジイソシアネート、ヘキサメチレンジイソシアネート、メタキシレンジイソシアネート等)とを含むものが使用できる。 Two-component curable urethane resins are not particularly limited, but include polyol components (acrylic polyols, polyester polyols, polyether polyols, epoxy polyols, etc.) having an OH group as a main component, and isocyanate components (tolylene diethylene chloride) as a curing agent component. isocyanate, hexamethylene diisocyanate, metaxylene diisocyanate, etc.) can be used.
 上記例示の架橋硬化型樹脂は1種又は2種以上を併用して用いることができる。 The crosslinked curable resins exemplified above can be used alone or in combination of two or more.
 架橋硬化型樹脂層は、架橋硬化型樹脂の硬化物に加えて抗ウイルス剤を含有する。一般にウイルスはエンベロープ(脂質膜)の有無によって、エンベロープウイルス(エンベロープを有する)とノンエンベロープウイルス(エンベロープを有さない)に大別される。エンベロープウイルスには、例えばインフルエンザウイルス、ヘルペスウイルス、エイズウイルス、B型肝炎ウイルス等が含まれる。また、ノンエンベロープウイルスには、例えばノロウイルス、ネコカリシウイルス、ライノウイルス、アデノウイルス等が含まれる。 The crosslinked curable resin layer contains an antiviral agent in addition to the cured product of the crosslinked curable resin. Viruses are generally classified into enveloped viruses (having an envelope) and non-enveloped viruses (having no envelope), depending on the presence or absence of an envelope (lipid membrane). Enveloped viruses include, for example, influenza virus, herpes virus, AIDS virus, hepatitis B virus, and the like. Furthermore, non-enveloped viruses include, for example, norovirus, feline calicivirus, rhinovirus, adenovirus, and the like.
 本発明で用いる抗ウイルス剤(以下、「本発明の抗ウイルス剤」ともいう)としては、ノンエンベロープウイルスに対して抗ウイルス性を有する抗ウイルス剤であって、カルボン酸誘導体及びスチレンポリマー誘導体を含有し、少なくとも前記カルボン酸誘導体の構成成分としてトリエチルアミン、N,N-ジメチルアリルアミン、ジメチルピロール、テトラメチル-1、3-プロパンジアミン、及びN,N,2,2-テトラメチル-1,3-プロパンジアミンを全て含有することを特徴とする。なお、本発明の抗ウイルス剤は、更にスチレンポリマー誘導体の構成成分としてもトリエチルアミン、N,N-ジメチルアリルアミン、ジメチルピロール、テトラメチル-1、3-プロパンジアミン、及びN,N,2,2-テトラメチル-1,3-プロパンジアミンを全て含有することが好ましい。これらは、カルボン酸誘導体及びスチレンポリマー誘導体をそれぞれ有機構造解析した際に構成成分として検出される化合物としての位置付けである。 The antiviral agent used in the present invention (hereinafter also referred to as "the antiviral agent of the present invention") is an antiviral agent that has antiviral properties against non-enveloped viruses and contains carboxylic acid derivatives and styrene polymer derivatives. The carboxylic acid derivative contains at least triethylamine, N,N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1,3- It is characterized by containing all propanediamine. The antiviral agent of the present invention further contains triethylamine, N,N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2- as constituent components of the styrene polymer derivative. Preferably, all of the tetramethyl-1,3-propanediamine is contained. These compounds are detected as constituents when the organic structures of carboxylic acid derivatives and styrene polymer derivatives are analyzed.
 前記カルボン酸誘導体としては、有機構造解析した際に上記所定の構成成分が検出される限り限定的ではないが、調製方法の一例としては、例えばシクロヘキサンカルボン酸(新日本理化株式会社製)、トリエチルアミン(東京化成工業株式会社製)、N,N-ジメチルアリルアミン(東京化成工業株式会社製)、2,4-ジメチルピロール(東京化成工業株式会社製)及びN,N,2,2-テトラメチル-1,3-プロパンジアミン(東京化成工業株式会社製)を含む原料を混合、反応させることによりカルボン酸誘導体を調製することができる。 The carboxylic acid derivative is not limited as long as the above-mentioned predetermined component is detected when the organic structure is analyzed, but examples of preparation methods include, for example, cyclohexanecarboxylic acid (manufactured by Shin Nippon Chemical Co., Ltd.), triethylamine, etc. (manufactured by Tokyo Chemical Industry Co., Ltd.), N,N-dimethylallylamine (manufactured by Tokyo Chemical Industry Co., Ltd.), 2,4-dimethylpyrrole (manufactured by Tokyo Chemical Industry Co., Ltd.), and N,N,2,2-tetramethyl- A carboxylic acid derivative can be prepared by mixing and reacting raw materials containing 1,3-propanediamine (manufactured by Tokyo Chemical Industry Co., Ltd.).
 また、前記スチレンポリマー誘導体としては、有機構造解析した際に上記所定の構成成分が検出されるものであることが好ましく、調製方法の一例としては、例えばp-スチレンスルホン酸ナトリウム(東ソー株式会社製;商品名「スピノマーNaSS」)、スチレンモノマー(和光純薬社製)及び変性エタノール(和光純薬社製;商品名「86%エタノール-ME」)を含む原料を混合、反応させることにスチレンポリマー誘導体を調製することができる。 The styrene polymer derivative is preferably one in which the above-described predetermined constituent components are detected when the organic structure is analyzed, and examples of preparation methods include, for example, sodium p-styrene sulfonate (manufactured by Tosoh Corporation). ; trade name "Spinomer NaSS"), styrene monomer (manufactured by Wako Pure Chemical Industries, Ltd.), and denatured ethanol (manufactured by Wako Pure Chemical Industries, Ltd.; trade name "86% Ethanol-ME") are mixed and reacted to form a styrene polymer. Derivatives can be prepared.
 本発明の抗ウイルス剤は、上記カルボン酸誘導体及び上記スチレンポリマー誘導体を所望の混合割合で混合(混練)し、例えばジェットミルなどの公知の粉砕手段により所望の大きさとなるように粉砕することにより調製することができる。なお、上記カルボン酸誘導体及び上記スチレンポリマー誘導体の含有割合は限定的ではないが、順に質量比で1:1~10:1の割合であることが好ましく、2:1~5:1の割合であることがより好ましい。かかる含有割合(混合割合)とすることにより、ノンエンベロープウイルスに対する抗ウイルス効果が得られ易くなる。 The antiviral agent of the present invention can be produced by mixing (kneading) the above carboxylic acid derivative and the above styrene polymer derivative at a desired mixing ratio, and pulverizing the mixture to a desired size using a known pulverizing means such as a jet mill. It can be prepared. Although the content ratio of the carboxylic acid derivative and the styrene polymer derivative is not limited, it is preferable that the mass ratio is 1:1 to 10:1, and 2:1 to 5:1. It is more preferable that there be. By setting such a content ratio (mixing ratio), it becomes easier to obtain an antiviral effect against non-enveloped viruses.
 本発明の抗ウイルス剤(一次粒子)の形状は限定されないが、例えば球、楕円体、多面体、鱗片形等が挙げられる。また、本発明の抗ウイルス剤の平均粒子径は限定的ではないが、平均粒子径は2μm以上15μm以下であることが好ましく、3μm以上12μm以下であることがより好ましい。なお、本明細書における平均粒子径は、レーザー光回折法による粒度分布測定における質量平均値D50として特定される値である。 The shape of the antiviral agent (primary particles) of the present invention is not limited, but examples thereof include spheres, ellipsoids, polyhedrons, scales, and the like. Further, the average particle diameter of the antiviral agent of the present invention is not limited, but it is preferably 2 μm or more and 15 μm or less, and more preferably 3 μm or more and 12 μm or less. Note that the average particle diameter in this specification is a value specified as the mass average value D50 in particle size distribution measurement by laser light diffraction method.
 本発明の抗ウイルス剤がウイルス(特にノンエンベロープウイルス)に対して抗ウイルス性を有する理由については下記のように推測されるが、下記に推測されるメカニズムに拘束される訳ではない。各種ウイルスは宿主細胞表面の糖鎖受容体(糖鎖末端はノイラミン酸)に結合して宿主細胞内に侵入するところ、本発明の抗ウイルス剤はノイラミン酸と類似したイオン基を有するため、宿主細胞の代わりにウイルスと結合してウイルスを捕捉することで、ウイルスが宿主細胞の受容体に結合するのを防止して抗ウイルス効果を発揮すると考えられる。具体的には、エンベロープウイルスのスパイクタンパク質及びノンエンベロープウイルスのカプシド(タンパク質の殻)に対して、カルボン酸誘導体の構成成分である前述の複数種のアミノ基が結合(補捉)する。それと同時又は従属的にスチレンポリマー誘導体のスルホン酸基がエンベロープを破壊することでエンベロープウイルスは不活性化し、カルボン酸誘導体化合物のカルボキシ基がカプシドを酸化することでノンエンベロープウイルスを不活性化すると考えられる。また、スルホン酸基は上述の通り主にエンベロープの破壊に寄与していると考えられるが、酸化力を有しているためカルボキシ基同様にノンエンベロープウイルスのカプシドの酸化にも関係する。そのためノンエンベロープウイルスを効率的に不活性化しつつ、更にエンベロープウイルスも不活性化するにはカルボン酸誘導体とスチレンポリマー誘導体を同時に用いることが有効となる。本発明の抗ウイルス剤は、表面保護層の表面性能を阻害しない含有量でノンエンベロープウイルスの不活化が可能である点で従来品に対する優位性があるが、エンベロープウイルスを不活化する推測メカニズムも上記の通りであり、本発明の抗ウイルス剤はノンエンベロープウイルスだけでなくエンベロープウイルスに対しても抗ウイルス効果を有している。 The reason why the antiviral agent of the present invention has antiviral properties against viruses (particularly non-enveloped viruses) is presumed as follows, but is not limited to the mechanism presumed below. Various viruses bind to sugar chain receptors on the surface of host cells (the sugar chain end is neuraminic acid) and invade into host cells, but the antiviral agent of the present invention has an ionic group similar to neuraminic acid, so it By binding to and capturing the virus instead of cells, it is thought to prevent the virus from binding to host cell receptors and exert an antiviral effect. Specifically, the plurality of amino groups described above that are constituents of the carboxylic acid derivative bind (capture) to the spike protein of an enveloped virus and the capsid (protein shell) of a non-enveloped virus. At the same time or dependently, enveloped viruses are thought to be inactivated by the sulfonic acid groups of styrene polymer derivatives destroying their envelopes, and non-enveloped viruses are thought to be inactivated by the carboxyl groups of carboxylic acid derivative compounds oxidizing capsids. It will be done. Furthermore, as mentioned above, the sulfonic acid group is thought to mainly contribute to the destruction of the envelope, but since it has oxidizing power, it is also involved in the oxidation of the capsid of non-enveloped viruses, just like the carboxy group. Therefore, in order to efficiently inactivate non-enveloped viruses and also inactivate enveloped viruses, it is effective to use a carboxylic acid derivative and a styrene polymer derivative at the same time. The antiviral agent of the present invention has an advantage over conventional products in that it can inactivate non-enveloped viruses at a content that does not impede the surface performance of the surface protective layer, but there is also a presumed mechanism for inactivating enveloped viruses. As described above, the antiviral agent of the present invention has an antiviral effect not only against non-enveloped viruses but also against enveloped viruses.
 架橋硬化型樹脂100質量部に対する本発明の抗ウイルス剤の含有量は、1質量部以上10質量部以下が好ましく、2質量部以上6質量部以下がより好ましい。かかる含有量の範囲内であれば、一般に表面保護層の表面性能に影響を与えることなく所定の抗ウイルス効果を発揮することができる。 The content of the antiviral agent of the present invention with respect to 100 parts by mass of the crosslinked curable resin is preferably 1 part by mass or more and 10 parts by mass or less, more preferably 2 parts by mass or more and 6 parts by mass or less. Within this content range, a predetermined antiviral effect can generally be exhibited without affecting the surface performance of the surface protective layer.
 架橋硬化型樹脂層の厚さは、架橋硬化型樹脂層が本発明の抗ウイルス剤に起因した凸部を有していない場合は平滑部の平均厚さが2μm以上であることが好ましく、本発明の抗ウイルス剤に起因した凸部を有している場合は凸部を除く平滑部の平均厚さが2μm以上であることが好ましい。平滑部の平均厚さは2μm以上の中でも、4μm以上がより好ましく、平均厚さの上限値としては35μm程度である。なお、架橋硬化型樹脂層の平均厚さは、エンボス凹凸模様及び本発明の抗ウイルス剤による凸部(架橋硬化型樹脂層の盛り上がり)が形成されていない平坦な箇所(図1の厚さA参照)における測定平均値であり、本明細書では架橋硬化型樹脂層の断面観察像の幅1cmにおける任意の10点の厚さの平均値を意味する。「幅」は厚さ方向に対して垂直な方向である。 The thickness of the cross-linked curable resin layer is preferably such that the average thickness of the smooth portion is 2 μm or more when the cross-linked curable resin layer does not have convex portions caused by the antiviral agent of the present invention. When it has convex portions caused by the antiviral agent of the invention, it is preferable that the average thickness of the smooth portion excluding the convex portions is 2 μm or more. The average thickness of the smooth portion is preferably 4 μm or more among 2 μm or more, and the upper limit of the average thickness is about 35 μm. The average thickness of the cross-linked curable resin layer is determined by the thickness of the flat area (thickness A in FIG. In this specification, it means the average value of the thickness of arbitrary 10 points in the width of 1 cm of the cross-sectional observation image of the cross-linked curable resin layer. "Width" is a direction perpendicular to the thickness direction.
 架橋硬化型樹脂層は、例えば、プライマー層上に架橋硬化型樹脂と本発明の抗ウイルス剤とを含有する架橋硬化型樹脂層形成用組成物をグラビアコート、ロールコート等の公知の塗工法により塗工後、樹脂を硬化させることにより形成できる。具体的には、架橋硬化型樹脂層形成用組成物を塗工後、完全に硬化する前に塗膜中で本発明の抗ウイルス剤がリフトアップすることにより架橋硬化型樹脂層の最表面に抗ウイルス剤に起因した凸部を形成したり、塗膜中で抗ウイルス剤が部分的に凝集し、抗ウイルス剤の粒子径が見た目上で大きくなったとしても抗ウイルス性能の発現に問題は無い。 For example, the crosslinked curable resin layer is formed by applying a composition for forming a crosslinked curable resin layer containing a crosslinked curable resin and the antiviral agent of the present invention onto the primer layer by a known coating method such as gravure coating or roll coating. It can be formed by curing the resin after coating. Specifically, after coating the composition for forming a cross-linked curable resin layer, the antiviral agent of the present invention lifts up in the coating film before it is completely cured, so that it reaches the outermost surface of the cross-linked curable resin layer. Even if protrusions are formed due to the antiviral agent, or the antiviral agent partially aggregates in the coating film, and the particle size of the antiviral agent becomes larger in appearance, there is no problem with the expression of antiviral performance. None.
 本発明では、架橋硬化型樹脂層の平滑部の厚さを三等分して下層、中層及び上層と区分した際に本発明の抗ウイルス剤の全体(数としての全体)のうち50%以上の抗ウイルス剤の中心点が前記中層又は前記上層(すなわち中層以上)に存在することが好ましい。図4は架橋硬化型樹脂層の平滑部の厚さAと抗ウイルス剤の中心点の位置との関係を例示的に示している。ここで、抗ウイルス剤9-1及び9-2は、抗ウイルス剤の中心点の位置が架橋硬化型樹脂層の平滑部の厚さを三等分したうちの中層又は上層(中層には下層と中層の境界を含み、上層には中層と上層との境界を含む)に存在する例示であり、抗ウイルス剤9-3は、抗ウイルス剤の中心点の位置が下層に存在する例示である。なお、抗ウイルス剤の中心点は、架橋硬化型樹脂層の断面観察像において、円形とは限らない各種形状の本発明の抗ウイルス剤が完全に収まるように最小径の円を描き、当該円の中心を中心点と定める。本発明の抗ウイルス剤の中心点が中層又は上層(すなわち中層以上)に存在する割合は上記の通り50%以上が好ましく、67%以上がより好ましい。かかる範囲内とすることにより、本発明の抗ウイルス剤の抗ウイルス効果が得られ易くなる。なお、このような好ましい態様においても、前述の通り架橋硬化型樹脂100質量部に対する本発明の抗ウイルス剤の含有量が10質量部以下であれば一般に表面保護層の表面性能に影響を与えることなく所定の抗ウイルス効果を発揮することができる。なお、断面観察は、片刃トリミング用カミソリ、ミクロトーム等の鋭利な刃物により架橋硬化型樹脂層を厚さ方向に切断した後、切断面(幅200μm分)をデジタルマイクロスコープ(キーエンス社製、型番:VHX-7000、倍率:200倍)により観察することにより行う。 In the present invention, when the thickness of the smooth part of the cross-linked curable resin layer is divided into three equal parts and divided into a lower layer, a middle layer, and an upper layer, 50% or more of the entire antiviral agent of the present invention (the entire number) It is preferable that the central point of the antiviral agent exists in the middle layer or the upper layer (that is, the middle layer or above). FIG. 4 exemplarily shows the relationship between the thickness A of the smooth portion of the crosslinked curable resin layer and the position of the center point of the antiviral agent. Here, for antiviral agents 9-1 and 9-2, the position of the center point of the antiviral agent is the middle layer or upper layer of the thickness of the smooth part of the crosslinked curing resin layer (the middle layer includes the lower layer). The antiviral agent 9-3 is an example in which the central point of the antiviral agent exists in the lower layer. . The center point of the antiviral agent is determined by drawing a circle with the smallest diameter in the cross-sectional observation image of the cross-linked cured resin layer so that the antiviral agent of the present invention, which has various shapes that are not necessarily circular, can be completely accommodated. The center of is set as the center point. The proportion of the central point of the antiviral agent of the present invention in the middle layer or upper layer (that is, the middle layer or above) is preferably 50% or more, more preferably 67% or more, as described above. Within this range, the antiviral effect of the antiviral agent of the present invention can be easily obtained. In addition, even in such a preferable embodiment, as mentioned above, if the content of the antiviral agent of the present invention is 10 parts by mass or less with respect to 100 parts by mass of the crosslinked curable resin, it generally does not affect the surface performance of the surface protective layer. It is possible to exert the desired antiviral effect without any need for treatment. For cross-sectional observation, after cutting the cross-linked cured resin layer in the thickness direction with a sharp blade such as a single-edged trimming razor or microtome, the cut surface (width 200 μm) was observed using a digital microscope (manufactured by Keyence Corporation, model number: This is done by observing with a VHX-7000 (magnification: 200x).
 本発明では、架橋硬化型樹脂層は、最表面に算術平均粗さRaが0.1μm以上である微細凹凸を有することが好ましい。かかる微細凹凸は、前記抗ウイルス剤のリフトアップにより抗ウイルス剤に起因して形成されていてもよく、サンドブラスト、微細エンボス等の物理加工により形成されていてもよい。なお、最表面に算術平均粗さRaは1.0μm以上がより好ましく、Raの好ましい上限は40μm以下程度である。このような微細凹凸が形成されていることにより最表面の表面積が増大することから、微細凹凸を有していない場合と比較して抗ウイルス効果が得られ易くなる。なお、本明細書における算術平均粗さRaは、JIS B0601(2001)に準拠し、表面粗さ測定器(「SURFCOM-FLEX-50A」、東京精密社製)により測定される値である。 In the present invention, it is preferable that the crosslinked curable resin layer has fine irregularities with an arithmetic mean roughness Ra of 0.1 μm or more on the outermost surface. Such fine irregularities may be formed due to the antiviral agent by lifting the antiviral agent, or may be formed by physical processing such as sandblasting or fine embossing. In addition, the arithmetic mean roughness Ra of the outermost surface is more preferably 1.0 μm or more, and the preferable upper limit of Ra is about 40 μm or less. Since the surface area of the outermost surface increases due to the formation of such fine irregularities, it becomes easier to obtain an antiviral effect compared to a case without fine irregularities. Note that the arithmetic mean roughness Ra in this specification is a value measured by a surface roughness measuring device (“SURFCOM-FLEX-50A”, manufactured by Tokyo Seimitsu Co., Ltd.) in accordance with JIS B0601 (2001).
 本発明では、架橋硬化型樹脂層のマルテンス硬さは30N/mm以上180N/mm以下が好ましく、60N/mm以上180N/mm以下がより好ましい。 In the present invention, the Martens hardness of the crosslinked curable resin layer is preferably 30 N/mm 2 or more and 180 N/mm 2 or less, more preferably 60 N/mm 2 or more and 180 N/mm 2 or less.
 なお、本明細書におけるマルテンス硬さは、ISO14577に準拠したマルテンス硬さ測定装置PICODENTOR HM-500(フィッシャ-・インストルメンツ製)を用いて測定した値である。具体的には、図5(a)に示されるダイヤモンド圧子(ビッカーズ圧子)を用いて、図5(b)に示すように測定試料にダイヤモンド圧子を押し込むことにより測定する。押し込み条件は、室温(実験室環境温度)において、図5(c)に示される通り、先ず0~5mNまでの負荷を10秒間で加え、次に5mNの負荷で5秒間保持し、最後に5~0mNまでの除荷を10秒間で行う。なお、本明細書では、架橋硬化型樹脂層以外の層の硬度の影響を回避するために架橋硬化型樹脂層の断面のマルテンス硬さを測定した。これに際し、化粧シートを樹脂(冷間硬化タイプのエポキシ2液硬化樹脂やUV硬化性樹脂などの樹脂)で埋包し、室温(23±5℃)で24時間以上放置して硬化させた後、硬化した埋包サンプルを切断し、機械研磨して架橋硬化型樹脂層の断面を露出させ、当該断面に(充填材等の微粒子が層中に含まれる場合には当該微粒子を避けた位置に)ダイヤモンド圧子を押し込むことにより断面のマルテンス硬さを測定した。 Note that the Martens hardness in this specification is a value measured using a Martens hardness measuring device PICODENTOR HM-500 (manufactured by Fisher Instruments) in accordance with ISO14577. Specifically, the measurement is performed by using a diamond indenter (Vickers indenter) shown in FIG. 5(a) and pushing the diamond indenter into the measurement sample as shown in FIG. 5(b). The indentation conditions were as shown in Figure 5(c) at room temperature (laboratory environment temperature), first a load of 0 to 5 mN was applied for 10 seconds, then a load of 5 mN was held for 5 seconds, and finally a load of 5 mN was applied for 10 seconds. Unload to ~0 mN in 10 seconds. In this specification, the Martens hardness of the cross-section of the cross-linked curable resin layer was measured in order to avoid the influence of the hardness of layers other than the cross-linked curable resin layer. At this time, the decorative sheet is embedded in a resin (resin such as a cold-curing type epoxy two-component curing resin or UV-curing resin), and is left at room temperature (23 ± 5°C) for at least 24 hours to harden. , cut the cured embedding sample, mechanically polish it to expose the cross-section of the cross-linked cured resin layer, and place it on the cross-section (if fine particles such as fillers are included in the layer, avoid the fine particles). ) The Martens hardness of the cross section was measured by indenting it with a diamond indenter.
 本発明では、架橋硬化型樹脂層のマルテンス硬さを好ましくは30N/mm以上180N/mm以下に設定することにより、防滑性の指標として、滑り抵抗値(C.S.R.値)を0.25以上に調整し易くなる。ここで、C.S.R.値における各種用途での防滑性の指標としては、0.25以上(特に0.25以上0.30未満)であれば建具用途として適していると判断でき、0.30以上(特に0.30以上0.38未満)であれば通常フロア用途として適していると判断でき、0.38以上(特に0.38以上0.50未満)であれば高度な防滑性を発揮する防滑フロア用途として適していると判断できる。なお、本明細書における滑り抵抗値(C.S.R.値)は東工大式滑り試験機(O-Y・PSM)を用いて、靴下による滑り抵抗値(C.S.R.値)を測定した値である。架橋硬化型樹脂層のマルテンス硬さが30N/mm以上180N/mm以下である場合において、これと対応する基材シート及び/又は透明性熱可塑性樹脂層のマルテンス硬さとしては、例えば30N/mm以上80N/mm以下であることが好ましい。 In the present invention, by setting the Martens hardness of the crosslinked curable resin layer to preferably 30 N/mm 2 or more and 180 N/mm 2 or less, the slip resistance value (C.S.R. value) is used as an index of anti-slip property. It becomes easier to adjust the value to 0.25 or more. Here, C. S. R. As an index of anti-slip property for various uses in terms of value, if it is 0.25 or more (especially 0.25 or more and less than 0.30), it can be judged that it is suitable for fittings, and if it is 0.30 or more (especially 0.30 If the value is 0.38 or more (especially 0.38 or more and less than 0.50), it is considered suitable for use as a normal floor, and if it is 0.38 or more (particularly 0.38 or more and less than 0.50), it is suitable for use as an anti-slip floor that exhibits a high level of anti-slip properties. It can be determined that In addition, the slip resistance value (C.S.R. value) in this specification is the slip resistance value (C.S.R. value) with socks using a Tokyo Institute of Technology slip tester (O-Y PSM). This is the value measured. When the Martens hardness of the cross-linked curable resin layer is 30 N/mm 2 or more and 180 N/mm 2 or less, the corresponding Martens hardness of the base sheet and/or transparent thermoplastic resin layer is, for example, 30 N/mm 2 or more and 180 N/mm 2 or less. /mm 2 or more and 80 N/mm 2 or less.
 本発明では、架橋硬化型樹脂層の抗ウイルス性能を補完するために架橋硬化型樹脂層にフェニルエーテル誘導体化合物を含有することができる。フェニルエーテル誘導体化合物としては、例えばポリオキシエチレンアルキルエーテルが挙げられ、これはエーテル型非イオン界面活性剤として抗ウイルス性能を発現し得ることが知られている。 In the present invention, a phenyl ether derivative compound can be contained in the crosslinked curable resin layer in order to complement the antiviral performance of the crosslinked curable resin layer. Examples of phenyl ether derivative compounds include polyoxyethylene alkyl ether, which is known to exhibit antiviral performance as an ether type nonionic surfactant.
 また、架橋硬化型樹脂層には、表面保護層の表面性能及び所定の抗ウイルス性に影響を与えない範囲で染料,顔料等の着色剤、無機フィラー等の充填剤、耐候剤、消泡剤、レベリング剤、チクソトロピー性付与剤、難燃剤、前記抗ウイルス剤とは異なる抗菌剤、前記抗ウイルス剤とは異なる抗アレルゲン剤等の各種添加剤を加えてもよい。例えば、本発明では、前記抗ウイルス剤に加えて、更に抗菌剤及び抗アレルゲン剤からなる群から選択される少なくとも一種を含有する態様を採用することができる。また、無機フィラーは主に艶消し剤として用いられる場合が多いが、架橋硬化型樹脂層に無機フィラーを含むことにより表面保護層の硬化収縮を抑制する効果も期待できる。 In addition, the cross-linked curable resin layer contains coloring agents such as dyes and pigments, fillers such as inorganic fillers, weathering agents, and antifoaming agents within the range that does not affect the surface performance of the surface protective layer and the specified antiviral properties. Various additives may be added, such as a leveling agent, a thixotropic agent, a flame retardant, an antibacterial agent different from the antiviral agent, and an antiallergen agent different from the antiviral agent. For example, in the present invention, an embodiment may be adopted in which, in addition to the antiviral agent, at least one selected from the group consisting of an antibacterial agent and an antiallergen agent is further included. In addition, inorganic fillers are often used mainly as matting agents, but by including an inorganic filler in the crosslinked curable resin layer, it can also be expected to have the effect of suppressing curing shrinkage of the surface protective layer.
 上記抗菌剤としては、無機系抗菌剤、及び有機系抗菌剤がある。特に無機系抗菌剤は有機系抗菌剤に比べ一般に安全性が高く、耐久性、及び耐熱性にも優れているため望ましい。本明細書における無機系抗菌剤とは、銀、銅、亜鉛等の抗菌性金属を各種の無機物担体に担持したものである。この中でも、銀含有無機系抗菌剤(銀含有無機粒子)が好ましく、具体的には銀担持ゼオライト粒子などが好ましい。 The above antibacterial agents include inorganic antibacterial agents and organic antibacterial agents. In particular, inorganic antibacterial agents are desirable because they are generally safer than organic antibacterial agents and have excellent durability and heat resistance. In this specification, the inorganic antibacterial agent refers to one in which antibacterial metals such as silver, copper, and zinc are supported on various inorganic carriers. Among these, silver-containing inorganic antibacterial agents (silver-containing inorganic particles) are preferred, and specifically silver-supported zeolite particles are preferred.
 上記抗アレルゲン剤は、無機化合物又は有機化合物のいずれか一方を含むものであり、各々単体で用いても良いし、異なる2種以上を混合させても良い。無機化合物としては金属を担持してなる材料であることが好ましい。 The above anti-allergen agent contains either an inorganic compound or an organic compound, and each may be used alone, or two or more different types may be mixed. The inorganic compound is preferably a material supporting a metal.
 抗アレルゲン剤としては、抗菌剤と類似又は同一の剤でも効果を発現する場合がある。その場合は所望の抗菌性と所望の抗アレルゲン性が得られるように抗菌剤及び抗アレルゲン剤の含有量の最適化を図ればよい。 As an anti-allergen agent, an agent similar or the same as an antibacterial agent may also be effective. In that case, the content of the antibacterial agent and antiallergen agent may be optimized so as to obtain the desired antibacterial property and the desired antiallergenic property.
 無機化合物の無機材料としては例えば、酸化チタン、リン酸カルシウム、珪酸カルシウム、リン酸ジルコニウム、ゼオライト、シリカアルミナ、珪酸マグネシウム及びリン酸マグネシウムからなる群から選択される少なくとも一種が好ましく、この中でも酸化チタン、リン酸ジルコニウム等が好ましい。 The inorganic material of the inorganic compound is preferably at least one selected from the group consisting of titanium oxide, calcium phosphate, calcium silicate, zirconium phosphate, zeolite, silica alumina, magnesium silicate, and magnesium phosphate, among which titanium oxide and phosphorus are preferred. Acid zirconium etc. are preferred.
 無機材料に担持される金属としては、例えば、銀、金、白金、亜鉛及び銅からなる群から選択される少なくとも一種が好ましく、この中でも亜鉛等が好ましい。市販品として例えば、日揮触媒製「アトミーボールTZ-R:酸化チタンに亜鉛担持」等を好適に用いることができ、これらの抗アレルゲン剤は、ダニや花粉などの種々のアレルゲンに対して有効に作用するものである。 The metal supported on the inorganic material is preferably at least one selected from the group consisting of silver, gold, platinum, zinc, and copper, and among these, zinc is preferred. As a commercially available product, for example, "Atomy Ball TZ-R: Zinc supported on titanium oxide" manufactured by JGC Shokubai can be suitably used, and these anti-allergen agents are effective against various allergens such as dust mites and pollen. It acts on
 有機化合物としては、フェノール性水酸基を含有する非水溶性高分子又はポリフェノール化合物が無機固体酸に担持されたもの、スチレンスルホン酸及びその塩からなる群から選択される少なくとも1種の単量体成分を含む重合体であることが好ましい。 As the organic compound, at least one monomer component selected from the group consisting of water-insoluble polymers containing phenolic hydroxyl groups or polyphenol compounds supported on inorganic solid acids, styrene sulfonic acid and salts thereof; It is preferable that it is a polymer containing.
 フェノール性水酸基を含有する非水溶性高分子としては、市販品として例えば積水化学工業株式会社製「アレルバスター(商品名)」、丸善石油株式会社製「マルカリンカーM(商品名)」等を使用することができる。また、ポリフェノール化合物とジルコニウム化合物とを組み合わせたものとしては、東亜合成株式会社製「アレリムーブ(商品名)」などが挙げられる。これらの抗アレルゲン剤は、ダニや花粉など種々のアレルゲンに対して有効に作用するものである。 As water-insoluble polymers containing phenolic hydroxyl groups, commercially available products such as "Aller Buster (trade name)" manufactured by Sekisui Chemical Co., Ltd. and "Maruka Linker M (trade name)" manufactured by Maruzen Sekiyu Co., Ltd. are used. can do. Further, as a combination of a polyphenol compound and a zirconium compound, there is "Aleli Move (trade name)" manufactured by Toagosei Co., Ltd., and the like. These anti-allergen agents act effectively against various allergens such as dust mites and pollen.
 スチレンスルホン酸及びその塩からなる群から選択される少なくとも一種の単量体成分としては、特許第6136433号に示されるような材料を用いることができる。 As at least one monomer component selected from the group consisting of styrene sulfonic acid and its salts, materials such as those shown in Japanese Patent No. 6136433 can be used.
 その他に、有機化合物と無機化合物とを混合させる場合は、例えばアニオン性フェノール系と抗アレルゲン性を有する亜鉛系材料が挙げられる。 In addition, when an organic compound and an inorganic compound are mixed, for example, an anionic phenol-based material and a zinc-based material having anti-allergenic properties may be used.
 アニオン性フェノール系材料としては、タンニン、タンニン酸-吐酒石、フェノールスルホン酸ホルムアルデヒド樹脂、ノボラック型樹脂のスルホン化合物、ノボラック型樹脂のメタンスルホン酸、レゾール型樹脂のメタンスルホン酸、ベンジル化フェノールスルホン酸、チオフェノール系化合物、ジヒドロオキシ、ジフェニルスルホン系化合物、リガント化合物及びこれらの金属キレート化合物などから適宜選択して用いられる。 Anionic phenolic materials include tannin, tannic acid tartarite, phenolsulfonic acid formaldehyde resin, sulfone compounds of novolac type resin, methanesulfonic acid of novolac type resin, methanesulfonic acid of resol type resin, and benzylated phenol sulfone. It is appropriately selected and used from acids, thiophenol compounds, dihydroxy, diphenylsulfone compounds, ligand compounds, metal chelate compounds thereof, and the like.
 亜鉛系材料としては、水溶性亜鉛化合物又は非水溶性亜鉛化合物、亜鉛/金属酸化物複合素材などから適宜選択され、非水溶性亜鉛化合物及び/又は非水溶性亜鉛・金属酸化物の複合粒子が水分散され、粒子径が50μm以下であり、前記金属酸化物がチタニア、シリカ、アルミナのいずれかを少なくとも一種含むものであることが好ましい。 The zinc-based material is appropriately selected from water-soluble zinc compounds, water-insoluble zinc compounds, zinc/metal oxide composite materials, etc., and water-insoluble zinc compounds and/or water-insoluble zinc/metal oxide composite particles are used. It is preferable that the metal oxide is water-dispersed, has a particle size of 50 μm or less, and contains at least one of titania, silica, and alumina.
 エンボス加工
 エンボス加工は、化粧シートに木目模様等の所望のテクスチャーを付与するために行い、透明性樹脂層上、及び/又は、架橋硬化型樹脂層上からエンボス加工が施されていてもよい。例えば、架橋硬化型樹脂層を加熱軟化させた後、所望の形の凹凸模様を有するエンボス板で加圧及び賦型し、冷却固定することによりテクスチャーを付与する。エンボス加工は、公知の枚葉又は輪転式エンボス機で行える。
Embossing Embossing is performed to impart a desired texture such as a wood grain pattern to the decorative sheet, and may be performed on the transparent resin layer and/or on the crosslinked curable resin layer. For example, a cross-linked curable resin layer is heated and softened, then pressed and shaped with an embossing plate having a desired pattern of unevenness, and then cooled and fixed to give a texture. Embossing can be performed with a known single-fed or rotary embossing machine.
 エンボス加工の凹凸模様としては、例えば、木目導管溝、浮造模様(浮出した年輪の凹凸模様)、ヘアライン、砂目、梨地等が挙げられる。 Examples of the embossed uneven pattern include wood grain conduit grooves, raised patterns (embossed annual ring uneven patterns), hairlines, sand grains, satin finishes, and the like.
 エンボス加工を施した場合には、必要に応じて、エンボス凹部にワイピング加工によりインキを充填してもよい。例えば、エンボス凹部にドクターブレードで表面をかきながらインキを充填する。充填するインキ(ワイピングインキ)としては、通常は2液硬化型のウレタン樹脂をバインダーとするインキを用いることができる。特に木目導管溝凹凸に対してワイピング加工を行うことによって、より実際の木目に近い意匠を表現することにより商品価値を高めることができる。 When embossing is performed, the embossed recesses may be filled with ink by wiping, if necessary. For example, ink is filled into the embossed recesses while scraping the surface with a doctor blade. As the ink to be filled (wiping ink), it is usually possible to use an ink having a two-component curing type urethane resin as a binder. In particular, by performing a wiping process on the unevenness of the wood grain conduit groove, the product value can be increased by expressing a design that is closer to the actual wood grain.
 裏面プライマー層
 基材シートの裏面には、必要に応じて裏面プライマー層を設けてもよい。例えば、基材シートと化粧板基材とを接着して化粧板を作製する際に効果的である。
A back primer layer may be provided on the back side of the back primer layer base sheet, if necessary. For example, it is effective when producing a decorative laminate by bonding a base sheet and a decorative laminate base material.
 裏面プライマー層は、公知のプライマー剤を基材シートに塗布することにより形成できる。プライマー剤としては、例えば、アクリル変性ウレタン樹脂(アクリルウレタン系共重合体樹脂)、ポリカーボネート系アクリルウレタン共重合体樹脂等からなるウレタン樹脂系プライマー剤、ウレタン-セルロース系樹脂(例えば、ウレタンと硝化綿の混合物にヘキサメチレンジイソシアネートを添加してなる樹脂)からなるプライマー剤、アクリルとウレタンのブロック共重合体からなる樹脂系プライマー剤等が挙げられる。 The back primer layer can be formed by applying a known primer agent to the base sheet. Examples of primer agents include acrylic modified urethane resins (acrylic urethane copolymer resins), urethane resin primers made of polycarbonate-based acrylic urethane copolymer resins, and urethane-cellulose resins (for example, urethane and nitrified cotton). A resin-based primer agent made of a block copolymer of acrylic and urethane, etc. may be mentioned.
 プライマー剤には、必要に応じて、添加剤を配合してもよい。添加剤としては、例えば、炭酸カルシウム、クレー等の充填剤、水酸化マグネシウム等の難燃剤、酸化防止剤、滑剤、発泡剤、紫外線吸収剤、光安定剤などが挙げられる。添加剤の配合量は、製品特性に応じて適宜設定できる。 Additives may be added to the primer agent if necessary. Examples of additives include fillers such as calcium carbonate and clay, flame retardants such as magnesium hydroxide, antioxidants, lubricants, foaming agents, ultraviolet absorbers, and light stabilizers. The blending amount of the additive can be appropriately set depending on the product characteristics.
 裏面プライマー層の厚さは特に限定されないが、通常0.01~10μm、好ましくは0.1~1μm程度である。 The thickness of the back primer layer is not particularly limited, but is usually about 0.01 to 10 μm, preferably about 0.1 to 1 μm.
 合成樹脂製バッカー層
 基材シートの裏面には、必要に応じて合成樹脂製バッカー層を設けてもよい。合成樹脂製バッカー層を有することにより、化粧シートの耐衝撃性がより一層向上する。なお、前述の裏面プライマー層も設ける場合には、基材シートの裏面に基材シート側から合成樹脂製バッカー層及び裏面プライマー層の順に設ける。
Synthetic resin backer layer A synthetic resin backer layer may be provided on the back side of the base sheet, if necessary. By having the synthetic resin backer layer, the impact resistance of the decorative sheet is further improved. In addition, when the above-mentioned back primer layer is also provided, the synthetic resin backer layer and the back primer layer are provided on the back surface of the base sheet in this order from the base sheet side.
 合成樹脂製バッカー層を構成する樹脂としては、例えば、ポリプロピレン、エチレン-ビニルアルコール共重合体、ポリメチレン、ポリメチルペンテン、ポリエチレンテレフタレート、耐熱性の高いポリアルキレンテレフタレート〔例えば、エチレングリコールの一部を1,4-シクロヘキサンジメタノールやジエチレングリコール等で置換したポリエチレンテレフタレートである、いわゆる商品名PET-G(イーストマンケミカルカンパニー製)〕、ポリブチレンテレフタレート、ポリエチレンナフタレート、ポリエチレンナフタレート-イソフタレート共重合体、ポリカーボネート、ポリアリレート、ポリイミド、ポリスチレン、ポリアミド、ABS、スチレンブタジエンゴム、イソプレンゴム、クロロプレンゴムなどのジエン系ゴム、ブチルゴム、エチレンプロピレンゴムなどの非ジエン系ゴム、天然ゴム、熱可塑性エラストマー等が挙げられる。これらの樹脂は単独又は2種以上で使用できる。 Examples of the resin constituting the synthetic resin backer layer include polypropylene, ethylene-vinyl alcohol copolymer, polymethylene, polymethylpentene, polyethylene terephthalate, and highly heat-resistant polyalkylene terephthalate [for example, a portion of ethylene glycol , polyethylene terephthalate substituted with 4-cyclohexanedimethanol or diethylene glycol, so-called PET-G (manufactured by Eastman Chemical Company)], polybutylene terephthalate, polyethylene naphthalate, polyethylene naphthalate-isophthalate copolymer, Examples include diene rubbers such as polycarbonate, polyarylate, polyimide, polystyrene, polyamide, ABS, styrene-butadiene rubber, isoprene rubber, and chloroprene rubber, non-diene rubbers such as butyl rubber and ethylene propylene rubber, natural rubber, thermoplastic elastomers, etc. . These resins can be used alone or in combination of two or more.
 合成樹脂製バッカー層の厚みは、0.1~0.6mmが好ましく、0.15~0.45mmがより好ましく、0.20~0.40mmが更に好ましい。合成樹脂製バッカー層の厚みの下限が上記範囲であることにより、化粧シートの耐衝撃性がより一層向上する。また、合成樹脂製バッカー層の厚みの上限が上記範囲であることにより、化粧シートの反りがより一層抑制される。 The thickness of the synthetic resin backer layer is preferably 0.1 to 0.6 mm, more preferably 0.15 to 0.45 mm, and even more preferably 0.20 to 0.40 mm. When the lower limit of the thickness of the synthetic resin backer layer is within the above range, the impact resistance of the decorative sheet is further improved. Furthermore, by setting the upper limit of the thickness of the synthetic resin backer layer within the above range, warping of the decorative sheet is further suppressed.
 化粧シートの各層に含まれる各種添加剤のベシクル化
 本発明の化粧シートの上述の各層に添加される各種添加剤(プライマー層や架橋硬化型樹脂層に添加される無機フィラー等)は、当該各種添加剤がベシクル化されていることが好ましい。各種添加剤をベシクル化する方法としては特に限定されず、公知の方法によりベシクル化することができ、中でも超臨界逆相蒸発法が好ましい。
Vesicleization of various additives contained in each layer of the decorative sheet The various additives added to the above-mentioned layers of the decorative sheet of the present invention (such as inorganic fillers added to the primer layer and the cross-linked hardening resin layer) are Preferably, the additive is vesiculated. The method for forming various additives into vesicles is not particularly limited, and may be formed by any known method, and among them, supercritical reverse phase evaporation is preferred.
 ベシクル化処理方法としては、超臨界逆相蒸発法の他に、Bangham法、エクストルージョン法、水和法、逆相蒸発法、凍結融解法などが挙げられる。このようなベシクル化処理方法について簡単に説明すると、Bangham法は、フラスコなどの容器にクロロホルムまたはクロロホルム/メタノール混合溶媒を入れ、さらにリン脂質を入れて溶解する。その後、エバポレータを用いて溶媒を除去して脂質からなる薄膜を形成し、添加剤の分散液を加えた後、ボルテックスミキサーで水和・分散させることよりベシクルを得る方法である。エクストルージョン法は、薄膜のリン脂質溶液を調液し、Bangham法において外部摂動として用いたミキサーに代わってフィルターを通過させることによりベシクルを得る方法である。水和法は、Bangham法とほぼ同じ調製方法であるが、ミキサーを用いずに、穏やかに攪拌して分散させてベシクルを得る方法である。逆相蒸発法は、リン脂質をジエチルエーテルやクロロホルムに溶解し、添加剤を含んだ溶液を加えてW/Oエマルジョンを作り、当該エマルジョンから減圧下において有機溶媒を除去した後、水を添加することによりベシクルを得る方法である。凍結融解法は、外部摂動として冷却・加熱を用いる方法であり、この冷却・加熱を繰り返すことによってベシクルを得る方法である。 In addition to the supercritical reverse phase evaporation method, examples of the vesicle formation treatment method include the Bangham method, the extrusion method, the hydration method, the reverse phase evaporation method, and the freeze-thaw method. To briefly explain such a vesiculation treatment method, in the Bangham method, chloroform or a mixed solvent of chloroform/methanol is placed in a container such as a flask, and then phospholipids are added and dissolved. Thereafter, the solvent is removed using an evaporator to form a thin film made of lipids, and after a dispersion of additives is added, vesicles are obtained by hydration and dispersion using a vortex mixer. The extrusion method is a method for obtaining vesicles by preparing a thin film of phospholipid solution and passing it through a filter instead of the mixer used as an external perturbation in the Bangham method. The hydration method is a preparation method that is almost the same as the Bangham method, but it is a method in which vesicles are obtained by gentle stirring and dispersion without using a mixer. In the reverse phase evaporation method, phospholipids are dissolved in diethyl ether or chloroform, a solution containing additives is added to create a W/O emulsion, the organic solvent is removed from the emulsion under reduced pressure, and water is added. This method is used to obtain vesicles. The freeze-thaw method is a method that uses cooling and heating as external perturbations, and is a method that obtains vesicles by repeating this cooling and heating.
 以下、超臨界逆相蒸発法について詳細に説明する。超臨界逆相蒸発法とは、超臨界状態又は超臨界点以上の温度若しくは圧力条件下の二酸化炭素にベシクルの外膜を形成する物質を均一に溶解させた混合物中に、水溶性または親水性の封入物質としての各種添加剤を含む水相を加えて、一層の膜で封入物質としての各種添加剤を包含したカプセル状のベシクルを形成する方法である。なお、超臨界状態の二酸化炭素とは、臨界温度(30.98℃)および臨界圧力(7.3773±0.0030MPa)以上の超臨界状態にある二酸化炭素を意味し、臨界点以上の温度若しくは圧力条件下の二酸化炭素とは、臨界温度のみ、又は、臨界圧力のみが臨界条件を超えた条件下の二酸化炭素を意味する。当該方法により、直径50~800nmの単層ラメラベシクルを得ることができる。一般に、ベシクルとは、球殻状に閉じた膜構造を有する小胞の内部に液相を含むものの総称であり、特に、外膜がリン脂質等の生体脂質から構成されるものをリポソームと称する。 Hereinafter, the supercritical reverse phase evaporation method will be explained in detail. The supercritical reverse phase evaporation method is a method in which water-soluble or hydrophilic substances are uniformly dissolved in carbon dioxide in a supercritical state or at a temperature or pressure above the supercritical point. In this method, an aqueous phase containing various additives as an encapsulating substance is added to form a capsule-shaped vesicle containing various additives as an encapsulating substance in a single layer of membrane. In addition, carbon dioxide in a supercritical state means carbon dioxide in a supercritical state at a critical temperature (30.98°C) and a critical pressure (7.3773 ± 0.0030 MPa) or higher; Carbon dioxide under pressure conditions means carbon dioxide under conditions where only the critical temperature or only the critical pressure exceeds the critical condition. By this method, unilamellar vesicles with a diameter of 50 to 800 nm can be obtained. In general, a vesicle is a general term for a vesicle that has a closed spherical membrane structure and contains a liquid phase inside. In particular, a vesicle whose outer membrane is composed of biological lipids such as phospholipids is called a liposome. .
 上記リン脂質としては、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジン酸、ホスファチジルグリセロール、ホスファチジルイノシトール、カルジオリピン、卵黄レシチン、水添卵黄レシチン、大豆レシチン、水添大豆レシチン等のグリセロリン脂質、スフィンゴミエリン、セラミドホスホリルエタノールアミン、セラミドホスホリルグリセロール等のスフィンゴリン脂質が挙げられる。 The above-mentioned phospholipids include phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidic acid, phosphatidylglycerol, phosphatidylinositol, cardiolipin, egg yolk lecithin, hydrogenated egg yolk lecithin, soybean lecithin, glycerophospholipids such as hydrogenated soybean lecithin, sphingomyelin, and ceramide. Examples include sphingophospholipids such as phosphorylethanolamine and ceramide phosphorylglycerol.
 外膜を構成する物質としては、また、ノニオン系界面活性剤や、これとコレステロール類若しくはトリアシルグリセロールの混合物等の分散剤を用いることができる。 As the substance constituting the outer membrane, a dispersant such as a nonionic surfactant or a mixture of this and cholesterol or triacylglycerol can be used.
 上記ノニオン系界面活性剤としては、ポリグリセリンエーテル、ジアルキルグリセリン、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンソルビタン脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンポリオキシプロピレンコポリマー、ポリブタジエン-ポリオキシエチレン共重合体、ポリブタジエン-ポリ2-ビニルピリジン、ポリスチレン-ポリアクリル酸共重合体、ポリエチレンオキシド-ポリエチルエチレン共重合体、ポリオキシエチレン-ポリカプロラクタム共重合体等の1種又は2種以上を用いることができる。 Examples of the nonionic surfactants include polyglycerin ether, dialkylglycerin, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl ether, polyoxyethylene sorbitan fatty acid ester, sorbitan fatty acid ester, polyoxyethylene polyoxypropylene copolymer, and polybutadiene. One or two types of polyoxyethylene copolymer, polybutadiene-poly2-vinylpyridine, polystyrene-polyacrylic acid copolymer, polyethylene oxide-polyethylethylene copolymer, polyoxyethylene-polycaprolactam copolymer, etc. The above can be used.
 上記コレステロール類としては、コレステロール、α-コレスタノール、β-コレスタノール、コレスタン、デスモステロール(5,24-コレスタジエン-3β-オール)、コール酸ナトリウム、コレカルシフェロール等の1種又は2種以上を用いることができる。 The above-mentioned cholesterols include one or more of cholesterol, α-cholestanol, β-cholestanol, cholestane, desmosterol (5,24-cholestadien-3β-ol), sodium cholate, cholecalciferol, etc. Can be used.
 上記リポソームの外膜は、リン脂質と分散剤との混合物から形成されていてもよい。本発明の化粧シートにおいては、外膜をリン脂質から形成したリポソームとすることで、各層の主成分である樹脂組成物と各種添加剤との相溶性を良好なものとすることができる。 The outer membrane of the liposome may be formed from a mixture of a phospholipid and a dispersant. In the decorative sheet of the present invention, by forming the outer membrane as a liposome formed from phospholipid, it is possible to improve the compatibility between the resin composition, which is the main component of each layer, and various additives.
 2.抗ウイルス性粘着加工シート
 本発明の抗ウイルス性粘着加工シート(本発明の粘着加工シート)は、厚さ方向において順に、粘着シートと、本発明の化粧シートとを少なくとも備える積層体から構成される。粘着シートとしては特に限定されず、化粧シートその他の機能性シートの分野で使用されている粘着シートを適宜使用することができる。本発明の粘着加工シートは、裏面に粘着シートを有することにより、フロア用の各種物品及び被着体の表面に貼付することができ、任意に抗ウイルス性を付与することができる。
2. Antiviral Adhesive Processed Sheet The antiviral adhesive processed sheet of the present invention (adhesive processed sheet of the present invention) is composed of a laminate comprising at least an adhesive sheet and a decorative sheet of the present invention in this order in the thickness direction. . The pressure-sensitive adhesive sheet is not particularly limited, and any pressure-sensitive adhesive sheet used in the field of decorative sheets and other functional sheets can be used as appropriate. By having an adhesive sheet on the back side, the adhesive processed sheet of the present invention can be applied to the surfaces of various articles for floors and adherends, and can optionally be imparted with antiviral properties.
 図2に、粘着シート10上に本発明の化粧シート1(架橋硬化型樹脂層側とは反対面と粘着シート10とを貼り合わせる)がこの順に積層された抗ウイルス性粘着加工シート11の一例を示す。 FIG. 2 shows an example of an antiviral pressure-sensitive adhesive sheet 11 in which the decorative sheet 1 of the present invention (the surface opposite to the cross-linked curable resin layer and the pressure-sensitive adhesive sheet 10 are laminated in this order) on the pressure-sensitive adhesive sheet 10. shows.
 3.抗ウイルス性化粧板
 本発明の抗ウイルス性化粧板(本発明の化粧板)は、厚さ方向において順に、化粧板基材と、本発明の化粧シート又は本発明の粘着加工シートとを少なくとも備える積層体から構成される。
3. Antiviral Decorative Board The antiviral decorative board of the present invention (the decorative board of the present invention) comprises at least, in order in the thickness direction, a decorative board base material, and a decorative sheet of the present invention or an adhesive processed sheet of the present invention. Composed of laminates.
 図3に、化粧板基材12上に本発明の化粧シート1(架橋硬化型樹脂層側とは反対面と化粧板基材12とを貼り合わせる)がこの順に積層された抗ウイルス性化粧板13の一例を示す。 FIG. 3 shows an antiviral decorative board in which the decorative sheet 1 of the present invention (the surface opposite to the cross-linked curing resin layer side and the decorative board base material 12 are laminated) on the decorative board base material 12 in this order. An example of No. 13 is shown below.
 化粧板基材としては限定的ではないが、例えば、中密度木質繊維板、高密度木質繊維板、パーティクルボード、針葉樹合板、広葉樹合板、早成樹合板、コルクシート、コルク含有複合基材、熱可塑性樹脂板(ポリ塩化ビニル樹脂、ポリプロピレン樹脂、ポリエチレン樹脂、アクリル樹脂、ABS樹脂等を主成分とする樹脂板、又はそれらを発泡させたもの)等の少なくとも1種が挙げられる。これらの化粧板基材は、単独又は2種以上を組み合わせて積層することにより使用してもよい。 Decorative board base materials include, but are not limited to, medium-density wood fiberboard, high-density wood fiberboard, particle board, softwood plywood, hardwood plywood, early-wood plywood, cork sheet, cork-containing composite base material, thermoplastic At least one type of resin board (resin board whose main component is polyvinyl chloride resin, polypropylene resin, polyethylene resin, acrylic resin, ABS resin, etc., or a foamed version thereof) can be used. These decorative laminate base materials may be used alone or in combination and laminated together.
 ここで、針葉樹としては、例えば、椴松、唐松、蝦夷松、杉、ヒノキ、パイン、セコイヤ、トウヒ等が挙げられる。広葉樹としては、例えば、ラワン、シナ、カバ、セン、ブナ、ナラ、メランチ等が挙げられる。また、早成樹としては、ポプラ、ファルカタ、アカシア、カメレレ、ユーカリ、ターミナリア等が挙げられる。 Here, examples of coniferous trees include Japanese pine, Japanese pine, Ezo pine, cedar, cypress, pine, sequoia, spruce, and the like. Examples of broad-leaved trees include lauan, china, birch, sen, beech, oak, and meranti. Moreover, examples of fast-growing trees include poplar, falcata, acacia, chameleon, eucalyptus, terminaria, and the like.
 針葉樹合板、広葉樹合板、早成樹合板等の木質合板を用いる場合の木質単板の積層数(プライ数)は限定的ではないが、通常3~7枚が好ましく、5~7枚がより好ましい。また、木質合板作製時に用いる接着剤も限定されず、公知の木工用接着剤が広く使用できる。接着剤としては、例えば、ポリ酢酸ビニル、ポリ塩化ビニル、塩化ビニル-酢酸ビニル共重合体、エチレン-アクリル酸共重合体、アイオノマー、ブタジエン-アクリルニトリルゴム、ネオプレンゴム、天然ゴム等を有効成分とする接着剤が挙げられる。また、熱硬化型接着剤として、メラミン系、フェノール系、ユリア系(酢酸ビニル-尿素系など)等の接着剤も挙げられる。 When using wood plywood such as softwood plywood, hardwood plywood, and early-maturity plywood, the number of laminated wood veneers (number of plies) is not limited, but is usually preferably 3 to 7, more preferably 5 to 7. Further, the adhesive used when producing the wood plywood is not limited, and a wide variety of known woodworking adhesives can be used. Examples of the adhesive include polyvinyl acetate, polyvinyl chloride, vinyl chloride-vinyl acetate copolymer, ethylene-acrylic acid copolymer, ionomer, butadiene-acrylonitrile rubber, neoprene rubber, natural rubber, etc. as active ingredients. Examples include adhesives that can be used. Further, examples of thermosetting adhesives include melamine-based, phenol-based, urea-based (vinyl acetate-urea, etc.) adhesives, and the like.
 前記コルクシートとしては、コルク樫の樹皮のコルク組織を剥離及び加工した弾力性に富む素材であるいわゆる天然コルクだけでなく、コルクに似せて作られたいわゆる合成コルクのいずれも用いることができる。なお、コルクシートは単層であってもよく、弾性率や密度が異なる複数のコルクシートの積層体であってもよい。 As the cork sheet, not only so-called natural cork, which is a highly elastic material made by exfoliating and processing the cork tissue of cork oak bark, but also so-called synthetic cork, which is made to resemble cork, can be used. Note that the cork sheet may be a single layer, or may be a laminate of a plurality of cork sheets having different elastic moduli and densities.
 前記コルク含有複合基材としては、コルクシートと他の材質(例えば、中密度木質繊維板、高密度木質繊維板)とを積層して貼り合わせてなる複合材などが挙げられる。 Examples of the cork-containing composite base material include a composite material formed by laminating and bonding a cork sheet and other materials (for example, medium-density wood fiberboard, high-density wood fiberboard).
 化粧板基材の厚さは限定的ではないが、2~15mm程度が好ましく、2~12mm程度がより好ましい。 The thickness of the decorative board base material is not limited, but is preferably about 2 to 15 mm, more preferably about 2 to 12 mm.
 化粧シート又は粘着加工シートと化粧板基材とを積層する積層方法は限定的でなく、例えば接着剤によりそれぞれを貼着する方法等を採用することができる。また、粘着加工シートが化粧板基材と十分な接着性を有している場合には、更に接着剤を介することなく粘着加工シートと化粧板基材とを貼着する方法を採用することができる。接着剤は、被着材の種類等に応じて公知の接着剤から適宜選択すればよい。例えば、ウレタン、アクリル、ウレタン-アクリル、ポリ酢酸ビニル、ポリ塩化ビニル、塩化ビニル-酢酸ビニル共重合体、エチレン-アクリル酸共重合体、アイオノマー等のほか、ブタジエン-アクリルニトリルゴム、ネオプレンゴム、天然ゴム等が挙げられる。これら接着剤は、単独で又は2種以上を組み合わせて用いる。 The lamination method for laminating the decorative sheet or adhesive processed sheet and the decorative laminate base material is not limited, and for example, a method of pasting each with an adhesive can be adopted. In addition, if the adhesive sheet has sufficient adhesion to the decorative laminate base material, it is possible to adopt a method of attaching the adhesive sheet and the decorative laminate base material without using an adhesive. can. The adhesive may be appropriately selected from known adhesives depending on the type of adherend. For example, in addition to urethane, acrylic, urethane-acrylic, polyvinyl acetate, polyvinyl chloride, vinyl chloride-vinyl acetate copolymer, ethylene-acrylic acid copolymer, ionomer, butadiene-acrylonitrile rubber, neoprene rubber, natural Examples include rubber. These adhesives may be used alone or in combination of two or more.
 以下に実施例及び比較例並びに試験例を示して本発明を具体的に説明する。但し、本発明は実施例に示す内容に限定されない。 The present invention will be specifically described below with reference to Examples, Comparative Examples, and Test Examples. However, the present invention is not limited to the contents shown in the examples.
 実施例1
 基材シートとして60μm厚の着色ポリプロピレンフィルムを用意した。
Example 1
A 60 μm thick colored polypropylene film was prepared as a base sheet.
 基材シートの裏面に裏面プライマー層(厚さ2μm)を形成した。また、基材シートのおもて面に、2液型ウレタンインキ(商品名「V180」、東洋インキ社製)を用いて厚さ2μmとなるように絵柄模様層をグラビア印刷により形成した。 A back primer layer (thickness: 2 μm) was formed on the back side of the base sheet. Further, a pattern layer was formed on the front surface of the base sheet by gravure printing using a two-component urethane ink (trade name "V180", manufactured by Toyo Ink Co., Ltd.) to a thickness of 2 μm.
 絵柄模様層上に、ウレタン系樹脂を用いて厚さ2μmとなるように透明性接着剤層を形成した。 A transparent adhesive layer was formed on the pattern layer using urethane resin to a thickness of 2 μm.
 透明性接着剤層上に、厚さ80μmとなるように透明ランダムポリプロピレン系樹脂のシートを押し出しラミネート方式で積層し、透明性樹脂層を形成した。 A sheet of transparent random polypropylene resin was laminated on the transparent adhesive layer by an extrusion lamination method to a thickness of 80 μm to form a transparent resin layer.
 透明性樹脂層のおもて面にコロナ放電処理を施した後、2液硬化型ウレタン樹脂を含むプライマー剤を厚さ2μmで塗工することによりプライマー層を形成した。 After corona discharge treatment was applied to the front surface of the transparent resin layer, a primer layer was formed by applying a primer agent containing a two-component curable urethane resin to a thickness of 2 μm.
 プライマー層のおもて面に、下記の架橋硬化型樹脂層形成用組成物をグラビアコート方式により15μmの塗工量で塗工した後、酸素濃度200ppm以下の環境下、電子線照射装置を用いて加速電圧165KeV、5Mradの条件で電子線を照射して電子線硬化型樹脂を硬化させることで架橋硬化型樹脂層を形成し、化粧シートを作製した。ここで、下記の抗ウイルス剤が架橋硬化性樹脂100質量部に対して3質量部含有されるように設定した。なお、架橋硬化型樹脂層の断面観察における、抗ウイルス剤の中心点が中層又は上層(すなわち中層以上)に存在する割合は全体の60%であった。 After applying the following composition for forming a crosslinked curable resin layer to the front surface of the primer layer in a coating amount of 15 μm using a gravure coating method, using an electron beam irradiation device in an environment with an oxygen concentration of 200 ppm or less. A crosslinked curable resin layer was formed by irradiating the electron beam under the conditions of an acceleration voltage of 165 KeV and 5 Mrad to cure the electron beam curable resin, thereby producing a decorative sheet. Here, the following antiviral agent was set to be contained in an amount of 3 parts by mass based on 100 parts by mass of the crosslinked curable resin. In addition, in the cross-sectional observation of the crosslinked curable resin layer, the proportion of the central point of the antiviral agent present in the middle layer or upper layer (that is, the middle layer or above) was 60% of the total.
(架橋硬化型樹脂層形成用組成物)
・架橋硬化性樹脂として、多官能ウレタンオリゴマー30質量部、及び2官能オリゴマー70質量部からなる合計100質量部のウレタンアクリレート樹脂(硬化後の架橋硬化型樹脂層のマルテンス硬さが110N/mmとなる処方)
・抗ウイルス剤(樹脂100質量部に対する含有量は3質量部)
 カルボン酸誘導体は、シクロヘキサンカルボン酸(新日本理化株式会社製)、トリエチルアミン(東京化成工業株式会社製)、N,N-ジメチルアリルアミン(東京化成工業株式会社製)、2,4-ジメチルピロール(東京化成工業株式会社製)及びN,N,2,2-テトラメチル-1,3-プロパンジアミン(東京化成工業株式会社製)を含む原料を混合、反応させることにより調製した。
(Crosslinked curable resin layer forming composition)
- As a crosslinked curable resin, a total of 100 parts by mass of urethane acrylate resin consisting of 30 parts by mass of a polyfunctional urethane oligomer and 70 parts by mass of a bifunctional oligomer (the Martens hardness of the crosslinked curable resin layer after curing is 110 N/mm 2 (prescription)
・Antiviral agent (3 parts by mass per 100 parts by mass of resin)
The carboxylic acid derivatives include cyclohexanecarboxylic acid (manufactured by New Japan Chemical Co., Ltd.), triethylamine (manufactured by Tokyo Chemical Industry Co., Ltd.), N,N-dimethylallylamine (manufactured by Tokyo Chemical Industry Co., Ltd.), and 2,4-dimethylpyrrole (manufactured by Tokyo Chemical Industry Co., Ltd.). It was prepared by mixing and reacting raw materials containing N,N,2,2-tetramethyl-1,3-propanediamine (manufactured by Tokyo Chemical Industry Co., Ltd.) and N,N,2,2-tetramethyl-1,3-propanediamine (manufactured by Tokyo Chemical Industry Co., Ltd.).
 また、スチレンポリマー誘導体は、p-スチレンスルホン酸ナトリウム(東ソー株式会社製;商品名「スピノマーNaSS」)、スチレンモノマー(和光純薬社製)及び変性エタノール(和光純薬社製;商品名「86%エタノール-ME」)を含む原料を混合、反応させることに調製した。 In addition, styrene polymer derivatives include sodium p-styrene sulfonate (manufactured by Tosoh Corporation; trade name "Spinomer NaSS"), styrene monomer (manufactured by Wako Pure Chemical Industries, Ltd.), and denatured ethanol (manufactured by Wako Pure Chemical Industries, Ltd.; trade name "86"). % ethanol-ME") were mixed and reacted.
 抗ウイルス剤は、上記カルボン酸誘導体及び上記スチレンポリマー誘導体を順に3:1の質量比で混合した後、ジェットミル(日清エンジニアリング、商品名「SJ-100」)で粉砕することにより調製した。抗ウイルス剤を、JIS Z8825-1に準拠したレーザー回折式粒度分布測定装置(HORIBA社製)を用いて測定したところ、平均粒子径は10μmであった。
・抗菌剤(樹脂100質量部に対する含有量は0.5質量部)
 銀担持ゼオライト粒子(商品名「ゼオミック」、シナネンゼオミック社製、平均粒子径10μm)
・耐候剤
 トリアジン系紫外線吸収剤(UVA「LA-F70」、ADEKA社製)(樹脂100質量部に対する含有量は1質量部)
 光安定剤(ラジカル捕捉剤)(HALS「Tinuvin152」、BASF社製)(樹脂100質量部に対する含有量は0.3質量部)
The antiviral agent was prepared by sequentially mixing the above carboxylic acid derivative and the above styrene polymer derivative at a mass ratio of 3:1, and then pulverizing the mixture with a jet mill (Nissin Engineering, trade name "SJ-100"). When the antiviral agent was measured using a laser diffraction particle size distribution analyzer (manufactured by HORIBA) in accordance with JIS Z8825-1, the average particle diameter was 10 μm.
- Antibacterial agent (content is 0.5 parts by mass per 100 parts by mass of resin)
Silver-supported zeolite particles (trade name "Zeomic", manufactured by Sinanen Zeomic Co., Ltd., average particle size 10 μm)
・Weather resistant agent: triazine-based ultraviolet absorber (UVA "LA-F70", manufactured by ADEKA) (content: 1 part by mass per 100 parts by mass of resin)
Light stabilizer (radical scavenger) (HALS "Tinuvin 152", manufactured by BASF) (content is 0.3 parts by mass per 100 parts by mass of resin)
 実施例2
 架橋硬化性樹脂100質量部に対して光反応開始剤(商品名「イルガキュア184」、BASF製)9質量部を添加し、架橋硬化型樹脂層形成用組成物の塗工量を5μmとし、抗ウイルス剤の平均粒子径を4μmとし、抗菌剤の平均粒子径を2.5μmとし、紫外線照射装置を用いて波長300nmの紫外線を照射すること(硬化後の架橋硬化型樹脂層のマルテンス硬さが70N/mmとなる条件)、紫外線吸収剤をベンゾトリアゾール系(UVA「Tinuvin329」、BASF社製)(樹脂100質量部に対する含有量は5質量部)に変更し、更に光安定剤の含有量を樹脂100質量部に対して2質量部に変更して架橋硬化型樹脂層を形成した以外は、実施例1と同様にして化粧シートを作製した。なお、架橋硬化型樹脂層の断面観察における、抗ウイルス剤の中心点が中層又は上層(すなわち中層以上)に存在する割合は全体の65%であった。
Example 2
9 parts by mass of a photoreaction initiator (trade name "Irgacure 184", manufactured by BASF) was added to 100 parts by mass of the crosslinked curable resin, and the coating amount of the composition for forming a crosslinked curable resin layer was 5 μm. The average particle size of the virus agent is 4 μm, the average particle size of the antibacterial agent is 2.5 μm, and ultraviolet rays with a wavelength of 300 nm are irradiated using an ultraviolet irradiation device (the Martens hardness of the crosslinked resin layer after curing is 70 N/ mm2 ), the ultraviolet absorber was changed to a benzotriazole type (UVA "Tinuvin 329", manufactured by BASF) (content per 100 parts by mass of resin was 5 parts by mass), and the content of light stabilizer was A decorative sheet was produced in the same manner as in Example 1, except that 2 parts by mass was changed from 100 parts by mass of the resin to form a crosslinked curable resin layer. In addition, in the cross-sectional observation of the cross-linked curable resin layer, the proportion of the central point of the antiviral agent present in the middle layer or upper layer (ie, above the middle layer) was 65% of the total.
 比較例1
 抗ウイルス剤を、実施例1に記載のスチレンポリマー誘導体のみをジェットミルで粉砕することにより調製した以外は、実施例1と同様にして化粧シートを作製した。なお、架橋硬化型樹脂層の断面観察における、抗ウイルス剤の中心点が中層又は上層(すなわち中層以上)に存在する割合は全体の60%であった。
Comparative example 1
A decorative sheet was produced in the same manner as in Example 1, except that the antiviral agent was prepared by pulverizing only the styrene polymer derivative described in Example 1 using a jet mill. In addition, in the cross-sectional observation of the crosslinked curable resin layer, the proportion of the central point of the antiviral agent present in the middle layer or upper layer (that is, the middle layer or above) was 60% of the total.
 実施例3
 基材シートとして80μm厚の着色ポリエチレンシートを用意した。
Example 3
A colored polyethylene sheet with a thickness of 80 μm was prepared as a base sheet.
 基材シートの裏面に裏面プライマー層(厚さ2μm)を形成した。また、基材シートのおもて面に、2液型ウレタンインキ(商品名「V180」、東洋インキ社製)を用いて厚さ2μmとなるように絵柄模様層をグラビア印刷により形成した。 A back primer layer (thickness: 2 μm) was formed on the back side of the base sheet. Further, a pattern layer was formed on the front surface of the base sheet by gravure printing using a two-component urethane ink (trade name "V180", manufactured by Toyo Ink Co., Ltd.) to a thickness of 2 μm.
 絵柄模様層上に、下記の透明性樹脂層をドライラミネート用接着剤(商品名「タケラックA540」、三井化学社製;塗布量2g/m)を介してドライラミネート法にて貼り合わせた。更に、貼り合わせた透明性樹脂層のおもて面にエンボス模様を施した。 On the picture pattern layer, the following transparent resin layer was laminated by a dry laminating method using a dry laminating adhesive (trade name "Takelac A540", manufactured by Mitsui Chemicals, Co., Ltd.; coating amount: 2 g/m 2 ). Furthermore, an embossed pattern was applied to the front surface of the bonded transparent resin layer.
 透明性樹脂層は、高結晶性ホモポリプロピレン樹脂100質量部に対して、ヒンダードフェノール系酸化防止剤(商品名「イルガノックス1010」、BASF社製)を0.5質量部、トリアジン系紫外線吸収剤(商品名「CYASORBUV-1164」、SUNCHEM社製)を0.5質量部、NOR型光安定剤(商品名「TinuvinXT850FF」、BASF社製)を0.5質量部それぞれ配合した樹脂組成物を、押出機を用いて溶融押出しし、厚さ100μmの透明な高結晶性ホモポリプロピレンシートを製膜することにより得た。なお、透明性樹脂層の両面にはコロナ処理を施し、シート表面の濡れ張力を40dyn/cm以上とした。 The transparent resin layer contains 0.5 parts by mass of a hindered phenolic antioxidant (trade name "Irganox 1010", manufactured by BASF) and triazine-based ultraviolet absorber based on 100 parts by mass of highly crystalline homopolypropylene resin. A resin composition containing 0.5 parts by mass of an agent (trade name "CYASORBUV-1164", manufactured by SUNCEM) and 0.5 parts by mass of a NOR type light stabilizer (trade name "Tinuvin XT850FF", manufactured by BASF). It was obtained by melt-extruding using an extruder to form a transparent highly crystalline homopolypropylene sheet with a thickness of 100 μm. In addition, both surfaces of the transparent resin layer were subjected to corona treatment, and the wetting tension of the sheet surface was set to 40 dyn/cm or more.
 エンボス模様を施した透明性樹脂層に下記の架橋硬化型樹脂層形成用組成物を塗工し、塗膜を硬化させることにより化粧シートを得た。なお、架橋硬化型樹脂層の断面観察における、抗ウイルス剤の中心点が中層又は上層(すなわち中層以上)に存在する割合は全体の80%であった。
(架橋硬化型樹脂層形成用組成物)
 架橋硬化型樹脂層形成用組成物(熱により架橋硬化する熱硬化型)は、下記のポリマー溶液Aに、下記の硬化剤、光沢調整剤、紫外線吸収剤、光安定剤及び希釈溶剤を配合することにより調製した。
・ポリマー溶液A
 撹拌機、窒素導入管及び還流冷却管を備えた4つ口フラスコ内に、メチルメタクリレート80g、2-ヒドロキシエチルメタクリレートを20gを導入し、酢酸エチル100gを加えて溶解し、油浴上、窒素雰囲気下で撹拌した。次いで0.2gのα,α’-アゾビスイソブチロニトリルを配合することにより重合を開始し、60℃の油浴上で5時間加熱撹拌を続けて、無色、粘ちょうなポリマー溶液Aを得た。
 配合: 80質量部
・硬化剤
 商品名: デュラネート24A-100(旭化成社製)
 配合: 5質量部
・光沢調整剤(無機粒子)
 品名: サンスフェアH122(AGCエスアイテック社製)
 性状: 球状、平均粒子径12μm、細孔容積2ml/g
 配合: 10質量部
・紫外線吸収剤
 品名: TinuvinP、Tinuvin326、Tinuvin399(いずれもBASF社製)
 配合:各2.0質量部
・光安定剤
 品名: Tinuvin765(BASF社製)
 配合: 2.0質量部
・希釈溶剤
 品名: 酢酸エチル
 配合: 50質量部
A decorative sheet was obtained by applying the following composition for forming a crosslinked curable resin layer to a transparent resin layer provided with an embossed pattern and curing the coating film. In addition, in cross-sectional observation of the cross-linked curable resin layer, the proportion of the central point of the antiviral agent present in the middle layer or upper layer (ie, above the middle layer) was 80% of the total.
(Crosslinked curable resin layer forming composition)
The composition for forming a crosslinked curable resin layer (thermocurable type that crosslinks and cures with heat) is prepared by blending the following curing agent, gloss modifier, ultraviolet absorber, light stabilizer, and diluting solvent into the following polymer solution A. It was prepared by
・Polymer solution A
80 g of methyl methacrylate and 20 g of 2-hydroxyethyl methacrylate were introduced into a four-necked flask equipped with a stirrer, a nitrogen inlet tube, and a reflux condenser, and 100 g of ethyl acetate was added and dissolved, and placed on an oil bath in a nitrogen atmosphere. Stir at the bottom. Next, polymerization was started by blending 0.2 g of α,α'-azobisisobutyronitrile, and heating and stirring was continued for 5 hours on an oil bath at 60°C to form a colorless and viscous polymer solution A. Obtained.
Compound: 80 parts by mass/hardening agent Product name: Duranate 24A-100 (manufactured by Asahi Kasei Corporation)
Formulation: 5 parts by mass/gloss modifier (inorganic particles)
Product name: Sunsphere H122 (manufactured by AGC SI Tech)
Properties: Spherical, average particle size 12μm, pore volume 2ml/g
Formula: 10 parts by mass/UV absorber Product name: TinuvinP, Tinuvin326, Tinuvin399 (all manufactured by BASF)
Formulation: 2.0 parts by mass each, light stabilizer Product name: Tinuvin765 (manufactured by BASF)
Blend: 2.0 parts by mass/diluent Solvent Name: Ethyl acetate Blend: 50 parts by mass
 実施例4
 実施例3で使用した架橋硬化型樹脂層形成用組成物を下記の組成物に変更した以外は、実施例3と同様にして化粧シートを得た。なお、架橋硬化型樹脂層の断面観察における、抗ウイルス剤の中心点が中層又は上層(すなわち中層以上)に存在する割合は全体の58%であった。
[熱硬化・光硬化ハイブリッド硬化型組成物]
 熱硬化・光硬化ハイブリッド硬化型組成物は、下記のポリマー溶液A及びモノマーに、下記の硬化剤、光開始剤、光沢調整剤、紫外線吸収剤、光安定剤及び希釈溶剤を配合することにより調製した。
・ポリマー溶液A
 撹拌機、窒素導入管および還流冷却管を備えた4つ口フラスコ内に、メチルメタクリレート80g、2-ヒドロキシエチルメタクリレートを20g導入し、酢酸エチル100gを加えて溶解し、油浴上、窒素雰囲気下で撹拌した。次いで0.2gのα,α’-アゾビスイソブチロニトリルを配合することにより重合を開始し、60℃の油浴上で5時間加熱撹拌を続けて、無色、粘ちょうなポリマー溶液Aを得た。
 配合: 40質量部
・モノマー
 品名: ジペンタエリスリトールヘキサアクリレート
 配合: 40質量部
・硬化剤
 品名: デュラネート24A-100(旭化成社製)
 配合: 10質量部
・光開始剤
 品名: イルガキュア184(BASF社製)
 配合: 10質量部
・光沢調整剤(無機粒子)
 品名: サンスフェアH122(AGCエスアイテック(株)製)
 性状: 球状、平均粒子径12μm、細孔容積2ml/g
 配合: 10質量部
・紫外線吸収剤
 品名: Tinuvin400(BASF社製)
 配合: 5.0質量部
・光安定剤
 品名: Tinuvin123(BASF社製)
 配合: 2.0質量部
・希釈溶剤
 品名: 酢酸エチル
 配合: 50質量部
Example 4
A decorative sheet was obtained in the same manner as in Example 3, except that the composition for forming a crosslinked curable resin layer used in Example 3 was changed to the following composition. In addition, in the cross-sectional observation of the cross-linked curable resin layer, the proportion of the central point of the antiviral agent existing in the middle layer or upper layer (ie, the middle layer or above) was 58% of the total.
[Thermosetting/photocuring hybrid curable composition]
The thermosetting/photocuring hybrid curable composition is prepared by blending the following curing agent, photoinitiator, gloss modifier, ultraviolet absorber, light stabilizer, and diluting solvent with the following polymer solution A and monomer. did.
・Polymer solution A
80 g of methyl methacrylate and 20 g of 2-hydroxyethyl methacrylate were introduced into a four-necked flask equipped with a stirrer, a nitrogen inlet tube, and a reflux condenser, and 100 g of ethyl acetate was added and dissolved, and the mixture was placed on an oil bath under a nitrogen atmosphere. It was stirred with Next, polymerization was started by blending 0.2 g of α,α'-azobisisobutyronitrile, and heating and stirring was continued for 5 hours on an oil bath at 60°C to form a colorless and viscous polymer solution A. Obtained.
Blending: 40 parts by mass, monomer Product name: Dipentaerythritol hexaacrylate Blending: 40 parts by mass, curing agent Product name: Duranate 24A-100 (manufactured by Asahi Kasei Corporation)
Formula: 10 parts by mass/photoinitiator Product name: Irgacure 184 (manufactured by BASF)
Blend: 10 parts by mass/Gloss modifier (inorganic particles)
Product name: Sunsphere H122 (manufactured by AGC SI Tech Co., Ltd.)
Properties: Spherical, average particle size 12μm, pore volume 2ml/g
Formula: 10 parts by mass/UV absorber Product name: Tinuvin400 (manufactured by BASF)
Formula: 5.0 parts by mass/light stabilizer Product name: Tinuvin123 (manufactured by BASF)
Blend: 2.0 parts by mass/diluent Solvent Name: Ethyl acetate Blend: 50 parts by mass
 試験例1
 実施例及び比較例で作製した化粧シートについて、抗ウイルス剤の中心点が架橋硬化型樹脂層の中層又は上層(すなわち中層以上)に存在する割合、架橋硬化型樹脂層の表面の算術平均粗さRa、及び抗ウイルス性能の評価を行った。各測定方法及び評価方法は下記の通りである。
Test example 1
Regarding the decorative sheets produced in Examples and Comparative Examples, the proportion of the central point of the antiviral agent in the middle layer or upper layer (i.e., the middle layer or above) of the crosslinked curable resin layer, and the arithmetic mean roughness of the surface of the crosslinked curable resin layer. Ra and antiviral performance were evaluated. Each measurement method and evaluation method are as follows.
 <表面粗さ>
 JIS B0601(2001)で定義される算術平均粗さRaを表面粗さ測定器(品番「SURFCOM-FLEX-50A」、東京精密社製)を用いて下記条件により測定した。また、測定したRaによって、適した評価長さ及びカットオフ値に変更して改めて測定を行うこととした。
(測定条件)Ra=0.1μm超2μm以下の場合
測定回数:n=5(任意の5点)
算出規格:JIS′01
測定種別:粗さ測定
評価長さ:4.0mm
カットオフ値:0.8mm
測定速度:0.60mm/s
フィルタ種別:ガウシアン
形状除去:直線
(測定条件)Ra=2μm超10μm以下の場合
測定回数:n=5(任意の5点)
算出規格:JIS′01
測定種別:粗さ測定
評価長さ:12.5mm
カットオフ値:2.5mm
測定速度:0.60mm/s
フィルタ種別:ガウシアン
形状除去:直線
(測定条件)Ra=10μm超80μm以下の場合
測定回数:n=5(任意の5点)
算出規格:JIS′01
測定種別:粗さ測定
評価長さ:40mm
カットオフ値:8mm
測定速度:0.60mm/s
フィルタ種別:ガウシアン
形状除去:直線
<Surface roughness>
Arithmetic mean roughness Ra defined in JIS B0601 (2001) was measured using a surface roughness measuring device (product number "SURFCOM-FLEX-50A", manufactured by Tokyo Seimitsu Co., Ltd.) under the following conditions. In addition, depending on the measured Ra, we decided to change the evaluation length and cutoff value to a suitable value and perform the measurement again.
(Measurement conditions) When Ra = more than 0.1 μm and less than 2 μm Number of measurements: n = 5 (5 arbitrary points)
Calculation standard: JIS'01
Measurement type: Roughness measurement evaluation length: 4.0mm
Cutoff value: 0.8mm
Measurement speed: 0.60mm/s
Filter type: Gaussian shape removal: Straight line (measurement conditions) When Ra = more than 2 μm and less than 10 μm Number of measurements: n = 5 (5 arbitrary points)
Calculation standard: JIS'01
Measurement type: Roughness measurement evaluation length: 12.5mm
Cutoff value: 2.5mm
Measurement speed: 0.60mm/s
Filter type: Gaussian shape removal: Straight line (measurement conditions) When Ra = more than 10 μm and less than 80 μm Number of measurements: n = 5 (5 arbitrary points)
Calculation standard: JIS'01
Measurement type: Roughness measurement evaluation length: 40mm
Cutoff value: 8mm
Measurement speed: 0.60mm/s
Filter type: Gaussian shape removal: Straight line
 <断面観察>
 1)作製した化粧シートの断面を観察するために、任意に選択した領域を片刃トリミング用カミソリにより、化粧シートの厚さ方向に切断した。
2)切断した化粧シートの断面側からデジタルマイクロスコープで幅200μmを観察した(キーエンス社製、型番:VHX-7000、倍率:200倍)。
3)観察した断面写真全域において、存在する抗ウイルス剤の中心点の位置を確認し、架橋硬化型樹脂層の中層又は上層(すなわち中層以上)に中心点が存在する抗ウイルス剤の割合を下記式により算出した。
<Cross-sectional observation>
1) In order to observe the cross section of the produced decorative sheet, an arbitrarily selected area was cut in the thickness direction of the decorative sheet using a single-edged trimming razor.
2) A width of 200 μm was observed from the cross-sectional side of the cut decorative sheet using a digital microscope (manufactured by Keyence Corporation, model number: VHX-7000, magnification: 200x).
3) Confirm the position of the center point of the antiviral agent present in the entire area of the cross-sectional photograph observed, and calculate the proportion of the antiviral agent whose center point exists in the middle layer or upper layer (i.e., above the middle layer) of the crosslinked curing resin layer as shown below. Calculated using the formula.
 (中層又は上層(すなわち中層以上)に中心点が存在する抗ウイルス剤個数/観察した断面写真全域に存在する抗ウイルス剤個数)×100(%) (Number of antiviral agents whose center point is present in the middle layer or upper layer (i.e. above the middle layer)/Number of antiviral agents present in the entire area of the observed cross-sectional photograph) x 100 (%)
 <抗ウイルス性能>
 実施例及び比較例で作製した化粧シートについて、抗ウイルス試験方法(ISO21702)に準拠した方法で抗ウイルス性能試験を行い、ノンエンベロープウイルスとしてネコカリシウイルスに対する抗ウイルス活性値を下記評価基準に基づいて評価した。評価基準は下記の通りである。
ウイルス種:ノンエンベロープウイルス(ネコカリシウイルス)
 + :24時間後の抗ウイルス活性値が2.0以上、
 - :24時間後の抗ウイルス活性値が2.0未満
 結果を下記表1に示す。
<Antiviral performance>
The decorative sheets produced in Examples and Comparative Examples were subjected to an antiviral performance test in accordance with the antiviral testing method (ISO21702), and the antiviral activity value against feline calicivirus as a non-enveloped virus was determined based on the following evaluation criteria. evaluated. The evaluation criteria are as follows.
Virus species: Non-enveloped virus (feline calicivirus)
+: Antiviral activity value after 24 hours is 2.0 or more,
-: Antiviral activity value after 24 hours is less than 2.0 The results are shown in Table 1 below.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-I000002
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-I000002
 表1の結果から分かる通り、本発明の抗ウイルス剤を含有する実施例1~4の化粧シートは、表面保護層の表面性能を損なうことのない含有量においてノンエンベロープウイルスに対する抗ウイルス性能が得られていることが分かる。 As can be seen from the results in Table 1, the decorative sheets of Examples 1 to 4 containing the antiviral agent of the present invention have antiviral performance against non-enveloped viruses at a content that does not impair the surface performance of the surface protective layer. I can see that it is being done.
1.抗ウイルス性化粧シート
2.基材シート
3.絵柄模様層
4.透明性接着剤層
5.透明性樹脂層
6.プライマー層
7.架橋硬化型樹脂層(表面保護層)
8.裏面プライマー層
9.抗ウイルス剤
10.粘着シート
11.抗ウイルス性粘着加工シート
12.化粧板基材
13.抗ウイルス性化粧板
A.架橋硬化型樹脂層(表面保護層)の平滑部の厚さ
a.上層
b.中層
c.下層
1. Antiviral decorative sheet 2. Base sheet 3. Picture pattern layer 4. Transparent adhesive layer5. Transparent resin layer 6. Primer layer7. Cross-linked curing resin layer (surface protection layer)
8. Back primer layer9. Antiviral agent 10. Adhesive sheet 11. Antiviral adhesive processed sheet 12. Decorative board base material 13. Antiviral decorative board A. Thickness of the smooth part of the crosslinked curable resin layer (surface protection layer) a. Upper layer b. middle layer c. Underlayer

Claims (18)

  1.  最表層に架橋硬化型樹脂層を備える化粧シートであって、
    (1)前記架橋硬化型樹脂層は、架橋硬化型樹脂の硬化物及び抗ウイルス剤を含有し、
    (2)前記抗ウイルス剤は、ノンエンベロープウイルスに対して抗ウイルス性を有する抗ウイルス剤であって、カルボン酸誘導体及びスチレンポリマー誘導体を含有し、少なくとも前記カルボン酸誘導体の構成成分としてトリエチルアミン、N,N-ジメチルアリルアミン、ジメチルピロール、テトラメチル-1、3-プロパンジアミン、及びN,N,2,2-テトラメチル-1,3-プロパンジアミンを全て含有する、
    ことを特徴とする抗ウイルス性化粧シート。
    A decorative sheet comprising a crosslinked curable resin layer on the outermost layer,
    (1) The crosslinked curable resin layer contains a cured product of a crosslinked curable resin and an antiviral agent,
    (2) The antiviral agent is an antiviral agent having antiviral properties against non-enveloped viruses, and contains a carboxylic acid derivative and a styrene polymer derivative, and at least triethylamine, N , N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1,3-propanediamine,
    An antiviral cosmetic sheet characterized by:
  2.  前記抗ウイルス剤は、前記スチレンポリマー誘導体の構成成分としてトリエチルアミン、N,N-ジメチルアリルアミン、ジメチルピロール、テトラメチル-1、3-プロパンジアミン、及びN,N,2,2-テトラメチル-1,3-プロパンジアミンを全て含有する、請求項1に記載の抗ウイルス性化粧シート。 The antiviral agent contains triethylamine, N,N-dimethylallylamine, dimethylpyrrole, tetramethyl-1,3-propanediamine, and N,N,2,2-tetramethyl-1, as constituent components of the styrene polymer derivative. The antiviral decorative sheet according to claim 1, which contains all of 3-propanediamine.
  3.  前記架橋硬化型樹脂層は、最表面に算術平均粗さRaが0.1μm以上である微細凹凸を有する、請求項1又は2に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 1 or 2, wherein the crosslinked curable resin layer has fine irregularities on the outermost surface with an arithmetic mean roughness Ra of 0.1 μm or more.
  4.  前記微細凹凸の前記算術平均粗さRaが40μm以下である、請求項3に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 3, wherein the arithmetic mean roughness Ra of the fine irregularities is 40 μm or less.
  5.  前記架橋硬化型樹脂層は、更に銀含有無機粒子からなる抗菌剤を含有する、請求項1又は2に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 1 or 2, wherein the crosslinked curable resin layer further contains an antibacterial agent made of silver-containing inorganic particles.
  6.  前記架橋硬化型樹脂層は、更にトリアジン系紫外線吸収剤及び/又は光安定剤を含有する、請求項1又は2に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 1 or 2, wherein the crosslinked curable resin layer further contains a triazine-based ultraviolet absorber and/or a light stabilizer.
  7.  前記抗ウイルス剤は、前記カルボン酸誘導体及び前記スチレンポリマー誘導体を、順に質量比で1:1~10:1の割合で含有する、請求項1又は2に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 1 or 2, wherein the antiviral agent contains the carboxylic acid derivative and the styrene polymer derivative in a mass ratio of 1:1 to 10:1.
  8.  前記架橋硬化型樹脂層の平滑部の厚さを三等分して下層、中層及び上層と区分した際に前記抗ウイルス剤の全体のうち50%以上の前記抗ウイルス剤の中心点が前記中層又は前記上層に存在する、請求項1又は2に記載の抗ウイルス性化粧シート。 When the thickness of the smooth part of the cross-linked curable resin layer is divided into thirds and divided into a lower layer, a middle layer, and an upper layer, the central point of the antiviral agent that accounts for 50% or more of the entire antiviral agent is the middle layer. or the antiviral decorative sheet according to claim 1 or 2, which is present in the upper layer.
  9.  前記架橋硬化型樹脂100質量部に対して前記抗ウイルス剤を1質量部以上10質量部以下含有する、請求項1又は2に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 1 or 2, wherein the antiviral agent is contained in a range of 1 part by mass to 10 parts by mass based on 100 parts by mass of the crosslinked curable resin.
  10.  前記架橋硬化型樹脂層の平滑部の平均厚さが2μm以上35μm以下である、請求項1又は2に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 1 or 2, wherein the average thickness of the smooth portion of the crosslinked curable resin layer is 2 μm or more and 35 μm or less.
  11.  前記抗ウイルス剤の平均粒子径が2μm以上15μm以下である、請求項1又は2に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 1 or 2, wherein the antiviral agent has an average particle diameter of 2 μm or more and 15 μm or less.
  12.  前記架橋硬化型樹脂は、電離放射線硬化型樹脂を含有する、請求項1又は2に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 1 or 2, wherein the crosslinked curable resin contains an ionizing radiation curable resin.
  13.  前記架橋硬化型樹脂層のマルテンス硬さが30N/mm以上180N/mm以下である、請求項1又は2に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 1 or 2, wherein the crosslinked curable resin layer has a Martens hardness of 30 N/mm 2 or more and 180 N/mm 2 or less.
  14.  厚さ方向において順に、基材シートと、絵柄模様層と、透明性熱可塑性樹脂層と、前記架橋硬化型樹脂層とを少なくとも備える積層体から構成される、請求項1又は2に記載の抗ウイルス性化粧シート。 The resistor according to claim 1 or 2, comprising a laminate comprising at least a base sheet, a picture pattern layer, a transparent thermoplastic resin layer, and the crosslinked curable resin layer in this order in the thickness direction. Viral makeup sheet.
  15.  前記基材シート及び/又は前記透明性熱可塑性樹脂層のマルテンス硬さが30N/mm以上80N/mm以下である、請求項14に記載の抗ウイルス性化粧シート。 The antiviral decorative sheet according to claim 14, wherein the base sheet and/or the transparent thermoplastic resin layer has a Martens hardness of 30 N/mm 2 or more and 80 N/mm 2 or less.
  16.  厚さ方向において順に、粘着シートと、請求項1又は2に記載の抗ウイルス性化粧シートとを少なくとも備える積層体から構成される抗ウイルス性粘着加工シート。 An antiviral adhesive processed sheet comprising a laminate comprising at least an adhesive sheet and the antiviral decorative sheet according to claim 1 or 2 in this order in the thickness direction.
  17.  厚さ方向において順に、化粧板基材と、請求項1又は2に記載の抗ウイルス性化粧シートとを少なくとも備える積層体から構成される抗ウイルス性化粧板。 An antiviral decorative board comprising a laminate comprising at least a decorative board base material and the antiviral decorative sheet according to claim 1 or 2 in order in the thickness direction.
  18.  厚さ方向において順に、化粧板基材と、請求項16に記載の抗ウイルス性粘着加工シートとを少なくとも備える積層体から構成される抗ウイルス性化粧板。 An antiviral decorative laminate comprising a laminate comprising at least a decorative laminate base material and the antiviral pressure-sensitive adhesive sheet according to claim 16 in this order in the thickness direction.
PCT/JP2023/024007 2022-06-30 2023-06-28 Anti-viral decorative sheet, and anti-viral adhesive processed sheet and anti-viral decorative board each using same WO2024005082A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022-106366 2022-06-30
JP2022106366 2022-06-30

Publications (1)

Publication Number Publication Date
WO2024005082A1 true WO2024005082A1 (en) 2024-01-04

Family

ID=89382464

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2023/024007 WO2024005082A1 (en) 2022-06-30 2023-06-28 Anti-viral decorative sheet, and anti-viral adhesive processed sheet and anti-viral decorative board each using same

Country Status (1)

Country Link
WO (1) WO2024005082A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019045110A1 (en) * 2017-09-04 2019-03-07 株式会社Nbcメッシュテック Antibacterial/antiviral composition
JP2022041101A (en) * 2020-08-31 2022-03-11 凸版印刷株式会社 Decorative sheet and decorative material
JP2022093256A (en) * 2020-12-11 2022-06-23 東亞合成株式会社 Active energy ray-curable antiviral composition
JP2023050182A (en) * 2021-09-29 2023-04-10 大日本印刷株式会社 Antiviral decorative sheet and antiviral decorative plate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019045110A1 (en) * 2017-09-04 2019-03-07 株式会社Nbcメッシュテック Antibacterial/antiviral composition
JP2022041101A (en) * 2020-08-31 2022-03-11 凸版印刷株式会社 Decorative sheet and decorative material
JP2022093256A (en) * 2020-12-11 2022-06-23 東亞合成株式会社 Active energy ray-curable antiviral composition
JP2023050182A (en) * 2021-09-29 2023-04-10 大日本印刷株式会社 Antiviral decorative sheet and antiviral decorative plate

Similar Documents

Publication Publication Date Title
WO2018062340A1 (en) Decorative sheet and decorative plate
WO2019124510A1 (en) Cosmetic sheet and cosmetic plate
WO2016088897A1 (en) Decorative material using cork sheet
JP7243729B2 (en) Decorative sheet and board
JP6307792B2 (en) Decorative sheet and method for producing the same
JP2023050182A (en) Antiviral decorative sheet and antiviral decorative plate
WO2024005082A1 (en) Anti-viral decorative sheet, and anti-viral adhesive processed sheet and anti-viral decorative board each using same
JP7459581B2 (en) Decorative sheet and decorative board using same
WO2021230386A2 (en) Antiviral hard-coat film, antiviral adhesive-treated sheet using same, and antiviral veneer
JP2023146729A (en) Antiviral decorative sheet for anti-slip floor, and antiviral adhesive-processed sheet for anti-slip floor and antiviral decorative plate for anti-slip floor using the same
JP2023147192A (en) Antiviral decorative sheet, antivirus adhesion processing sheet using the same and antivirus decorative plate
TW202411071A (en) Antiviral cosmetic sheets, antiviral adhesive processed sheets using the same, and antiviral cosmetic sheets
EP4119342A1 (en) Decorative sheet, and decorative plate
EP4316810A1 (en) Decorative sheet and decorative panel
JP7103117B2 (en) A transparent resin layer for a decorative sheet and a method for manufacturing the same, and a decorative sheet and a decorative board provided with the transparent resin layer.
JP5353162B2 (en) Floor decorative sheet having a protective film
JP2021142750A (en) Decorative sheet and decorative plate
JP2023050188A (en) Antiviral decorative sheet and antiviral decorative plate using the same
JP2023050187A (en) Antiviral decorative sheet and antiviral decorative plate using the same
JP2023050186A (en) Antiviral decorative sheet and antiviral decorative plate using the same
JP2023152698A (en) Decorative sheet and decorative material
JP2021142749A (en) Decorative sheet and decorative plate
JP2023152697A (en) Antiviral decorative sheet and antiviral decorative laminate
JP2023046319A (en) Film and decorative sheet
JP6983488B2 (en) Cosmetic material using cork sheet

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23831522

Country of ref document: EP

Kind code of ref document: A1